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A women who has experienced 3 or more consecutive abortions 
without ever maintaining a pregnancy to term, can be defined as a 
recurrent aborter, if there has been no therapeutic intervention 
of the pregnancies. A full clinical history may reveal the cause 
of an abortion and if corrected, allow subsequent pregnancies to 
proceed to term. The causes of recurrent abortion have not been 
fully identified however, and it is this group of patients, with 
abortions of unknown aetiology, that have been selected for 
investigation,
Recurrent abortion represents approximately 1% of all 
pregnancies, consequently the number of patients to be examined 
is small. The study is justified when the reasons proposed for 
recurrent abortion of unknown aetiology are considered:
Unlike organ transplants, a normally progressing pregnancy 
does not experience the problems associated with immunological 
rejection although paternal antigens foreign to the mother are 
present. In recurrent abortions therefore, one may be examining 
a defective immunological mechanism associated with pregnancy.
Any conclusions reached, could have implications beyond those of 
pregnancy.
A review of biochemical investigation reveals the importance 
of steroid hormones during gestation. Adequate levels of 
progesterone at critical periods in early pregnancy may directly 
dictate the success or failure of a pregnancy to reach term. The 
function of cytochromes in steroid biosynthesis and the existence 
of cytochrome P-448 in the placenta is of particular interest as 
this cytochrome predominates also in cancer cells. The 
localisation, function and period in which it can be detected in 
the placenta may collectively provide information regarding the 
cellular function of cancer cells.
The physiological function of several cell types (decidua, 
placental bed giant cells, endometrial granulocytes) is at 
present largely unknown and, morphological investigation has 
limitations in resolving this area of research without the 
support of biochemical and immunological techniques.
This thesis is concerned therefore, in exploring some of these 
avenues of investigation within the resources available.
v
CHAPTER-! 
im Q P H C U Q B .
Recurrent or habitual abortion can be defined as the spontaneous loss of 
three or more consecutive abortions. In practical terms, this definition is 
abused and many studies have included pregnant patients with two 
consecutive abortions, or abortions that are not even consecutive.
Recurrent abortions represent about 1% of all pregnancies [see Table lal 
(Malpas 1938, see Jeffcoate 1975). However, the cause of pregnancy failure 
in this select group has yet to be determined.
There has been a very diverse, though perhaps not unpredictable, range 
of investigations performed on recurrent aborters since its general 
acceptance as a clinical condition. Some of these have been 'all 
encompassing' , considering the problem as a whole, whilst others have been 
aimed at a select group from within what is already a select group.
Infective agents: herpes, human papilloma virus, toxoplasma, chlamydia, 
listeria, mycopiasma, brucella, and syphilis have all been incriminated but 
evidence is really lacking for all of these micro-organisms, and others too 
(Stirrat 1983). Doubtless they have probably all been the causal agents of 
spontaneous abortions. Stress, smoking, drinking alcohol, coffee, or tea in 
excess, may all contribute positively towards an unsuccessful pregnancy 
(Kullander and Kallen 1971, Hopkins 1979, Maeye 1981) Much too, has been 
made of 'progesterone insufficiency' at conception and later in pregnancy 
(Abraham et al. 1974, Shearman and Garrett 1963) [see Table lb]. Certain 
disease states (systemic lupus erythematosus) have been responsible for 
recurrent abortions, and patients have long been counselled about becoming 
pregnant whilst the disease is active (Mund et al. 1963). Perhaps less
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obvious is the sub-clinical lupus antigen which may not be associated with 
the disease, but can nevertheless interfere with pregnancy outcome. This 
leads us to the major topic of current investigation, immunology.
There has been impetus in the last ten years or so, generated from the 
identification of a maternal blocking antibody, present in the sera of 
multiparous women but absent in recurrent aborters (Rocklin et al. 1976, 
Stimson et al. 1979, and Fizet and Bousquet 1983). Interest too, has been 
shown in the sharing between couples of major histocompatibility antigens, 
in particular class II, HLA-DR antigens. The lack of antigenic disparity 
between these partners may contribute in some way to abortion, although as 
with most areas studied, there is evidence to the contrary.
An understanding of the immunological mechanisms of pregnancy has 
contributed, and will contribute further as more information evolves, to the 
understanding of recurrent abortion in recent years. Other, important 
issues warrant evaluation, however, if only to put what is in vogue, into 
perspective.
The remainder of this introduction considers some of these alternatives and 
their contribution to identifying the cause of recurrent abortion.
2. PLACEFTAL DEVELOPMENT
This section of the introduction has been designed to illustrate and to 
put into perspective many of the anatomical and histological terms used
2
TABliB.-l ia )„^ Ihfi-iDclAenffe„of abortion ..in, clinic.&ny.. jggQgnfsed^regnancyi-
Spontaneous abortion occurs in approximately 15% of clinically diagnosed 
pregnancies, and about 6% of these, or 1% of all pregnancies, are recognised 
as recurrent or habitual abortions. The probability of a women 
experiencing 3 consecutive abortions is however, between 0,3-0,4% (Coulam 
1986) which does not suggest that recurrent pregnancy loss is a random 
event.
TABLE l<b) The causal factors incriminated in recurrent abortion.
The current thrust of investigation in the field of immunology has done 
much to reduce the number of unexplained recurrent pregnancy losses. The 
importance of this is illustrated in the most recent study published 
(Coulam 1986) when compared with other similar studies, and with other 
attributable causes of recurrent spontaneous abortion.
A: Tho et al, 1979
B: Harger 1983
C: Stray-Pedersen, Stray Pedersen 1984
D: Coulam 1986
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throughout the thesis. It is confined predominantly to placental structure 
in relation to the uterus, but includes also, specific cells and tissues of 
the placenta, and its development throughout the first trimester.
Fertilization of the ovum occurs in the ampullary segment of the 
fallopian tube usually within 24 hours of ovulation. Over a period of about 
6 days the fertilised ovum goes through a zygote, morula and blastocyst 
stage before being implanted in the endometrial wall of the uterus. 
Implantation then occurs approximately 7 days post ovulation, a period in 
which the endometrial glands are at the height of their secretion. The 
connective tissue stroma is oedematous, the stromal fibres loosely 
dispersed in a ground substance that is thin and watery. The maternal 
spiral arterioles that lie within the pre-decidua, hypertrophy and 
proliferate to just beneath the surface epithelium in the upper compacta 
(Figure 1).
At implantation, the spiral arteries in closest apposition to the 
embedding blastocyst undergo intense hypertrophy. The stromal capillaries 
become dilated and there is local dissolution of reticulin fibres. 
Endometrial granulocytes become more numerous and congregate around the 
embedding blastocyst. Contact is established between the embedded 
blastocyst and maternal blood vessels.
The primitive trophoblast encompassing the blastocyst begins secreting 
human chorionic gonadotrophin immediately after implantation and possibly 
before. The corpus luteum of the ovary responds by remaining active.
Increased progesterone levels, evidence that the corpus luteum has not 
involuted, re-establishes a secretory endometrium and hence, glycogen 
synthesis. The glands remain active for 8 weeks before finally regressing.
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-The stroma demonstrates an abundance of thin-walled vessels, and a true 
decidual reaction develops. The decidua associated with pregnancy is an 
enhanced version of the pre-decidua associated with late secretory phase 
endometrium and becomes manifest some 48 hours after implantation.
There is an increase in cell size, nuclear staining becomes paler, and 
nucleoli more prominent. The cytoplasm becomes richer in RNA, and there is 
secretion of glycogen and enzymes such as carbonic anhydrase and 3-j3 
steroid dehydrogenase, the latter an indication of steroid biosynthesis. 
Finally, after implantation, reticulin fibres again become dense, ground 
substance more viscous and there is further proliferation and dilation of 
local blood vessels.
The cytotrophoblast begins as a germ cell layer one cell thick. It forms 
a continuous sheet of cells that run beneath the syncytiotrophoblast which 
it forms (Figure 2). The cytotrophoblast is ultimately responsible for the 
formation not only of the syncytiotrophoblast, but also the cell columns, 
cytotrophoblastic shell, placental bed giant cells and syncytial knots.
The S'1-1"’ day of gestation, sees trophoblast making intimate contact with 
maternal blood. There is intense growth of the primitive trophoblast 
during the next 16 days resulting in the formation of primary, secondary 
and finally tertiary chorionic villi. The chorionic villi and trabeculae 
that form around the blastocyst regress to leave a smooth chorion laeve 
(Figure 3). The villi associated with the decidua basalis form the chorion 
frondosum, which eventually becomes the definitive placenta.
Whilst proliferating cytotrophoblast opens up and invades maternal 
spiral arteries after approximately 12 days of gestation, this is not fully 
established until much later (day 30). Endovascular cytotrophoblast 
invades and replaces the inner endothelial lining of these blood vessels
5
and, with other structural alterations, deposition of fibrin occurs. The 
damage to the arteries and their subsequent plugging by cytotrophoblast is 
likely to be responsible for the ischaemia and decidual necrosis that is 
evident in normal pregnancy.
In the first 8 weeks of gestation the spiral arteries run almost 
perpendicular to the developing intervillous spaces. As the placenta 
enlarges however, those arteries towards the periphery of the placenta 
became more obliquely disposed and by 10 weeks they terminate parallel to 
the basal plate.
Anchoring villi fasten the placenta to the endometrium. Unlike chorionic 
villi, which branch from these anchoring villi, there is neither a 
mesodermal core nor fetal blood vessels, Any minor trauma of the placenta 
can be accommodated therefore, as the anchoring villi are avascular and 
bleeding is unlikely to occur. As the anchoring villi become established, 
deposits of fibrinous material accumulate between the decidua and villi, at 
the basal plate. These are known as Rohr's and Ritabuch's striae. Similar 
layers of fibrin, the Langhans layer, exist at the interface of the 
chorionic plate. Fibrin develops also in the septa, the cytotrophoblastic 
shell, and in association with syncytial knots.
By about 10 weeks gestation, interstitial trophoblast, as distinct from 
endovascular trophoblast, has reached the myometrium. This presents 
initially as a mononuclear cell, invasion. Subsequently these cells form 
small groups that coalesce to form syncytiotrophoblast placental bed giant 
cells.
By this time, endovascular cytotrophoblast has extended along the artery 
walls as deeply as the endometrial/myometrial junction. At 10 weeks 
villous sprouts (syncytial knots) may break off to lie free in the
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intervillous spaces. It has long been known that these are able to enter 
the maternal vasculature and have been identified in sites such as the lung.
By 16 weeks, a second wave of endovascular cytotrophoblast penetrates 
the arteries as far as the radial artery terminations (Figure 4). Unlike 
the vascular invasion described so far, this second invasion is intramural. 
The main arteries, arcuates and radials undergo hypertrophy and hyperplasia 
that can withstand the 10-fold increase in blood volume that is experienced 
in pregnancy.
By the end of the first trimester the structure of the placenta is 
virtually complete. It becomes clearly demarcated on the maternal aspect 
by septae (seen as depressions or grooves), that sub-divide the placenta 
into cotyledons (Figure 5). In contrast, the fetal surface is smooth and 
lined by amnion. The function of some of the cell types mentioned remains 
obscure, the placental bed giant cells are an example. This short account 
does however, 'set the scene' for the chapters that follow and should be 
used for referral.
3.. STEFQIP■BIOSYNTHESIS
This section considers the synthesis of progesterone and oestrogens in 
pregnancy. These are produced in abundance and at term for instance, the 
fetus, placenta and mother together account for a daily output of 15-20mg 
oestradiol, 50-100mg oestriol and 250-600mg progesterone (Wilson and 
Foster 1985). Whilst it is now apparent that the corpus luteum of the 
ovary continues to function throughout pregnancy (Weiss et al 1977), 
steroid synthesis is quickly established by the placental trophoblast;
7
Figure 1 Endometrial, gland in. section
This diagram illustrates the 3 morphologically indistinct layers of the 
endometrium. The stratum compactum and stratum spongiosa are lost at 
menstruation, but regenerate during the new menstrual cycle.
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figure, The ..uterus._at. implantation.
Cross sections of the uterus at A-A illustrate the areas of decidua in 
relation to the developing placenta. The decidua distal to the uterine 
cavity is referred to as the decidua basalis, whilst that separating the 
developing blastocyst from the lumen is the decidua capsularis. The 
remaining decidua is all decidua parietalis,
Chorionic villi which are present around the periphery of the implanted 
blastocyst, soon confine their growth to the invasion of the decidua 
basalis. The luminal surface of the blastocyst becomes smooth (chorion 
laeve) as the trophoblast degenerates, The remaining villi (chorion 
frondosum) develop further to form the placenta.
9
UTERINE CAVITY
UTERINE CERVIX
SECTIONS AT A A
MYOMETRIUM
DECIDUA BASALIS
DECIDUA CAPSULARIS
DECIDUA PARIETALIS
CHORIONIC VILLI 
IMPLANTED BLASTOCYST
UTERINE CAVITY
DECIDUA BASALIS
CHORION FRONDOSUM
•CHORION LAEVE
Figure 3 Early placental development
The formation of the placenta following implantation. The far left of 
the diagram represents a single layer of trophoblast cells in contact with 
the decidual endometrium. Development of the placenta proceeds from left 
to right of the illustration. The days referred to are approximate days of 
gestation, and A-D are representative cross sections of placental villous 
growth.
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Figure 4 Vascular supply to the placenta
The spiral arteries are stretched throughout most of the endometrium. 
Their funnel-shaped ends 'spurt' maternal blood into the intervillous space. 
Other spiral arteries are invaded by endovascular cytotrophoblast, which in 
a mature placenta, penetrates as deeply as the radial artery termini.
11
PLACENTA <
ENDOMETRIUM s  
(DECIDUA)
MYOMETRIUM •<
Eigure 5(a) Placenta showing septae
Term placenta viewed from the maternal side, i.e. the surface seen is 
that normally in contact with the decidua. The cotyledons are clearly 
shown, demarcated by septae.
Eigure 5(b) Mature placenta in section
The relationship between the main anchoring villi, chorionic villi and 
intervillous spaces is shown in this cross-section of term placenta.
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Figure 6 Term placenta in section
Cross section of human term placenta. Discoid in appearance, it 
measures about 20 cm across and weighs approximately 500-600 grams. Many 
of the features seen in the earlier figures are seen here in relation to 
each other.
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oestrogens are being synthesised within 3-4 weeks of gestation (Wilson and 
Foster 1985).
3.1 Progesterone synthesis
For the placenta to synthesise progesterone a source of cholesterol is 
required. Whilst it has been established that the placenta has the enzymes 
necessary to manufacture its own cholesterol, it appears to utilise 
cholesterol derived from maternal low density lipoproteins (Simpson et al 
1978Cb3). The fetus may also contribute to progesterone synthesis, donating 
cholesterol derived from acetate, although in vitro this is suppressed 
(Mathur et al 1970, Telegdy et al 1970).
Maternally-derived cholesterol In 1974, Goldstein and Brown 
demonstrated that low density lipoproteins are bound to receptor sites at 
the cell surface membrane. These cross the cell membrane by endocytosis 
and fuse with lysosomes in the cytoplasm. Lysosomal enzymes then act on 
the cholesterol esters which are hydrolysed to fatty acids and cholesterol. 
Simpson et al 1978(b) and Simpson et al 1979(b) produced similar evidence 
and concluded that low density lipoprotein regulates progesterone synthesis.
Evidence that trophoblast could take up and hydrolyse low density 
lipoproteins was subsequently described by Winkel and Simpson in 1979, but 
the degradation of low density lipoprotein by lysosomal enzymes was not 
proven until 1981 (Simpson and. MacDonald). Trophoblast preferentially uses 
pre-farmed cholesterol although may synthesise its own from acetate. The 
synthesis of cholesterol from acetate is a rate-limiting reaction controlled 
by the enzyme HMG CoA reductase (3-hydroxy-3-methyl glutaryl Co-enzyme A 
reductase). Available cholesterol controls by inhibition, the activity of 
this enzyme (Simpson et al 1979Cb3) and accordingly, the amount of
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cholesterol synthesised in this way. Cholesterol synthesised from acetate 
is suppressed in vitro in favour of cholesterol derived from low density 
lipoproteins (Simpson et al 1979tb], Vinkel et al 1980), and in fact it is 
likely that progesterone synthesis is governed by the number of low density 
lipoprotein receptors on trophoblast cell membrane (Everett and MacDonald 
1979, Goebelsmann 1979).
Other possible sources of cholesterol (see Figure 7) Whilst cholesterol for 
the most, is derived from a source of low density lipoprotein, it was been 
shown that this is not the only source that can be used in the production 
of progesterone. The fetus can produce cholesterol from acetate via a 
number of intermediate reactions before its secretion into the umbilical 
circulation, and there some is evidence that the placenta may use this for 
the synthesis of progesterone (Mathur et al. 1970, and Telegdy et al. 1970). 
The placenta itself also has the enzymes necessary for the synthesis of its 
own cholesterol (Villee 1969). Small amounts of HMG Co-A reductase 
activity detected in placental extracts indicate that some conversion of 
acetate to cholesterol in this tissue takes place. It could though, only 
account for a very small proportion of the progesterone synthesised 
(Simpson et al. 1978(b), Simpson et al. 1979, Winkel et al. 1980).
Cholesterol side-chain cleavage and progesterone synthesis, Steroid 
synthesis invariably begins with the formation of pregnenolone from 
cholesterol, a reaction that takes place within the cell inner mitochondrial 
membrane (Yago et al 1970), It is achieved via the formation of 20a,22e- 
dihydroxycholesterol and the subsequent cleavage of the Cz7 cholesterol 
side chain. Cholesterol side chain cleavage is common to the synthesis of 
all steroids. In the adrenal for instance, adrenocorticotrophic hormone
15
Figure 7 Sources of cholesterol for progesterone synthesis
Progesterone synthesis is dependent upon a source of cholesterol, and 
the placenta obtains this from low density lipoproteins. Cholesterol can 
also be synthesised in small amounts from acetate by the placenta and the 
fetus, although these pathways are suppressed in favour of a maternal 
source of cholesterol.
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acts on cell membrane receptors inducing a cytochrome P-450 monooxygenase
enzyme system that results in the formation of pregnenolone (Simpson 1979). 
Vhilst there is evidence that cholesterol side-chain cleavage occurs in 
placenta syncytiotrophoblast cells at the inner mitochondrial membrane 
(Meigs and Ryan 1968, Mason and Boyd 1971, Simpson and Miller, 1978, 
Simpson and MacDonald 1981) a trophic hormone as described for the adrenal 
above, has not been identified (Simpson and MacDonald 1981).
Cytochrome P-450 is involved in a series of hydroxylation reactions 
utilising NADPH, that result in molecular oxygen being incorporated into the 
steroid. The cytochrome P-450 associated with cholesterol side chain 
cleavage has been designated cytochrome P-450«Cc (Jeffcoate et al. 1970, 
Vilson and Harding 1970). The demonstration of its existence in a high 
spin ferric form is indicative of the binding of its substrate cholesterol. 
The transfer of electrons from UADPH to cytochrome P-450 is achieved by an 
iron-sulphur protein common to steroid synthesising tissues (Simpson and 
Miller 1978).
The conversion of pregnenolone to progesterone, like the conversion of 
dehydroepiandrosterone to androstenedione and testosterone requires two 
enzymes, namely, 3£-hydroxysteroid dehydrogenase and 3£-0L-hydroxy A*-s 
isomerase. Both of these reactions are acknowledged to be rate-limiting, 
their inhibition probably controlled by a feed-back mechanism.
Progesterone, 20a-dihydroprogesterone, 2 0J3-dihydroprogesterone, oestradiol 
and androstenedione all have the ability to prevent progesterone being 
synthesised from pregnenolone (Veiner and Allen, 1968, Ferr6 et al. 1975). 
Vith the exception of androstenedione, none of these steroids have any 
affect on the synthesis of androstenedione and testosterone from 
dehydroepiandrosterone, and as suggested by Ferrd et al. (1975) there may
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in fact be two closely related enzyme systems in operation, specific for 
the appropriate reactions. Initially the two enzymes were thought to be 
associated not with the mitochondrial membranes, but with the smooth 
endoplasmic reticulum, any mitochondrial activity was regarded as being due 
to contamination (Koide and Torres 1965). The enzymes have since been 
located within placenta syncytiotrophoblast mitochondria (Cowan et al. 1972, 
Sulimovici et al. 1973), in keeping with the site of these enzyme activities 
in other tissues.
The placenta lacks hydroxylases <17-hydroxylase, 17, 20-desmolase) and 
consequently, there is no conversion of Cz^ to Ci«? steroids. Any 
metabolism of progesterone formed within the placenta, therefore, has to 
take place outside it (Wilson and Foster 1985). Progesterone enters the 
circulation conjugated to albumin and corticosteroid binding globulin 
(Goebelsmann 1979).
ZL2 Hie -gyn thesis ..of .jpestrogens
As stated previously, the placenta is not capable of converting C2i 
steroids to Cl?? steroids. Oestrogens then, are synthesised from Ci s 
androgens (Diczfalusy 1975), the main precursor for which, is dehydroepi­
androsterone or DHEA, a product of pregnenolone. Pregnenolone is available 
from two sources: the placenta, where it is used to synthesise progesterone, 
and the fetal adrenal cortex. Fetal pregnenolone is derived from 
cholesterol synthesised independently to the placenta. The fetal adrenal 
cortex conjugates both sources with sulphate to form pregnenolone sulphate. 
Hydroxylation (17cc-hydroxylation) of pregnenolone sulphate results in the 
formation of 17a-hydroxy pregnenolone sulphate, and is followed by side 
chain cleavage to form dehydroepiandrosterone sulphate (Jaffe et al 1972).
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Figure 6 The synthesis of progesterone from cholesterol.
Progesterone synthesis begins with the formation of 20oc,22€-dihydroxy- 
cholesterol from cholesterol. In a cytochrome P-450 mediated reaction, the 
cholesterol side chain is lost and pregnenolone is formed. The conversion 
of pregnenolone to progesterone, like that of dehydroepiandrosterone to 
androstendione and testosterone, requires 3£-hydroxysteroid dehydrogenase 
and 3^-OL-hydroxy A^-s isomerase.
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Further synthesis of androgens takes place in the placenta. DHEA- 
sulphate bound to albumin, is taken up from the umbilical circulation and, 
by simple diffusion, crosses the trophoblast cell membrane (MacDonald and 
Siiteri 1965). The sulphate group is hydrolysed from DHEA-sulphate by 
placental steroid-3-sulphatase. The following reaction, that of forming 
androstenedione and testosterone from dehydroepiandrosterone was considered 
previously, with respect to progesterone synthesis. The conversion requires 
3£-hydroxysteroid dehydrogenase and 3£-0L-hydroxy A4-© isomerase 
(Diczfalusy 1975). The subsequent formation of oestrone and oestradiol 
from the products of DHEA requires placental aromatase (Beigheim et al.
1973, Bolt6 et al. 1964).
3.3 Aromatase activity in the placenta
Aromatase is abundant in the placenta and essential for the conversion 
of androgens to oestrogens. The enzyme complex, which requires a source of 
EADPH and oxygen, was located in the microsomal fraction of placenta 
trophoblast cells, by Ryan in 1959. More recently it has been identified in 
mitochondria (Aleen et al 1970, Renwick and Oliver 1973) in association 
with the mitochondrial outer membrane (Canick and Ryan 1978). Ryan (1959) 
also reported the involvement of an enzyme system which is now known as 
the cytochrome P-450 mixed function oxidases. Substrates for placental 
aromatase are also the substrates for placental microsomal cytochrome P- 
450 (Thompson and Siiteri 1974), and cytochrome P-450 activity has been 
demonstrated at the same active-sites at which aromatisation occurs. 
Purification of the aromatase enzyme complex has revealed two components, 
both essential for activity: one component containing cytochrome P-450, the 
other MADPH-cytochrome c reductase (Thompson and Siiteri 1976).
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The synthesis of oestrone and oestradiol from androgens androstenedione 
and testosterone, requires three hydroxylations (Goto and Fishman 1977).
The first two occur at the C ie methyl group, and convert the androgen to an 
aldehyde. The final hydroxylation occurs at the 1# position following 
which, the product rearranges non-enzymically to its respective oestrogen 
(Simpson and MacDonald 1981).
Oestriol is not synthesised by the placenta as it lacks the enzyme 16a- 
hydroxylase. Oestriol production is dependent then, upon an initial 
hydroxylation step that takes place in the fetal liver. The fetal liver 
hydroxylates dehydroepiandrosterone sulphate, itself derived from the fetal 
adrenal, to 16a-hydroxy dehydroepiandrosterone sulphate. Further synthesis 
of this steroid is carried out in the placenta, namely the removal of the 
sulphate moiety to give 16a-hydroxy DHEA., its conversion to 16a-hydroxy 
androstenedione and 16a-hydroxy testosterone, and subsequent aromatisation 
(Diczfalusy 1975) and reduction at C-ir to form 16a-hydroxy oestrone and 
16a-hydroxy oestradiol (oestriol). There are other, less important 
pathways: aromatisation may take place prior to 16a-hydroxylation 
(Diczfalusy 1975); 16#-hydroxylated steroids may be utilised if first 
converted to their 16a-hydroxy lated forms (Diczfalusy 1968). The placenta 
also has the capacity to synthesise oestriol from pregnenolone sulphate, 
but this too, must be in an hydroxy lated form (Jaffe et al 1972). The 
major pathway associated with oestriol synthesis is though, analogous to 
that of the other oestrogens formed within the placenta.
Oestrogen biosynthesis is stimulated by human chorionic gonadotrophin 
(Volf et al. 1977), prostaglandins (Alsat 1973, Lehman 1975) and 
adrenocorticotrophic hormone, the latter assuming a more important role in 
this respect, after mid-gestation (Seron-Ferr6 1978).
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Kany steroids -also inhibit steroid-3-sulphatase activity (Townsley et al. 
1970, Townsley 1973). The inhibitory effects are cumulative and provide a 
further mechanism whereby placental oestrogen synthesis is controlled. 
Ultimately, regulation of oestrogen synthesis is probably controlled by the 
availability of Ci* steroids from the fetus, rather than by the components 
of the aromatase complex or hormones. The final placental steroids, 
oestrone and oestradiol are secreted into the fetal and maternal 
circulations, oestradiol bound to sex hormone-binding globulin. By term, 
the fetus contributes to approximately half of the oestrone/oestradiol 
produced in the placenta; the remaining contributions are maternal. In 
contrast to this, oestriol synthesis is dependent upon the fetal adrenals 
and liver.
L. STEROID HORMONE LEVELS IK RECURRENT ABORTION
Low levels of progesterone, or progesterone insufficiency has for many 
years been considered to be associated with spontaneous abortion. Attempts 
to correct deficient levels of this hormone in patients, either before or 
during pregnancy, are well documented (Grant et al 1959, Shearman and 
Garrett 1963, Goldzeiher 1964, Klopper and MacNaughton 1965, Dubin et al 
1979). A review of these studies reveals several problems that serve only 
to confuse the issue, namely, that of establishing whether raising levels of 
progesterone therapeutically in the pregnant patient increases the chances 
of a successful pregnancy. Claims to success were frequently based on 
comparisons to figures published by Malpas in 1938. The real problems 
though, centred around how progesterone levels were measured, whether 
progesterone or a synthetic analogue was administered, at what stage of the
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Figure 9 Oestrogen ..'biosynthesis ...1
The fetal adrenal cortex contributes towards oestrogen production in the 
placenta. Pregnenolone derived from cholesterol is conjugated with 
sulphate, and hydroxylated. Subsequent side-chain cleavage results in the 
formation of dehydroepiandrosterone sulphate. This is destined for further 
hydroxylation in the fetal liver, or may be taken up from the umbilical 
circulation by the placenta.
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Figure 10 .Oestrogen....biosynthesis.-J.I
Dehydroepiandrosterone (DHEA) sulphate is taken up from both the 
umbilical and maternal circulations by the placenta for the synthesis of 
oestrone and oestradiol. The placenta, rich in sulphatase, removes the 
sulphate group from DHEA sulphate, and DHEA is converted to 
androstenedione, and by a reversible reaction, to testosterone. The final 
conversion of these androgens to their respective oestrogens, involves three 
hydroxylation steps associated with an aromatase enzyme complex (see 
Figure 11).
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Aromatase activity in the placenta is essential for the final conversion 
of androgens to oestrogens. The aromatase enzyme complex essentially two 
components: cytochrome P-450 and HADPH-cytochrome c reductase, completes 
the synthesis of oestrone and oestradiol via 3 hydroxylations, as shown. 
After the final hydroxylation at Ci£, the product rearranges non- 
enzymically to oestrogen.
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Figure 12 Oestrogen biosynthesis _IY.
As the placenta lacks the enzyme 16a-hydroxylase, the synthesis of 
oestriol begins outside this organ. The fetal liver hydroxylates DHEA 
sulphate (derived from the fetal adrenal cortex), converting it to 16a- 
hydroxy DHEA sulphate, a form which the placenta can synthesise further. 
The subsequent steps are analogous with those depicted in Figure 10, 
hydroxy lated androgens are converted to hydroxy la ted oestrogens, one of 
which is oestriol.
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An overview of oestrogen synthesis. The source of their precursors and 
the controlling factors which affect their synthesis, are shown (see 
appropriate Figures 8-12 for detail).
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pregnancy therapy began, and how the study was controlled, Realising the 
constraints imposed on some of these studies has helped in understanding 
why some of the above problems existed. Since 1974, there has been a 
restriction on what drugs may be administered during pregnancy.
Furthermore, in some of the earlier studies, there was no reliable, 
sensitive method for accurately measuring levels of progesterone.
The following brief review illustrates the problems outlined above and 
attempts to reach a conclusion with respect to the importance of 
progesterone levels during pregnancy and its maintenance therapeutically.
In 1963, Shearman and Garrett performed a double-blind trial using a 
synthetic progesterone (17-hydroxyprogesterone caproate). The study, 
fallowed from 7-24 weeks of pregnancy, failed in its attempt to show a 
decrease in the number of abortions in patients treated with the 
progestagen.
Dosage of the progesterone analogue was based on pregnanediol excretion. 
This however, only poorly reflects progesterone metabolism, and between 15- 
77% of circulating progesterone has been recovered either as pregnanediol 
or pregnanediol conjugates (Gallagher and Bradlow 1954). Urinary levels of 
pregnanediol are dependent on hepatic and renal function (Abraham et al. 
1972). The study was complicated by delays in obtaining pregnanediol 
results (6 days) which affected any corrective measures, and by the 
assumption that the amount of progesterone recovered from the urine as 
pregnanediol was about 10%. Two similar studies by Goldzieher (1964) and 
Klopper and MacHaughton (1965), however, did support the findings of 
Shearman and Garrett (1963).
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Dubin et al. <1979), in the light of these previous studies, tested a 
hypothesis that endogenous hormone patterns in recurrent aborters differed 
from those found in normal pregnancy. Progesterone and oestradiol are both 
physiologically active steroids which influence uterine development and 
contractility, Decreasing ratios of progesterone to oestradiol have been 
reported during labour and adequate levels in this ratio have been shown to 
be necessary to the maintenance of pregnancy in some animals (Turnbull et 
al. 1974). Progesterone and oestradiol levels were measured in patients of 
12 weeks gestation, and followed through to term. The predominant source 
of progesterone in these patients would be the placenta and, as discussed 
earlier, the rate at which progesterone can be synthesised is governed by 
the number of low density lipoprotein receptors on the trophoblast cells. In 
contrast, oestradiol synthesis relies on androgen precursors supplied by 
the mother and fetus. The work by Dubin et al. (1979) does not prove that 
progesterone treatment and restoration of the progesterone/oestradiol ratio, 
was responsible for the normal deliveries encountered in their study. It 
did however illustrate that patients with a clinical history of spontaneous 
abortion, and who show signs of a progesterone deficiency, do have abnormal 
steroid profiles, usually low progesterone/oestradiol ratios.
The concentrations of steroid hormones in early pregnancy (up to 10 
weeks gestation) has also been considered. This covers a period in the 
which the corpus luteum of the ovary and not the placenta, is the 
predominant source of progesterone, although in some studies there must 
undoubtedly have been an overlap. Grant et al. in 1959, stressed the 
importance of "preparing the ground for seed". They took two groups of 
patients, and treated one group pre-conceptionally with a progesterone 
analogue, using endometrial biopsy and basal body temperature graphs as
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means of determining inadequate luteal phase endometrium. The second group 
were assessed but not treated until pregnancy was established. The results 
at best, compared well with untreated patients (¥arburton and Fraser 1959), 
and at worst, the patients would probably have done better had they not 
been treated at all. The use of a progestogen rather than progesterone may 
have introduced a luteolytic effect similar to that described by Johansson 
(1971). This would have been detected had serum progesterone levels been 
available.
Later studies did indeed evaluate ovulation and corpus luteum function 
using plasma progesterone levels (Abraham et al. 1974, Shepard and Senturia 
1977). Vhilst the timing and number of estimations was hotly disputed, it 
was agreed that serum progesterone levels were superior to endometrial 
biopsy as a means of assessing hormonal status (Shepard and Senturia 
1977).
The value of adequate progesterone levels pre-conceptionally and in 
early pregnancy was emphasisied in a study by Horta et al. (1977). These 
workers provided direct evidence of luteal insufficiency in women with a 
history of recurrent abortion. Using plasma progesterone levels as an 
indicator, they compared the values obtained during the luteal phase of 
menstrual cycles in both recurrent aborters and control patients. 
Progesterone levels in the recurrent abortion series were consistently 
lower. A comparison was also made retrospectively, between pregnant 
recurrent aborters 48-72 hours prior to evidence of abortion and control 
patients of the same gestational age. It was concluded that progesterone 
supplementation therapy could have been effective in the recurrent abortion 
group, but the use of progesterone analogues and indeed any drugs, are 
contra-indicated in pregnancy. Yip and Sung (1977) also concluded that an
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inadequate luteal phase endometrium is more likely in women with a history 
of early recurrent abortion.
Hensleigh and Fainstat (1979) in a strictly controlled study, determined 
normal serum levels of progesterone for the luteal phase and first 10 weeks 
of gestation in control patients. On the basis of these results, they then 
treated a select group of recurrent aborters with progesterone 
suppositories until they achieved normal progesterone values. None of the 
patients aborted, whether treated during pregnancy, or pre-conceptionally. 
This study perhaps illustrates that progesterone supplementation can allow 
a pregnancy, partially controlled by the corpus luteum, to continue until 
the placenta is able to take over. Llusid (1962) sums up the hormonal 
considerations of early, first trimester abortions when she says 
"Progesterone insufficiency plays a very important role in the genesis of 
early repeated abortion and a less important, but still significant role in 
more advanced abortion." This statement was supported by her work on 
•unsuspected' habitual abortions. These are early abortions, clinically 
undetected but proven histologically, that occur in apparently sterile 
women. Llusid attempted to prove a constant disease of the endometrium in 
the form of progesterone deficiency, arguing that it was progesterone that 
largely determined the conditions of nidation. Frequent, asymptomatic 
abortion was then, a consequence of defective implantation of a blastocyst, 
due to a poorly prepared endometrium. The results of Llusid's study 
supported this concept, as there was a particularly high incidence of 
progesterone insufficiency in her recurrent abortion group. Her work also 
supports that of Hertig et al. (1954) and Boyd (1959) who have provided the 
most extensive studies on nidation.
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The use of synthetic analogues of progesterone has been an unsuccessful 
means of supplementing endogenous progesterone. This may in part, have 
been due to inaccurate methods of measurement, which subsequently affected 
treatment. The period of gestation under study has been another 
consideration: was the endogenous source of progesterone luteal or 
placental? The benefits of progesterone therapy appear to be confined to 
its correction in early pregnancy when the source is ovarian. The 
monitoring of corpus luteal function by accurate determination of 
endogenous progesterone levels, offers the best method of maintaining 
pregnancy.
Ironically, synthetic oestrogens have been used successfully in the 
prevention of abortion for many years. Their use was only discontinued 
when the oestrogen analogue, diethyl stilboestrol was implicated in delayed 
carcinogenesis, pathological ageing of bone and abnormalities associated 
with secondary sexual development (Greenwald et al 1971). Tragically, 
stilboestrol taken during pregnancy to prevent threatened spontaneous 
abortion produced no obvious abnormalities in neonates, with the exception 
of a few reported cases of virilization of female fetuses CBongiovanni et al 
1959). The problem occurred subsequently following the onset of puberty, 
when the offspring developed carcinoma of the vagina (Greenwald et al 
1971).
The evidence to date, suggests that low levels of progesterone are 
associated with some recurrent abortions. This however, is likely to be due 
to pre-existing pathology, and is therefore not a cause but an effect. 
Further parameters encompassing progesterone activity, or dependent upon 
progesterone activity, would need to be examined to determine which of 
these is true.
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5, SMQKIKG IS PREGNAKCY
It is now well established that cigarette smoking during pregnancy is a 
risk to the health and well-being of both the mother and her baby. The 
association between smoking and low birthweight is well publicised and 
widely reported. There are other risks associated with smoking during 
pregnancy however, which is perhaps not surprising as there are over 4,000 
chemical compounds in cigarette smoke (Kaeye 1981), and only a very small 
number of these have ever been fully tested. Kan in common with many 
other species, has a natural defense mechanism which protects tissues from 
a wide range of toxic chemicals. Whilst several tissues are undoubtably 
involved, progressive metabolic detoxication is primarily the province of 
the liver. For example, it is part of the normal function of hepatic 
enzymes to prevent against an accumulation of 'non-nutrient* chemicals, 
which are invariably present in the environment and diet. It is logical 
that these enzymes will act on drugs in much the same way, metabolising 
them to more polar (water, rather than lipid soluble), less active forms 
which can be readily eliminated from the body.
This section examines some of the problems encountered with smoking in 
pregnancy. In addition to low birthweight babies, its effect on the 
placenta is considered, and proof of a relationship between smoking and 
abortion is sought.
5J. Steroids, drugs and cytochromes
The enzyme system involved in the detoxication of drugs comprises a 
carbon monoxide-binding pigment cytochrome P-450. This, with NADPH
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cytochrome c reductase and cytochrome P-450 reductase, catalyses the 
incorporation of oxygen into the substrate. As described in the previous 
section, placental steroid oxidising cytochrome P-450 is utilised in the 
side chain cleavage of cholesterol in the synthesis of progesterone from 
pregnenolone, and in the aromatisation of androgens in the synthesis of 
oestrogens. There is no direct evidence that the same enzyme system is 
responsible for both steroid biosynthesis and xenobiotic detoxication, 
although Pelkonen (1977) has shown this to be so in the fetal liver. There 
are fundamental differences in the metabolic activities of these organs, as 
fetal liver hydroxylates sulphated steroids, whilst the placenta metabolises 
unconjugated steroids (sulphate is removed prior to aromatisation in the 
placenta). Induction studies too, have shown there to be several cytochrome 
P-450's in the liver, with similar and overlapping enzymic activities. 
Exogenous substrates which readily induce hepatic cytochrome P-450 however, 
have consistently failed to induce this enzyme system in the placenta 
(Juchau and Zacharriah 1975, Hunter and Chausseaud 1976). The relatively 
small amounts of detectable cytochrome P-450 in the placenta and, in 
consequence the low drug-metabolising activity of this organ may in fact be 
due to the high concentration of steroids present (Chakraborty et al, 1971, 
Juchau 1971). Glucuronide conjugation for example, can certainly be 
inhibited by circulating levels of progesterone and pregnanediol (Hsia et 
al, 1963, Creaven and Parke 1965).
A further cytochrome called cytochrome P-448 has more recently been 
described. Although originally regarded as an artefact associated with 
induced cytochrome P-450, it is now thought that cytochrome P-448 is a 
primitive form of cytochrome P-450 (Parke 1981Ca]> found in the fetus and
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neonate in man, mice and more primitive species such as fishes (Parke 
1981Cb]).
Its importance lies in its ability to oxygenate chemicals in sterically 
hindered positions ('bay' regions). These then become unsuitable compounds 
for further detoxication, and instead become reactive intermediates which 
react with tissue macromolecules and D M  (Parke 19811a]).
The capacity of cytochrome P-448 to oxygenate molecules in sterically 
hindered positions might also enable it to perform, as an enzyme system, a 
less sinister role in the placenta. The aromatisation of androstenedione . 
and testosterone in the formation of oestrone and oestradiol occurs at ring 
A of the steroid molecule (Thompson and Siiteri 1974), and is in a 
sterically hindered position (see Figure 11). It follows that if the 
oxygenation of these steroids, a cytochrome P-450 mediated reaction, were 
in fact carried out by cytochrome P-448, then the low drug metabolising 
activity of the placenta (i.e. cytochrome P-450 activity) could be accounted 
for. This would conform to cytochrome P-448 being a primitive form of 
enzyme, active during gestation, and persisting neonatally. This does not 
identify the natural substrate that induces its activity, but supplementing 
cytochrome P-448 for cytochrome P-450 in the side-chain cleavage of 
cholesterol in progesterone synthesis and in the hydroxylation of 
androgens, does offer a physiological role for this enzyme system.
Unlike cytochrome P-450, placental cytochrome P-448 is readily induced 
by substrates like polycyclic aromatic hydrocarbons, which are present in 
tobacco smoke Pelkonen et al 1972, Longo 1982). One of these, 
benzo(a)pyrene, has been shown to affect both fetal and placental 
metabolism, although the stimulus for fetal induction is greater than that 
needed to induce activity in the placenta (Longo 1982).
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Benzo(a)pyrene concentrations, measured by their inductive effect on aryl 
hydrocarbon hydroxylase activity, correlate well too, with the number of 
cigarettes smoked by the pregnant mother (JTebert et al, 1969, Pelkonen et 
al, 1972). Levels of aryl hydrocarbon hydroxylase are higher in smokers 
than non-smokers (Vaught et al, 1979) and the dose related response of this 
enzyme to benzo(a)pyrene administered approaches saturation when the 
smoking mother exceeds 20-25 cigarettes/day (Pelkonen et al, 1979), 
although some variation amongst individuals does appear to exist (Gurtoo et 
al, 1983).
The relationship between cigarette smoking and the placenta is unusual 
in that cigarette smoke is the only 'classical' inducer, along with 
polycyclic aromatic hydrocarbons, able to stimulate xenobiotic‘-metabolism 
in this organ. The induction of aryl hydrocarbon hydroxylase activity by 
cigarette smoke and drugs in other organs is less than that seen in 
placental activity (Pelkonen and Pasanen 1984). This somewhat dynamic 
response to cigarette smoke may affect steroid metabolism adversely 
however, and there is some evidence to suggest this. Juchau et al, 1972, 
demonstrated an inverse correlation between aryl hydrocarbon hydroxylase 
activity and cholesterol side-chain cleavage in placentas from smokers, and 
Pelkonen and Pasanen (1983) reported that aromatase activity also seemed to 
be affected by maternal smoking in a dose-related fashion.
Cigarette smoking in pregnancy might affect the biosynthesis of 
hormones by interfering with cytochrome P-450- or cytochrome P-448- 
mediated enzyme induction. This suggests a possible explanation for low 
birth weight babies born to smoking mothers.
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5.2 -Reduction in birthweight of a fetus
A reduced birthweight of babies born to smoking mothers has been 
reported in virtually all studies on this subject published to date.
Large numbers of variables have been considered: socio-economic status, age, 
obstetric history, etc., and despite these the observation remains valid.
The adverse effects of smoking first become manifest after the fourth month 
of pregnancy (Lowe 1959, Fielding 1978) when there is a change in the 
feto/placental weight ratio (Wingard et al. 1976).
Simpson in 1957, reported on the first large scale study of smoking in 
pregnancy, involving more than 7,000 cases. The results showed that 
smoking mothers gave birth to babies weighing less than 2.5 kilograms 
twice as frequently as non-smoking mothers. Naeye (1978Cb3) highlighted 
the relationship between smoking and low birthweight, when he compared the 
fetal birthweights of mothers who smoked during one pregnancy but not in 
another. He found that regardless of the order of pregnancies in which *
mothers admitted smoking, the pregnancy in which they did smoke 
consistently produced the lighter baby.
Spira et al. (1977) after examining placentae from a smoking and non­
smoking group of patients, reported that whilst the placental weights from 
the two grpups were similar, the fetal weights were not. They proposed 
that the reduction in birthweight of fetuses born to smoking mothers might 
be due to a functional disorder of the placenta.
Alvear and Brooke (1977) did tentatively suggest from a pilot study they 
conducted, that there might be a social status issue. Their results 
indicated that infants born to smoking mothers of the same social class, 
were of similar weights to infants of non-smoking mothers of the same 
class. These observations were however, strongly contested by Murphy et
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al. (1977), who cited their studies (Murphy and Mulcahy 1974) on this very 
issue, and by Alberman et al. (1977) who made reference to their own 
studies.
The number of cigarettes smoked daily also appears to be a risk factor. 
It seems that the mother who stops or reduces her smoking within the first 
four months of pregnancy, takes on the risks associated with her new level 
of smoking (Butler et al. 1972). A reduced birthweight related to the 
number of cigarettes smoked daily has been reported by Meyer et al (1976) 
and is representative of many others giving evidence of a dose/response 
relationship (MacMahon et al. 1965, Longo 1977, Meyer 1978, Pirani 1978, 
Pantakallio 1978, Longo 1982).
 Increase in maternal complications in pregnancy
There are two main complications associated with maternal smoking: 
placenta praevia (a condition in which the placenta may encroach or be 
sited over the cervix uteri) and abruptio placentae (premature separation of 
the placenta from the uterine wall). Both are serious and both usually 
involve extensive bleeding. More than half of the increase in fetal and 
neonatal deaths of smoking mothers can be attributed to one or other of 
these conditions (Haeye et al. 1977, Uaeye 1979). Again the condition is 
exacerbated by heavy smoking. The paper by Meyer et al. (1976) is 
representative of others in illustrating this. The risk associated with 
placenta praevia in mothers smoking less than 20 cigarettes daily is 257# 
greater than that for non-smokers. In heavy smokers the risk increases to 
92%. The figures for abruptio placentae are marginally lower. If mothers 
can stop smoking before or during early pregnancy then they can reduce 
their chances of fetal or neonatal death as a consequence of placenta
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praevia or abruptio placentae, considerably. 'The outcome is less 
encouraging however for long term, chronic smokers who are unlikely to 
avoid seriously compromising a pregnancy, and risk perinatal complications 
if they develop either of these conditions (Uaeye 1979, 1980).
5.4 Increase in fetal mortality
There is evidence of an increased risk of fetal mortality due to smoking 
(Andrews and Me Garry 1972, Meyer and Tonascia 1976), although this has 
been shown to vary considerably. As with other parameters, the risks 
increase with the number of cigarettes smoked, and begin to become manifest 
after 20 weeks gestation (Butler and Alberman 1969).
5.5 Congenital malformations
Because of the very high number of chemical compounds in cigarette 
smoke, many have not been tested for teratogenicity. Consequently, the 
cause of congenital abnormalities associated with maternal smoking (Naeye 
1978) have not been identified, and could as easily be attributed to 
drinking alcohol or coffee, since both of these are often consumed in 
greater amounts by smokers.
It is tempting to suggest that fetal loss in a maternal smoking 
population is due largely to complications associated with the pregnancy 
rather than to any fetal abnormality. Smoking-related spontaneous 
abortions certainly appear to have a lower frequency of abnormal 
karyotypes, and the abortions of these patients also occur later in 
pregnancy (Longo 1982). There is also some evidence that infants of 
smoking mothers have marginally lower mortality rates due to congenital 
malformations than those of non-smoking mothers (Andrews and McGarry
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1972). Several other studies have also failed to find any association 
between smoking and congenital abnormalities (Underwood et al. 1965, 
Richards 1969, Kullander and Kallen 1971). All this, if true, sadly points 
to smoking as the sole cause of abortion in these patients.
There are some interesting exceptions to these general findings. Whilst 
Evans et al. (1979) agree with others that smoking does not appear to be a 
significant cause of developmental abnormality, they did find, in their 
study of 67,000 pregnancies, an association between smoking mothers of high 
social class and neural tube defects in their offspring. Fedrick et al. in 
1971 reported an association between smoking during pregnancy and 
congenital heart disease, and Uaeye (1978) demonstrated a statistical 
increase of anencephaly in fetuses of smoking mothers.
With respect to the number of cigarettes smoked daily by pregnant 
mothers, Himmelberger et al. 1978 reported the risk of congenital 
malformations to be more than twice in heavy smokers compared with non- 
smokers. It should be pointed out however, that they also showed an 
increase in congenital abnormalities in the offspring of smokers generally, 
in accordance with fiaeye (1978).
A dichotomy seems to exist therefore, where on the one hand a very large 
number of births need to be reviewed to establish a relationship between 
congenital defects and smoking during pregnancy. On the other hand, 
analysis of a relationship between potential teratogens in cigarette smoke 
and specific congenital abnormalities is not feasible because of the large 
numbers of these chemicals.
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5L6 Hypertension
High blood pressure in pregnancy appears to be less common in smokers 
than in non-smokers (Andrews and He Garry 1972). Cigarette smoke does not 
however offer any protective role in this respect since smokers who do 
develop hypertension are much more likely to have a still-birth or lose a 
child in infancy than non-smokers with the same condition (Lancet 1978).
The decreased number of hypertensive patients in pregnant smoking 
groups is likely to be due to a constituent of tobacco smoke, namely 
cyanide. This is detoxified in the body to thiocyanate, which is 
acknowledged to have a hypotensive effect. It should not be assumed 
though, that this will have any beneficial role, as a smoking hypertensive 
mother could be 3 times more likely to lose her baby than her non-smoking 
counterpart.
5LZ Spontaneous abortion
One of the major problems of establishing an association between two 
parameters like smoking and abortion, is the number of variables that need 
to be considered. There have been several large studies (Zabriskie 1963, 
Downing and Chapman 1966, Fedrick et al. 1971, Murphy and Mulcahy 1974, 
Kline et al. 1977 and Himmelberger et al. 1978) and still the results are 
inconclusive. Whilst this has in part been due to inadequate consideration 
of variables, it has been compounded by the inclusion in studies of, 
previously undetected, criminal abortions. American publications post 1973, 
when abortions were legalised, are likely to be more accurate.
In 1971, Kullander and Kallen demonstrated an increased risk of 
spontaneous abortion in smokers. The results were, however, shown to be of 
borderline significance when patients were counselled and asked whether
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their pregnancy was wanted. Me Kean (1978) made a similar criticism of a 
study by Kline et al. 1977, who failed to accommodate the behavioural 
attitude of their patients in their analysis. It now seems reasonable to 
assume that an unwanted pregnancy may account for a proportion of 
abortions associated with smoking. Whether it is the stress or the 
smoking, or both, remains to be determined.
It has become apparent from the above sections that the number of 
cigarettes smoked daily has some bearing on the outcome of a pregnancy. 
Having previously established that cigarette smoking becomes more prevalent 
with age and parity (Mulcahy 1968), Murphy and Mulcahy (1974) attempted to 
confirm that these parameters were responsible for some spontaneous 
abortions. Their results indicated however, that the greater part of the 
increased incidence of spontaneous abortions could be attributed to smoking 
alone. The outcome of pregnancy in this study was dose related with 
respect to the light smoker; any more than 5 cigarettes a day put the 
pregnancy at significant risk.
Himmelberger et al. 1978, in their retrospective study of 13,000 
pregnancies considered 4 variables: pregnancy history, age, occupation and 
number of cigarettes smoked; the risk of spontaneous abortion for the 
smoking mother was put between 20-70%, and was greatest for the young 
mother (20 years old) who smokes. Hemminki et al. 1983 also considered, in 
2 occupational groups, the effects of smoking on spontaneous abortion with 
respect to age, parity, alcohol and coffee consumption; a similar predicted 
incidence of abortion to Kline et al. 1977, and Himmelberger et al. 1978 was 
reported, which was exacerbated if more than 10 cigarettes a day were 
smoked.
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Smoking cigarettes during pregnancy may be -responsible for an increase 
of spontaneous abortion. The risk appears highest between the fourth and 
seventh months of gestation (Kullander and Kallen 1971), unlike abortions 
involving fetal abnormalities, which tend to occur earlier in pregnancy.
This high risk period, confined to smokers, has been verified by Fielding 
(1978). The number of cigarettes smoked daily probably has some 
detrimental effect on the outcome of a pregnancy, but reports are 
inconsistent. Likewise, the psychological state of the smoking mother may 
increase the chances of an abortion.
With regard to recurrent abortion, there appears to be a less definite 
association with smoking (leading article, BMJ, 1978). This is perhaps 
logical as patients in this category are likely to have been counselled on 
the health consequences of smoking during pregnancy, and one would expect 
this group to take heed more readily than patients experiencing a single 
loss. Also, this group are more likely to have an inherent defect 
independent of social habits.
6, SYSTEMIC__LUPUS- ERYTHEMATOSUS (S.L.E.)
Systemic lupus erythematosus (SLE) is a connective tissue autoimmune 
disease that produce both acute and chronic inflammatory lesions in a range 
of organs and tissues in the body. The presence of auto-antibodies that 
react with normal cell constituents is also a feature of the disease. It 
has long been known that SLE and an increased incidence of spontaneous 
abortion are associated (Gimovsky et al 1984), and indeed, the poor 
prognosis appears not to be confined to patients manifesting this syndrome.
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Vhat is also apparent is that other, in many ways similar conditions, like 
rheumatoid arthritis, do not generally, adversely affect the outcome of 
pregnancy (Kaplan and Diamond 1965).
With the advent of early detection methods for SLE., and other, milder 
connective tissue autoimmune diseases, came the realisation that sub- 
clinical, serological evidence of autoimmunity could also be related to 
complications in pregnancy although the mothers were often clinically well 
(Cowchock et al. 1984, Lubbe et al. 1985). In vitro laboratory tests 
identified an IgG or IgM antibody to phospholipid that prolonged 
phospholipid-dependent coagulation times (like the prothrombin and partial 
thromboplastin time) by binding to epitopes on the phospholipid portion of 
prothrombinase. The serum from patients with this antibody usually also 
gave a false positive VDRL (Venereal Disease Reference Laboratory test for 
syphilis) and high titres of anti-cardiolipin antibody. It has now been 
established that this antibody, designated lupus anticoagulant antibody, 
whilst originally described in patients with systemic lupus erythematosus, 
is more often encountered in patients without clinical symptoms of the 
disease (Feinstein 1985). It is however, described in other autoimmune 
diseases, neoplastic and drug induced syndromes, cerebral disease and may 
predispose arterial and venous thromboses, as well as contributing to 
recurrent spontaneous abortion (Firkin et al. 1980, Boey et al. 1983, 
Rothfield and Parke 1985).
The cause of recurrent abortion in lupus anticoagulant antibody positive 
patients is not known. It is perhaps not surprising that placental 
vasculature might be affected in some way, and indeed the placentae are 
often extensively necrotic and infarcted (Lubbe et al. 1985), though rarely
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sufficiently bad enough to be considered responsible for the abortion. The 
few studies that have been undertaken are confined to patients with SLE.. 
Abramovsky et al. (1980) reported on 5 placentae with fibrinoid necrosis of 
decidual vessels, necrotic dissolution of vessel walls and infiltration of 
the vessels with inflammatory cells. In general terms, these are changes 
one would normally describe in preeclampsia. In two of the placentae 
described by Abramovsky et al. (1980), there were large amounts of IgM 
deposited. Deposits of immunoglobulin is not an uncommon finding in the 
placenta (Grennan et al. 1978) and, unless in amounts that would physically 
impair placental function, may be regarded as normal (Johnson et al. 1977).
There is some evidence to support the view that autoantibodies may 
inflict their damage on fetal tissues: Scott, Maddison et al.,(1983) reported 
on congenital heart block and Litsey, Noonan et al.,(1985) have demonstrated 
such antibodies in the fetal atrium. Attempts to prevent abortions in 
patients with circulating lupus anticoagulant antibody by treatment with 
high doses of prednisone and low doses of aspirin to minimise thrombosis 
(Lubbe et al. 1983) have met with mixed success. This regime has not 
always prevented hypertension and fetal growth retardation in utero (Vare- 
Branch et al 1985), and in some instances one wonders seriously about the 
risk to the patient.
These observations, together with reports of lupus anticoagulant 
antibody present throughout pregnancy (Reece and Romero 1984), plus a 
general ignorance of the immunological and physiological mechanisms 
involved, comprise a spurious approach to the understanding of recurrent 
abortion.
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7, THE ROLE OF THE ENDOMETRIAL GRANULOCYTE
Endometrial granulocyte, stromal granulocyte or 'K1 (Kornchenzellen) cell, 
are names that have been attributed to what is probably a single cell type 
found in the human female reproductive tract. Similar, analogous cells have 
been described in primates (Cardell et al. 1969) and rodents (Smith 1966, 
Peel and Bulmer 1977, and Bulmer et al. 1983(a)). In the human, endometrial 
granulocytes may be found in small numbers between the endometrial glands 
in the supporting stroma or pre-decidua throughout the normal menstrual 
cycle. Their numbers increase substantially towards the end of the 
secretory phase, and are most numerous just prior to the end of the 
menstrual cycle. Endometrial granulocytes can be recognised in 
haematoxylin and eosin stained sections by their intense nuclear staining. 
Close examination reveals an oval or slightly indented nucleus with 
eosinophilic granules within, or in close proximity to, the cytoplasm of 
many of these cells. Visualisation of the granules is improved by staining 
with phloxine (Lendrum 1947), as the bright red, phloxinophilic granules 
contrast well against a yellow, tartrazine background.
The endometrial granulocyte is also a prominent feature of the decidua 
in pregnancy. Large numbers accumulate at the implantation site around the 
embedding blastocyst in humans. (Dallenbach-Hellweg 1981) and animals 
(Dickson and Bulmer 1961, Stewart and Peel 1978, Jbara and Stewart 1982). 
Later in pregnancy, they are seen to congregate along the spiral arterioles 
(Pijnenborg et al, 1980, Dallenbach-Hellweg 1981). They persist within the 
decidua of early, first trimester pregnancy (Pijnenborg et al. 1980, Bulmer 
and Sunderland 1983), diminishing throughout the remainder of gestation to
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be virtually absent at parturition (Hamperl 1955, Hamperl and Heliweg 1958, 
Kazzaz 1972).
In 1891, Duval (Cardell et al. 1969) described a secretory role for the 
endometrial granulocyte (granulated metrial gland cell) in the rat metrial 
gland. There has been considerable speculation as to the role of these 
cells since, and their function remains unresolved today. An endocrine 
function was postulated by both Baker and Bridgman in 1948, and by Ellis 
1957 who implicated lipid-bearing cells of the rat metrial gland with 
steroid metabolism. More recent electron microscope studies however, go 
against this hypothesis as, unlike other steroid synthesising cells, the 
granulocyte does not contain tubular agranular endoplasmic reticulum, but a 
lamellar form. The mitochondrial structure of the granulocyte is not 
suggestive of a steroid synthesising cell either, but rather suggests a 
capacity for the synthesis of proteins for export (Cardell et al. 1969). 
Vislocki et al. 1957 believed the cells described by Baker (1948) and 
others might in fact, be distinct from the granulocyte.
Szendi (Cardell et al. 1969) believed that endometrial granulocytes 
synthesised and secreted their granules into the circulation, ultimately 
providing nutrient to the yolk sac of the growing embryo. Selye and 
McKeown (1935), supported this view, as they too believed that the 
granulocyte was associated with the provision of nourishment to the 
developing fetus. Other workers have variously linked the function of the 
endometrial granulocyte to heparin (Asplund and Holmgren 1947, von Mumers 
1953), histamine (Vislocki et al. 1957) or holocrine (Bulmer and Peel 1977) 
secretion, whilst Peach and Bulmer (1965) regarded the granulated metrial 
gland cells of the rat to be of lysosomal origin. Current evidence favours 
one of two schools of thought. The first, probably first inspired by Veill
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in 1921 (Bulmer and Sunderland 1983) suggests that the granulocyte might 
he involved in immunological mechanisms associated with pregnancy. The 
second implicates the granulocyte in the synthesis and secretion of a 
polypeptide hormone called relaxin, which has been isolated in the 
reproductive tract of many ’ vertebrates including man (Dallenbach-Hellweg et 
al. 1965, Bigazzi et al. 1981, Yamamoto et al. 1981, Stewart et al. 1982), 
This second hypothesis was pioneered by Bridgman in 1948.-
7,1 An immunological role?
Weill, in 1921 (Bulmer and Sunderland 1983) described granulated cells 
with eccentric nuclei and acidophilic granules in human decidua of early 
pregnancy. These cells were regarded, on morphological grounds to be 
lymphoid in origin. Further support for this observation was not published 
until 1966, when Smith described several, morphologically similar cell types 
in the mouse which he believed related to granulocytes in various stages of 
maturation, and to be derived from lymphocyte precursor cells. There have 
since been further descriptions of granulated cells that are reported to 
have differentiated from lymphocyte precursor cells (Peel and, Bulmer 1977, 
Stewart and Peel 1977, 1978). Peel and Bulmer (1977), used the electron 
microscope to describe cell types in the rat that related to stages of 
maturation ranging from small lymphocytes to granulated metrial gland 
cells.
In an attempt to extend and confirm a possible immunological role for 
the granulated metrial gland cell, Dickson (1980) examined placentae from 
both inbred and outbred strains of mice. The greater numbers of 
granulocytes evident in the placentae of outbred matings compared to those 
placentae from inbred mice was considered a possible example of antigenic
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disparity in the two strains. This study was supported two years later by 
Jbara and Stewart (1982) who also found a significant increase in the 
number of granulocytes in placentae from outbred strains of mice, compared 
with inbred strains.
Hot all workers accept the morphological evidence that the granulated 
metrial gland cell is derived from the lymphocyte cell series (Larkin and 
Schultz 1968, Larkin and Cardell 1971). There has been greater impetus for 
this belief however, since Bulmer and Peel (1977) and Mitchell et al. (1980) 
demonstrated immunoglobulin in the metrial gland cells of the rat. Using 
immunofluorescence, these workers established in the rat, that granulated 
metrial gland cells are derived from lymphocytes and contain an IgG class 
of immunoglobulin.
Some of the more recent evidence (Bulmer and Sunderland 1977) favours 
an immunological role for the endometrial granulocyte in humans. Using a 
monoclonal antibody called leucocyte-common antigen, Bulmer and Sunderland 
(1983) demonstrated large numbers of endometrial granulocytes immuno- 
cytochemically, in the decidua of first trimester placentae. Leucocyte- 
common antigen is regarded as a marker for cells of the lymphocytic/ 
granulocytic cell series and indicative of bone marrow origin. A similar 
observation, with respect to the granulated metrial gland cells in mice had 
already been made by Peel, Stewart et al. in 1982. More recent studies 
(Krcek and Clark 1985) using mice, have identified the migration of 
fluorescent-labelled, small, bone-marrow derived cells, to implantation sites 
in the placental decidua. The cell population, though mixed, contained 
largely, granulated small lymphocytes, somewhat analogous to the cells 
described by Bulmer and Sunderland in 1983.
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7.2 A role In the synthesis of relaxin?
Relaxin is a low molecular weight polypeptide hormone secreted by the 
female reproductive tract and found in varying quantities in the ovaries 
(Anderson et al. 1975, Belt et al, 1971, Fields et al. 1980, Weiss et al. 
1976, 1977), placenta (Dallenbach-Hellweg and Nette 1964, Bigazzi et al, 
1980, Yamamoto et al, 1981, Fields and Larkin 1980, 1981, Stewart et al.
1982) and uterus (Dallenbach-Hellweg et al. 1965, Hisaw and Hisaw 1964, 
Cardell et al. 1969, Pardo et al. 1980, Dallenbach and Dallenbach-Hellweg 
1964, Schwabe et al. 1978) of many vertebrates including man. It was first 
discovered in the blood of pregnant rabbits by Hisaw in 1926, but it was 
not until 1948 that Bridgman, examining granular metrial gland cells in the 
pregnant rat, proposed that they might be secreting relaxin. Velardo et al, 
in 1953, and Dickson and Bulmer (1961) reached a similar conclusion from 
their studies on the development of granulocytes in the metrial gland of 
the rat.
In 1956 Hellweg demonstrated histochemically, a tryptophan and tyrosine 
containing polypeptide in granulated cell granules in the rat. This was 
supported a year later, by Hellweg and Sandritter (1957), using ultra violet 
microspectrophotometry. The absorption curve closely matched that of 
relaxin (see Dallenbach-Hellweg 1981). The cytochemical characteristics of 
these cells in the rat, at least, has been supported by others (Wislocki et 
al. 1957).
Zarrow (1961) established that the greatest concentration of circulating 
relaxin in the body occurs under physiological conditions that appear to be 
regulated by progesterone. Hormonal control of relaxin was considered by . 
Hisaw and Hisaw in 1957 but it was Cardell et al. in 1969, who, by
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excluding other tissues sites and controlling hormonal conditions, were able 
to attribute the source of relaxin in the monkey to the uterus.
Perhaps the most controversial evidence was published in 1964 by 
Dallenbach and Dallenbach-Hellweg. Using a fluorescein labelled indirect 
antibody technique they demonstrated relaxin in human granulocytes in the 
placenta and decidua. This was later confirmed in granulated metrial gland 
cells in the rat and analogous cells in monkeys (Dallenbach-Hellweg 1981). 
These studies have been contested by other workers however, including 
Larkin (1974) and later, Anderson and Long (1978).
It is likely that in humans, the endometrial granulocyte has a clearly 
defined role in both the menstrual cycle and pregnancy. This role has not 
been identified in the litature however, which is contradictory. Conclusive 
evidence, which is likely to point either towards an immunological or 
endocrine function, could be crucially important to the understanding of the 
mechanisms involved in recurrent abortion.
Conclusions and Proposed Research Programme
A review of the literature on recurrent abortion identifies perhaps six 
areas of investigation which have illustrated a cause/effect relationship.
It is clear that chromosomal abnormalities are generally not responsible 
for spontaneous abortions of a recurrent nature. Anatomical defects and 
infections by micro-organisms may be responsible for recurrent pregnancy 
loss until identified and corrected by appropriate therapy. Hormonal 
defects are a significant cause of pregnancy loss, particularly with regard 
to steroids in early pregnancy. Abnormal steroid patterns are not however, 
a feature of recurrent, as distinct from spontaneous, abortion. The current 
thrust of investigation, and what is purported to be the most likely single
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cause of recurrent spontaneous abortion, is immunological. A whole new set 
of parameters has been identified therefore, which now require evaluation. 
Systemic lupus erythematosus in its overt form, and sub-clinically, is 
responsible for some habitual abortions, the cause for which in essence, is 
immunological. The successful treatment of habitual aborters using pooled 
leucocyte transfusions (Taylor and Faulk 1981) is dependent upon 
stimulating maternal blocking antibody, although the immunological 
mechanisms involved are poorly understood (Lancet, 1983). The successful 
implantation of an ovum is largely a result of maternal recognition of 
trophoblast lymphocyte cross-reactive antigens (McIntyre and Page Faulk 
1986). Compatibility of these antigens between mother and fetus will then, 
dictate the success or failure of the pregnancy. This, and pregnancy 
failure due to the sharing of MHC (major histocompatibility complex) 
antigens, in particular Class II HLA-DR antigens between partners (Johnson
1983), has firmly indicated that recurrent abortion has both a maternal and 
paternal counterpart.
The investigations undertaken in this thesis have been directed by the 
quality and availability of tissues. There is little work published on the 
morphological evaluation of recurrent abortion material, consequently there 
will be a chapter devoted to this. The research will be predominantly 
concerned though with the characterisation of the endometrial granulocyte, a 
cell which, as described, is likely to have either an immunological or 
hormonal role in pregnancy. The histochemical characteristics of this cell 
will be evaluated and, in the light of current knowledge regarding its 
function, its distribution and enumeration investigated in recurrent 
abortion and matched control material. An attempt too, will be made to
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identify trophoblast and lymphocyte antigens using monoclonal antibodies, 
although this is restricted by the quality of abortion material available.
The quality of antiserum preparation has, in recent years, improved 
substantially, and a chapter will be devoted to the preparation of an 
antiserum to relaxin. The aim of this chapter will be to confirm or 
exclude the endometrial granulocyte as a source of relaxin synthesis in 
human pregnancy and to map out the distribution of this hormone in 
recurrent abortion and control material of the reproductive organs. This 
may provide further insight into the role of this polypeptide hormone in 
normal pregnancy and abortion.
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CHAPTER 2
MORPHOLOGICAL ■ASPECTS OF RECURRENT ABORTION
INTRODUCTION
The morphological changes in the endometrium that occur in early human 
pregnancy are well documented. The literature is diverse, encompassing 
maternal vasculature (Pijnenborg et al,1980, Robertson 1981, Lichtig et al,
1984), structure and speculative functions of cell types like the placental 
bed giant cell (Boyd and Hamilton 1960, Wooding 1982) and endometrial 
granulocyte (Dallenbach-Hellweg 1981), and treatises of a more general 
nature (Hertig 1964, Sutcliffe et al, 1982). Changes associated with the 
developing placenta have also received attention (Arias-Stella 1954, Enders 
1968).
It would perhaps be reasonable to assume therefore, that reports 
relating to morphological changes in recurrent abortion as distinct from 
spontaneous abortion would also have been documented. The paucity of such 
reports is perhaps a reflection of the lack of tangible histological 
evidence of changes attributable to recurrent abortion (Rushton 1978). 
Alternatively, this area of investigation may have received little attention.
It has been the aim of this chapter to consider, on the material and 
cases available, whether the cause of an abortion can be identified on 
morphological grounds. Sectioned and stained material from recurrent 
aborters and matched controls were examined by light microscopy. A 
comprehensive checklist was compiled, and the histological changes in the 
two groups evaluated.
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MATERIALS AMD METHODS -
Following a random, cursory examination of routine formol-saline fixed, 
paraffin wax processed sections stained by haematoxylin and eosin, a 
checklist was compiled, designed to encompass the morphological criteria 
present. This was divided into three main sections: decidua, endometrium 
and chorionic villi. Each section was further sub-divided into sub­
sections, and provision made for any miscellaneous observations (Table 2).
Requests for histopathological investigation of abortion tissue received 
by the department are not often- accompanied by a comprehensive obstetric 
history. A distinction is not always made between spontaneous and 
recurrent aborters, for example. Consequently, to identify the maximum 
number of recurrent abortion cases for review, every file card in the blood 
transfusion laboratory of St James hospital, London, since records began, 
was examined. The file cards record, in addition to the blood group and 
units of blood cross-matched for a patient, the parity of that patient if 
relevant. In the period 1971-1982, 234 habitual or recurrent aborters were 
blood grouped. A history of any histological investigations was then 
sought and a further screening procedure undertaken for those patients on 
file in the department of histopathology. Some of the material was 
unacceptable by virtue of the histological findings (blood clot or necrotic 
debris only), some was irrelevant as it was unrelated to the study (eg. 
appendicectomy specimens). Examination of the clinical history provided 
further information and in some cases, avoided unnecessary assessment of 
the material (eg. incompetent cervix, bicornuate uterus, venereal disease, 
cancer). In the final count, only 19 cases appeared suitable for review.
These cases were matched using material received in the department 
following elective, suction terminations of pregnancy. A similar screening
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procedure was adopted to ensure as near as possible, a control population 
that was suitable for comparison with the recurrent abortion series.
Parity between the two groups was attempted in two areas:
1) the average age of the patients: 27.2 years (control), 27.5 years
(recurrent abortion).
2) the average gestational age of the material examined: 9.3 weeks 
(control), 10.6 weeks (recurrent abortion).
The average number of pregnancies in the control group, by virtue of the 
nature of the study, was lower than the recurrent abortion group (1.5 and
4.2 respectively).
In addition to attempting parity in the number of cases in the 2 groups,
an attempt was made to marry the number of tissue sections from each case
in the control group with those in the recurrent group. The number of 
blocks taken from any one case destined for histopathological examination 
is broadly designed to be representative of the amount of tissue obtained 
at surgery. Therefore each control case, in addition to the above criteria, 
had to match the recurrent abortion group in terms; of representative tissue 
under examination. In the final count, the 19 cases in each group involved 
the histological examination of 70 sections (35 from each group). All of 
the sections examined were of formalin fixed, routinely processed, paraffin 
wax embedded tissues cut at 4pm, and stained by haematoxylin and eosin. 
Further sections were cut and stained by the Papanicolaou method (Difruscio 
and Desa 1977) or by Lendrum's phloxine-tartrazine method (Lendrum 1947). 
Both of these techniques were found to be useful on occasion, in 
distinguishing fetal cells from maternal cells (Difruscio and Desa 1977, 
Pijnenborg et al, 1980).
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The checklist used for each sectiQn_examined
A qualitative report of each section examined by light microscopy was 
recorded using the format overleaf. The information is broadly divided 
into 3 sections (decidua, endometrial glands and chorionic villi), and each 
is further sub-divided. The results from each stained tissue section were 
collated and put into their appropriate case for subsequent evaluation.
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PATIENTS NAME
HOSPITAL REGISTRATION NUMBER
A G S _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
PARITY_____ I_ _ _ _ _ _ _ _ _ _ _
SLIDE NUMBER(S)______________
1 DECIDUA
2 inf lamination (cell type)_______________
3 involution of decidual cells___________
4 shrinking cell margins_________________
5 intervening spaces between cells
6 homogeneous spaces between cells______
7 necrosis_________________________________
8 invasion of decidua by cytotrophoblast
9 fibrin (distribution)__________________
10 Blood vessels
11 size (dilatation)______________________
12 endothelial proliferation_____________
13 invasion by cytotrophoblast___________
14 Endometrial granulocytes.
15 percentage granulated_________________
16 ENDOMETRIAL GLANDS
17 nuclear enlargement____
18 hyperchromasia__________
19 cytoplasmic vacuolation.
20 glandular degeneration_
21 CHORIONIC VILLI
22 syncytiotrophoblast______________________________________
23 placental bed giant cells________________________________
24 intact trophoblast sheath/involution of decidual cells.
25 hyalinisation (loss of trophoblast sheath)_____________
26 vascularisation___________________________________________
27 hydropic change___________________________________________
28 necrosis__________________________________________________
29 inf lamination (cell type)__________________________________
30 syncytial knots__________________________________________
ADDITIONAL OBSERVATIONS/NOTES
RESULTS.
For each of the main sections (decidua, endometrial glands and chorionic 
villi) a direct comparison can be made between the two groups (see Table
3). For example decidua was present in 92% of the sections examined in the 
control group and 79% of sections in the recurrent abortion series.
However, for the sub-sections to be of value, the results have to be 
assessed in the light of the above disparity (see Table 4). For example, 
involution of decidual cells was evident in 25% (control) and 53%
(recurrent abortion) of the sections examined. As 79% of the sections from 
the recurrent abortion group contained decidua, as stated above, the" 
percentage of sections showing involution of decidual cells was:
53 x 79
--------- = 41.9%
100
This adjustment was made because the cases were examined and then 
recorded in a qualitative rather than critical fashion. Each feature on the 
form was listed, as either + (present) or - (absent), although provision was 
made for any particular observations which could be taken into 
consideration when the information was evaluated.
Decidua
The extent of decidual necrosis and fibrin deposition was marked in both 
the recurrent abortion and control groups. In the control group, and to a 
lesser extent in the recurrent abortion group, there was a cellular 
infiltration of polymorphonuclear leucocytes (Figure 14 and 15). The most 
prominent features, most commonly seen in the abortion sections, were those 
of a slow decidual cell degeneration. Sections varied in the severity of
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decidual cell involution but exhibited many of the characteristics listed in 
Table 2, from shrinking cell margins resulting in intervening spaces 
between cells, to the more pronounced pyknotic nuclei and deep staining, 
homogeneous cytoplasm associated with advanced cellular degeneration 
(Figure 16).
In addition, the control sections showed some degree of endothelial 
proliferation of decidual blood vessel walls. Cytotrophoblast cell invasion 
of these blood vessels was not obvious to any great extent, despite the 
gestational maturity of the material examined. Evidence of endovascular 
cytotrophoblast was at best minimal, and only seen in the recurrent 
abortion group (Figure 17).
Endometrial glands
Endometrial glands were identified in 58% of sections examined from the 
control group and 21% in the abortion series. An Arias-Stella reaction, a 
feature characteristic of endometrial glands under the influence of human 
chorionic gonadotrophin (Figure 18 and 19), showed high disparity in the 
two groups in favour of the control group. Convolution of endometrial 
glands and glandular degeneration were not very evident in either group 
(controls: 5%, recurrent aborters: 2%).
Chprionlc„.yilli
Chorionic villi were identified in approximately 55% of the cases 
examined from each group. Only about one quarter of these cases showed 
evidence of fetal vessels in the villous mesoderm (Figure 20), although 
otherwise they appeared normal. Of the villi that appeared hyalinised, most 
could be described as 'ghost forms' embedded in and surrounded by red blood
59
cells and fibrin (Figure 21 and 22). Hyalinised villi both in stages of 
partial and complete hyalinisation, were more pronounced in the recurrent 
abortion group (17%/5%). In contrast, associated syncytiotrophoblast was 
more often recorded in sections from the control group. This is presumably 
a reflection of the higher percentage of normal villi seen in this group: 
villous necrosis was not evident in any sections from the control series, 
but represented 20% of the villi seen in sections from the recurrent 
aborters. Hydropic changes were only found in villi from the abortion 
group (Figure 23). Affected villi were swollen, avascular and surrounded by 
trophoblast in varying degrees of atrophy. An inflammatory cell infiltrate 
analogous to that seen in the decidua, was more apparent in the control 
sections than in those sections from the recurrent abortion group. In view 
of the intimacy of the two tissue types (decidua and chorionic villi) in 
situ, this cellular reaction was not interpreted as significant (see 
discussion).
Several anomalies associated with chorionic villi have been examined 
(hyalinisation, hydropsis, necrosis). Together, these were seen in over half 
(54%) of the sections containing chorionic villi in the recurrent abortion 
group, but only 5% of those in the control group. The presence of 
syncytiotrophoblast, placental bed giant cells, vascularised villi and 
inflammatory cells (not associated with villous destruction or invasion), 
all considered to be normally present in the tissues examined, were seen 
twice as frequently in sections from the control group.
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Table 3
Morphological characteristics from each ..section - collated but unadjusted
In this table, the information obtained by the histological examination of 
stained sections for particular morphological characteristics, has been 
collated and expressed as percentages. For example, 92% of the control 
sections and 79% of the sections from the recurrent abortion group 
examined, contained decidua. For the true degree of disparity for other 
features listed in this table, see Table 4
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MORPHOLOGICAL
CHARACTERISTICS
PERCENTAGE OF SECTIONS.
SHOVING MORPHOLOGICAL CHARACTERISTICS
CONTROL RECURRENT ABORTION
GROUP GROUP
1 Decidua 92 79
2 Inflammation 83 68
3 Involution of decidual cells 25 53
4 Shrinking cell margins 25 53
5 Intervening spaces between cells 25 47
6 Homogeneous cytoplasm/pyknotic nuclei 8 21
7 Necrosis 67 74
8 Invasion of decidua by cytotrophoblast 8 11
9 Fibrin 83 79
10 Blood vessels 67 53
11 Size (dilatation)
12 Endothelial proliferation 17 0
13 Invasion 0 11
14 Endometrial granulocytes
15 Percentage granulated -
16 Endometrial glands 58 21
17 Nuclear enlargement 42 16
18 Hyperchromasia 42 16
19 Cytoplasmic vacuolation 42 16
20 Glandular degeneration 8 11
21 Chorionic villi 58 53
22 Syncytiotrophoblast 50 21
23 Placental bed giant cells 42 21
24 Intact trophoblast sheath 
/involution of decidual cells
25 Hyalinisation 8 32
26 Vascularisation 42 42
27 Hydropic change 0 32
28 Necrosis 0 37
29 Inflammation (cell type) 17 5
30 Syncytial knots 33 53
Morphological characteristics froro..each-section - collated and adjusted
This table considers the sub-sections under the main headings: 1 
Decidua, 16 Endometrial glands and 21 Chorionic villi. The percentage of 
sections exhibiting the histological features (numbered 2-15, 17-20 and 22- 
30), as reported in the previous table, has been adjusted to demonstrate the 
true disparity that exists between the two groups for each feature, as 
explained in the Results section. The Discussion is drawn from this Table,
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MDRPHOLOGICflL P E R C E N T S  OF SECTIONS.
CHflRflCTERISTICS 5HQUIH6 HORPHOLOGICflL CHARACTERISTICS
CONTROL RECURRENT ABORTION
GROUP GROUP
1 Decidua 92 79
2 Inflammation 76 54
3 Involution of decidual cells 23 42
4 Shrinking cell margins 23 42
5 Intervening spaces between cells 23 37
6 Homogeneous cytoplasm/pyknotic nuclei 7 17
7 Hecrosis 62 59
8 Invasion of decidua by cytotrophoblast 7 9
9 Fibrin 76 62
10 Blood vessels 62 42
11 Size (dilation) - -
12 Endothelial proliferation 10 0
13 Invasion 0 4
14 Endometrial granulocytes - -
15 Percentage granulated - —
16 Endometrial glands 58 21
17 Huclear enlargement 24 3
18 Hyperchromasia 24 3
19 Cytoplasmic vacuolation 24 3
20 Glandular degeneration 5 2
21 Chorionic villi 58 53
22 Syncyt i ot rophoblast 29 11
23 Placental bed giant cells 42 21
24 Intact trophoblast sheaths/ 
involution of decidual cells —
25 Hyalinisation 5 17
26 Vascularisation 24 22
27 Hydropic change 0 17
28 necrosis 0 20
29 Inflammation (cell type) 17 5
30 Syncytial knots 19 28
Figure. .14.
Ia fiItr.atlo ii_Qf_^ecid»a,...i?y.-pQlyiP.or.phQnuQle.ar. leuc.Qgy.teg
Case number 10665/60
The growth and subsequent invasion of the maternal decidua <D) by 
placental tissue is rapid. Consequently, the separation of the decidua into 
decidua basal is and decidua parietalis is associated with some localised 
tissue damage. This destruction and regeneration process induces a focal 
infiltration of polymorphonuclear leucocytes <PL>. 
haematoxylin and eosin, microscope magnification xlOO
EigureJLS.
Infiltration of decidua by pQlymorphQiiuclear_leucocy_tes.
Case number 10.66.5.160.
Using a histochemical staining method (chloroacetate esterase) the 
cellular infiltrate seen in Figure 14 has stained selectively' red. These 
cells are derived from the myeloid series and are predominantly 
polymorphonuclear neutrophils,
chloroacetate esterase, microscope magnification xl60
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Eigure,..16
Involutio n, of,. flecidjjal--cells 
Case number 10665/80
Shrunken decidual cells lie within the spaces they have created. 
Cellular debris (CD) can be seen bottom right. A more generalised 
involution of the decidua, in which both cytoplasmic and nuclear staining 
becomes intense, can be seen throughout. The decidual blood vessels <BV) 
are thrombosed,
haematoxylin and eosin, microscope magnification xlOO
Eigune-lZ.
Endovascular cytotrophoblast 
Case number 3999/85 SJH
The invasion and occlusion of decidual spiral arteries (BV) by 
endovascular cytotrophoblast (EC and arrows) is a feature of human 
placentation. The resulting ischaemia is responsible for the decidual 
necrosis and damage to spiral arterial walls that ensues locally in the 
decidua basalis.
haematoxylin and eosin, microscope magnification xlOO
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Arias-Stella phenomenon 
Case number 0046/66 SJH
The Periodic acid-Schiff <PAS) histochemical technique used here, detects 
aldehyde groups present in glycogen and mucins. Much of the magenta 
(positive) staining seen in endometrial glands influenced by HCG, is lost 
when the section is pre-treated with diastase (lower of 2 photographs).
This confirms the presence of glycogen in many of the vacuolated cells 
associated with Arias-Stella glands. Because of the use of appropriate 
control sections it is possible to say that the positive staining seen in 
the lower figure is due to mucin and not glycogen.
a) PAS b) Diastase PAS, microscope magnification x63
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Figure 19
AriaszStella .phenomenon 
Case number 0046/86 SJH
The endometrial glands affected by human gonadotrophin (A) are larger 
and more convoluted than their neighbours (B). The nuclei are somewhat 
variable in size and staining intensity and may appear shrunken and densely 
stained, or enlarged, irregular in shape and suspended in swollen, clear 
cytoplasm. The effects induced by human chorionic gonadotrophin may 
continue for some time after fetal death, if the trophoblast that 
synthesises this hormone remains viable. M: myometrium
haematoxylin and eosin, microscope magnification x25
Figure 20
Tertiary chorionic villi 
Case number 87/7557
Cross sections of tertiary villi. The fetal blood vessels can be clearly 
identified (FBV) in the mesodermal core. Syncytial knots (SK) can also be 
clearly identified. These multinucleate cellular aggregates may break off, 
and via the intervillous spaces (VS), enter the maternal vascular 
circulation,
haematoxylin and eosin, microscope magnification x63
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Figure 21 (a)
Villous necrosis 
Case number 67/7525
In villous necrosis, chorionic villi lose their trophoblastic sheath of 
cells and become embedded in a mix of blood and fibrin. The fetal 
mesoderm of the chorionic villi does not become vascularised. These 
features contribute towards a picture of degenerative changes most commonly 
seen in abnormal embryonic development.
haematoxylin and eosin, microscope magnification x63
Figure 21 (b)
Using a special staining technique, the MSB (Martius Scarlet Blue), fibrin 
is clearly seen as red, red blood cells are yellow and the connective tissue 
mesoderm of the degenerating chorionic villi is blue.
MSB, microscope magnification x63
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Figure ...22
Hyalinised chorionic villi 
Case number 87/1348A
The presence of hyalinised villi <HV) in section is usually evidence of a 
blighted or defective ovum. Tertiary chorionic villi, that is chorionic 
villi vascularised by fetal blood vessels, does not occur. The surrounding 
trophoblast sheath atrophies and the picture is one of a poorly staining, 
irregular outline of homogeneous tissue, surrounded by decidua and maternal 
blood and fibrin.
haematoxylin and eosin, microscope magnification x63
Figure 23
Hydropic chorionic villi 
Case number 87/1348A
Avascular, hydropic chorionic villi <CV) may be indicative of abnormal 
embryonic development due to a blighted or defective ovum. Note the 
absence of fetal blood vessels in the mesoderm core which has been 
disrupted by fluid, and seen here as empty spaces (arrows).
Hydatidiform mole, haematoxylin and eosin, microscope magnification x63
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DISCUSSION
Residua
Decidua was sampled in most of the sections from the control group 
(92%) and a good percentage of those from the abortion group (79%). The 
most striking feature with respect to this tissue, must be the focal 
infiltration of 'inflammatory' cells (Figure 14 and 15). This is an 
encompassing word used to describe a mixed population of cells, 
characterised in particular by polymorphonuclear neutrophils, red blood 
cells, fibrin and accompanying necrosis. Localised areas of decidual 
infiltration were evident in some three quarters of the control sections 
examined and half of those in the recurrent abortion group. This cellular 
reaction is in fact, part of the normal process associated with 
haemochorial placentation (Robertson 1981). Decidua becomes separated 
after implantation of the blastocyst, into decidua basalis and decidua 
parietalis. The latter is destined to be that area of decidua that lies on 
the luminal side of the embedded blastocyst, whilst decidua basalis 
develops to accomodate invading trophoblast emanating from the blastocyst 
surface. Decidual separation and the subsequent rapid growth of both the 
fetus and placenta that follows therefore, produces a relatively continuous 
process of destruction and regeneration of tissue in the first trimester of 
pregnancy. This process involves cell lysis with the subsequent release of 
enzymes and cell products. There is dissolution and re-modelling of 
reticulin and collagen fibres (Dallenbach-Hellweg 1981) which contribute to 
the accumulating debris and localised necrosis. As in any analogous
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situation, an inflammatory cell response is effected to remove debris from 
the area of tissue concerned.
It is probable also that some necrosis develops as a result of 
endovascular invasion of maternal vessels by cytotrophoblast. This begins 
about 20 days after fertilisation, approximating with the formation of 
tertiary chorionic villi (invasion of the villous mesoderm by fetal blood 
vessels). Endovascular cytotrophoblast as the term implies, invades the 
maternal vessels that permeate through the decidua. Many of these spiral 
arteries eventually become plugged by colonizing cytotrophoblast thus 
generating areas of stasis in blood flow. The combination of stasis and 
reduced blood flow which produces eddy currents, generates fibrin 
deposition (Fox 1976) which contributes to the development of areas of 
ischaemia described above.
Whilst cytotrophoblast (see Figure 17) was not seen very often in 
sections from either group (7%/9%), other features that develop 
concomitantly were reported (placental bed giant cells, tertiary chorionic 
villi). Endovascular cytotrophoblast was in fact, only evident in the 
recurrent abortion group (4%). These findings whilst lower than 
anticipated, are dependent upon sampling of the intact placental bed. 
Placental bed giant cells for example breach the decidua and, along with 
cytotrophoblast, invade the myometrium. It is reasonable therefore, to 
allow for some discrepancies to accomodate both the inappropriate sampling 
of tissue and the inappropriate gestational maturity of that tissue sampled.
The second area of note relates to the decidual degeneration that is 
present in both groups but in particular, the recurrent abortion group. The 
criteria associated with a slow decidual cell degeneration, (shrinking cell 
margins, intervening spaces between cells) are evident in 42% of the
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sections from the abortion group, and 23% of those from the control group. 
The cellular degeneration is characterised by shrinking cell margins, which 
leaves spaces of varying degrees between neighbouring cells, many of which 
are filled with an homogeneous matrix. In haematoxylin and eosin stained 
sections, decidual cell cytoplasm appears deeply stained with eosin, which 
increases as degeneration becomes more pronounced. The nuclei suffer 
similarly, becoming smaller in size, darker staining and pyknotic (Figure 
16). In view of the percentage of sections portraying these features in the 
control group, it is possible that this is a further example of a normal, 
common and localised phenomenon associated with any normal pregnancy. The 
natural morphological progression (homogeneity of cytoplasmic staining, 
small densely staining, pyknotic nuclei), is evident again, in sections from 
both groups (7% [control], 17% [recurrent abortion]), but as can be seen 
this is less pronounced, and mainly to the detriment of the abortion group. 
Some evidence of a pathological process describing a slow, steady 
degeneration of decidua has been suggested in the literature. Dallenbach- 
Hellweg (1981) reports on cases in which these features are seen in 
association with ectopic pregnancy. However, it is important to make the 
distinction between this type of cellular degeneration and the rapid cell 
death more often associated with bacterial infections for example. 
Endometrial glands
In early pregnancy, high levels of progesterone contribute towards 
maintaining the endometrium as decidua. This is an exaggeration or 
extension of the secretary phase endometrium that is seen towards the end 
of the menstrual cycle. The state of this decidua in the sections examined 
has been discussed, and it is perhaps not surprising that endometrial 
glands could only be identified in 58% of the control sections and 21% of
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-the .recurrent abortion sections. Of particular interest is that 
approximately one quarter (24%) of these glands in the control group 
fulfilled the criteria of hypersecretion (nuclear enlargement, 
hyperchromasia and cytoplasmic vacuolation). In 5% of these cases there 
was also neighbouring glandular degeneration and the combined morphological 
criteria are in accordance with the observations described by Arias-Stella 
in 1954, and later by Lloyd (1965), and known as the Arias-Stella 
phenomenon. The glandular changes are thought to occur in conditions of 
over-stimulation by human chorionic gonadotrophin (HCG). Certainly in 
Arias-Stella affected glands, the changes are a reflection of an 
accumulation of this hormone in the endometrial stroma and decidua.
If the Arias-Stella reaction had been well represented in the recurrent 
abortion series, it would have been tentative to suggest that fetal death in 
situ had occurred in these patients. A dead fetus is unable to metabolise 
HCG and this would therefore accumulate in the maternal circulation and 
decidua. There was little evidence from sections examined in either group 
not showing the frank features of an Arias-Stella reaction, that there was 
a waning of this phenomenon (ie. glandular degeneration). Neither was 
there an indication of pregnancy failure of either fetal or maternal origin, 
when there might be decidual and endometrial glands portraying a prominent 
"star-like" appearance due to cessation of maternal hormone production 
(Arias-Stella 1954).
Chorionic vi lli
Chorionic villi were seen in a little over half of the sections in both 
groups (58% [control], 53% [recurrent abortion]). The degree of discernible 
vascularised chorionic villi (Figure 20) was lower than expected, although 
surprisingly, was consistent in both groups (24% [control], 22% [recurrent
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abortion]). Villous necrosis (Figure 21) and hydropic changes (Figure 23) 
were the two most significant features reported in this section.
The extent of villous necrosis in the recurrent abortion group (20%) 
unfortunately precluded any realistic attempt at identifying the cause of 
abortion. Any conclusions that can be drawn from looking at a transitional 
state between rapid and gradual villous degeneration of normal and 
maldeveloped chorionic villi can only really be attempted when the 
morphological appearance falls short of obvious necrosis. In all conditions 
in which there is a restriction of the blood flow to the villi (eg fetal 
artery thrombosis), the underperfused villi show fibrosis of the stroma and 
a marked increase in syncytial knot formation (Fox 1976). The presence of 
syncytial knots was more pronounced in the recurrent abortion group 
(19%/28%) as was the degree of villous necrosis, and it is logical to 
assume therefore that these findings may be a consequence of impairment of 
fetal vasculature. This cannot be determined for certain of course as it is 
not possible to establish the normal amount of syncytial knot formation, 
yet alone an increase, in the sections examined.
For a placenta to perform efficiently it must have a good complement of 
functioning villous units. It follows, that if the degree of necrosis is 
localised to small areas of the placenta and the placenta is uncompromised 
by other such anomalies then the villous necrosis is of no consequence. It 
does mean however, that placental function is dependent upon a reduced 
number of villi. If villous necrosis is a consequence of a haematoma 
occurring retroplacentally or a thrombosis of the maternal utero-placental 
vessels (Brosens and Renaer 1972), then it may be necessary to examine the 
entire placenta before a definitive opinion can be formed. Widespread 
thrombosis of maternal arterioles is found in some hypertensive patients
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and the ,utero-placental vessels in these patients are largely abnormal. In 
these cases the blood flow throughout the placenta is seriously impaired 
and the pregnancy is compromised (Robertson, personal communication).
In all sections in which there were chorionic villi, there was some 
evidence of villi emeshed in fibrin; described by Fox (1976), as perivillous 
fibrin deposition (see Figure 21). Whilst acknowledging that the total 
number of villi are present, it is obvious too, that villi surrounded by 
fibrin in this fashion are non-functioning; oxygen and nutrient exchange 
being physically impaired. Evidence of this is apparent from Tables 3 and 
4 (see hyalinisation). Fox (1976) attributes this fibrin deposition around 
the chorionic villi, to a combination of eddy currents and local cessation 
of maternal blood flow in the intervillous spaces. Physiologically it is 
only rarely considered to be of consequence as again, it is a localised 
anomaly.
There is other evidence of villous impairment in the sections examined. 
In both groups, less than a quarter of the cases had chorionic villi 
exhibiting fetal vessels. The gestational maturity of the material examined 
would suggest that this is not normal. The close relationship (24%/22%) 
shared by the groups in respect of this feature, suggests otherwise.
It is acknowledged that there is often no obvious reason for fetal artery 
thrombosis, which is usually the cause of avascular villi. The impaired 
fetal artery and the villi it serves are obviously not participating in 
oxygen and nutrient exchange, but it has been reported that the placenta 
can tolerate some 30% functional loss of this kind without fetal distress 
(Fox 1976). '
Hydropic changes of chorionic villi have also been considered common 
findings in spontaneous abortion, occurring most frequently when the fetus
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is abnormal (Hertig. and Edmonds 1959, see Elston 1981). Such villi develop 
from blighted ova, where there is evidence of actively secreting trophoblast 
encompassing an avascular (because the fetal circulation does not develop), 
hydropic villus. It should be noted that not all pathological ova produce 
hydropic villi and fetal death is not necessarily reflected by an 
accumulation of fluid within its functional units. Park (1971) suggests 
that hydropic change can sometimes be a consequence of oversecretion by 
the trophoblast (trophoblast dysplasia or hyperplasia), the fluid 
accumulating within the villous stroma. Hydropic villi associated with 
fetal death is not invariably due to a blighted ovum therefore, as hydropic 
changes instigated by an over-active trophoblast will also impair embryo 
development depending on the extent of this condition. It is quite normal 
for a few normally developing chorionic villi to undergo hydropic 
degeneration (Dallenbach-Hellweg 1981). The trophoblast surrounding these 
villi tend to be atrophic or degenerate though.
There is evidence that hydatidiform moles (in which hydropic changes 
are pronounced, see Figure 23) are associated with chromosomal 
abnormalities (Elston 1981). This finding is however, equivocal in partial 
and less well defined moles and has no relationship per se with hydropic 
changes seen in recurrent abortions.
Changes in both the decidua (slow involution of decidual cells) and 
chorionic villi (hydropic villi) would seem to suggest that in the recurrent 
abortion group, some 36% of the sections examined reflected features 
associated with faulty embryo development. The lack of an inflammatory 
cell infiltrate, if one accepts this to be a normal phenomenon associated, 
with pregnancy, is a further indication that the pregnancy is not 
developing well. This observation is tentative however, as although there
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are large numbers of polymorphonuclear leucocytes invading the decidua, the 
cell populations have not been fully assessed in a way performed by other 
workers (Bulmer and Johnson 1985).
The control series in particular, has posed some interesting and 
unexpected observations. The sections did not entirely reflect the 
morphological features one would expect from interrupting what is assumed 
to be an anatomically and physiologically normal pregnancy. This was 
allowing for the fact that statistically, a small number of the pregnancies 
in the control group would not have reached term anyway. In a substantial 
number of cases where comparisons were particularly difficult, the 
examination of unrepresentative material cannot be ruled out. Overall, the 
recurrent abortion material available for review has fallen into two groups. 
The first group contains cases that fulfill the requirements discussed 
above, and relate to faulty embryo development. Seven of the nineteen 
patients reviewed here, fall clearly into this category. The remaining 
cases that comprise the second group is ill defined. Whilst they may 
contain tissue that is unrepresentative, the reasons beyond -this observation 
remain speculative.
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CHAP.TER...3.
ENDOMETRIAL GRANULOCYTES IN RECURRENT ABORTION
INTRODUCTION
Endometrial granulocytes were probably first described by Duval in 1891 
(Cardell et al, 1969), who believed that these cells in the rat at least, 
performed a secretory function. Several other roles for this cell have been 
suggested (Selye and McKeown 1935, Baker and Bridgman 1948, Cardell et al, 
1969) but current evidence favours either an immunological or hormonal 
function.
The suggestion that the endometrial granulocyte may be associated with 
the immune response in pregnancy was first postulated on morphological 
grounds - the endometrial granulocyte was believed to be derived from the 
lymphoid cell series (Weill 1921, Smith 1966). Dickson (1980) sought more 
tangible evidence of this association by evaluating the endometrial 
granulocyte response in the decidua of in-bred and out-bred strains of 
mice. The antigenic disparity of these mice was reflected in the greater 
numbers of endometrial granulocytes appearing in the decidua of the out- 
bred strains of mice. Additional support for an immunological role was 
forthcoming, and in 1977 Bulmer and Peel demonstrated IgG in the metrial 
gland cells of the rat. More recently it has been confirmed by immuno- 
cytochemistry that endometrial granulocytes belong to the lymphocytic or 
granulocytic cell series (Bulmer and Sunderland 1983). This would suggest 
that they are derived from stem cells of the bone marrow, an observation 
supported by Krcek and Clark (1985) in their studies on mice. Fluorescent- 
labelled bone marrow-derived cells, predominantly granulated small
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lymphocytes, and fulfilling the morphological characteristics of. endometrial 
granulocytes, were shown to migrate to implantation sites in placental 
decidua. Accumulation of these cells in such localised areas in human 
placentation is well recognised (Dallenbach-Hellweg 1981) and collectively 
the evidence favouring an immunological role for the endometrial 
granulocyte is strong.
The alternative hypothesis which suggests that the endometrial 
granulocyte synthesises a hormone, is based on evidence emanating almost 
exclusively from studies on the polypeptide hormone called relaxin. It was 
probably Bridgman (1948) who first proposed that granular metrial gland 
cells, in the rat may secrete relaxin, and there has since been additional 
indirect evidence in support of this (Hellweg 1956, Dickson and Bulmer 
1961). In 1964, Dallenbach and Dallenbach-Hellweg demonstrated relaxin in 
endometrial granulocytes localised in the decidua of human placenta. This 
was performed using a fluorescein-labelled antibody technique and the 
results subsequently repeated in the rat and the monkey (Dallenbach-Hellweg 
1981).
The endometrial granulocyte doubtless has an important role in human 
pregnancy, and the evidence for this will be reviewed more fully in later 
chapters. This chapter is concerned with determining whether the 
distribution and population of the endometrial granulocyte in the decidua of 
human pregnancy in recurrent aborters differs from that seen in normal 
pregnancy. These cells are well placed to be involved in immunological 
surveillance since they migrate to the interface between maternal cells and 
fetal cells that have the potential to express paternal antigens. 
Alternatively, their distribution could equally be associated with the 
dissociation and dissolution of connective tissue fibres. This is seen in
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the endometrial stroma preceding menstruation (Figure 25), at sites of 
blastocyst implantation and where there is decidual invasion by fetal 
trophoblast. The morphological changes common to these three sites are a 
feature of relaxin activity; at all three sites too, endometrial granulocytes 
predominate. If a quantitative difference exists in these cells in 
pregnancy resulting in abortion, compared with pregnancy expected to reach 
term, then this would suggest that the endometrial granulocyte is concerned 
with, or is affected by, abortion. If the two current concepts postulated 
for the endometrial granulocyte are viable, a numerical reduction or 
significant increase in these cells in recurrent abortion could indicate 
either an immunological or endocrine disorder.
The enumeration of endometrial granulocytes in decidua can be performed 
with relative ease using the phloxine-tartrazine method of Lendrum (1947) 
(Figures 26 to 29). The combination of the morphological appearance of the 
deeply staining, oval or slightly indented nucleus, and the bright red, 
phloxinophilic cytoplasmic granules allows these cells to be identifed 
clearly against a yellow (tartrazine) background. It is unlikely however, 
that counting these cells will provide an accurate reflection of the total 
number of endometrial granulocytes within a defined area of tissue. As 
reported by Dallenbach-Hellweg (1981), endometrial granulocytes liberate 
their granules under defined physiological conditions, controlled probably 
by steroid hormones. To undertake a total cell count of endometrial 
granulocytes, it would also be necessary to identify the de-granulated 
population of cells. This poses problems, as the morphological appearance 
of the nucleus becomes the only criterion on which to count these cells.
The second half of this chapter therefore is devoted to finding a cell 
marker which would enable the endometrial granulocyte to be identified in
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its de-granulated state. A comprehensive,range of histological and 
histochemical staining techniques were attempted to this end, and these are 
now described and illustrated in a later chapter on the characterisation of 
this cell. This chapter assesses the value of lectins as cell markers. 
These are proteins of non-immune origin (many are purified from plant 
tissues) that bind specifically to carbohydrates occuring predominantly, 
though not exclusively at the cell surface (Leathern and Atkins 1983). Lee 
and Damjanov (1984) evaluated a large number of lectins on human placenta, 
and their results prompted their use in this chapter.
MATERIALS AFP METHODS
The tissue sections used for this chapter were cut from paraffin wax 
blocks used previously in Chapter 2. The screening of recurrent abortion 
cases was rigorous, 237 cases were identified over a 15 year period. 
Eventually, 19 cases were considered suitable for assessment. The extensive 
reduction in the number of suitable cases was due to several factors. Some 
of the material was morphologically unsuitable, in that the tissue sections 
contained either necrotic tissue or blood clot only. Other cases were found 
to be unrelated to the study (obstetric histories being recorded for 
appendicectomy or laparotomy). A final screening of the patients clinical 
history excluded cases in which there was evidence of venereal disease, 
cancer, physical abnormality or other predisposing conditions acknowledged 
to compromise pregnancy.
Each remaining case was then matched using material from elective, 
suction terminations of pregnancy, to ensure as near as possible a control
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population suitable for comparison with the recurrent abortion group.
Parity between the two groups was attempted in two areas:
1) the average age of the patient
24.5 years (control), 28.3 years (recurrent abortion)
2) the average gestational age of the material examined 
9.4 weeks (control), 11.2 weeks (recurrent abortion)
The average number of pregnancies in the control group, by the nature of 
the study, was lower than the recurrent abortion group (1.9 and 4.2 
respectively).
All of the sections examined were fixed in 10% buffered formol saline, 
routinely processed, paraffin wax embedded, cut at 4 pm and stained by 
haematoxylin and eosin. These sections were then examined for areas of 
intact, non-necrotic decidua, free from overt cellular infiltration by 
polymorphonuclear leucocytes. Due to the small amounts of decidua 
fulfilling these requirements in some of the sections, the cell counts were 
standardised throughout the study to 10 fields/section. Using a Leitz SM- 
Lux light microscope and a x40 objective, the area of a photographic eye­
piece graticule was calculated by micrometry (40.05pm x 28.35pm). A 'field' 
was taken to be the area within the rectangle delineated by the 
photographic eye-piece graticule. The total area examined for each section
was estimated to be 11354 square microns (40.05pm x 28.35pm x 10 fields).
)
Cell counts of granulated endometrial granulocytes were performed blind 
on sections stained by the phloxine-tartrazine method of Lendrum (1947). 
Only cells fulfilling the morphological criteria of endometrial granulocytes 
and containing at least one intact red staining cytoplasmic granule were 
counted.
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An attempt was also made to identify a population of de-granulated 
endometrial granulocytes. Without their distinguishing phloxinophilic. 
granules, these cells become morphologically difficult to identify and 
therefore some reliance was placed on the use of consecutive or serial 
sections. The first section was stained with phloxine-tartrazine and the 
distribution of endometrial granulocytes noted. The second and subsequent 
sections were stained immunocytochemically using a panel of 5 lectins: 
concanavalin A (jack bean), wheat germ agglutinin, peanut agglutinin, 
dolichos biflorus (horse gram) and ulex europaeus (common gorse). This 
technique relies on the selective binding of lectins to particular 
carbohydrate moieties, in this case, glycoconjugates associated with the 
cell membrane. Any binding is demonstrated by applying an appropriate 
anti-lectin antiserum and subsequently labelling this with horseradish 
peroxidase, itself labelled with diaminobenzidine. It was considered 
necessary to judge any positive cells firstly by the morphological 
appearance of their nuclei and secondly by comparing their distribution 
with those in the phloxine-tartrazine stained sections depicting granulated 
endometrial granulocytes. The results of any cell counts undertaken could 
then be interpreted in absolute numbers of endometrial granulocytes, and 
therefore include granulated cells in addition to de-granulated cells. 
Granulated (phloxinophilic) endometrial granulocytes could then be 
expressed as a percentage of the total cell population.
The staining methods used in this chapter can be found in the appendix 
on staining methods.
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Statistics
Statistics were used to determine whether the difference in the number 
of endometrial granulocytes counted in the recurrent abortion and control 
groups was statistically significant. The variance, or range of figures in 
both groups is wide which precluded the use of Student's t test, as this is 
dependent upon equality, or near equality of variance. The non-parametric 
Mann-Whitney U-test was therefore used, since this analysis is independent 
of variance (Snedecov and Cochran 1980).
RESULTS
Cursory examination of the haematoxylin and eosin stained sections from 
both groups revealed a wide variation in the probable number of endometrial 
granulocytes present in the decidua. Figure 25 (a and b) represents an area 
of decidua in which there appears to be substantial numbers of endometrial 
granulocytes. The section is stained by haematoxylin and eosin. Whilst 
the granulocytes can be recognised by their nuclei and eosinophilic 
granules (Figure 25(b)), small numbers of these cells would not be easy to 
discern, as could be envisaged in Figure 26, if this were stained by 
haematoxylin and eosin. Wide variations in the amount of decidua present 
were also encountered and these imposed limitations on the area in which 
cell counts could be undertaken. Confining the number of fields to 10, 
allowed 19 cases of recurrent abortion material to be screened from a 
possible 22 cases shortlisted from 237 cases identified.
Cell counts were not performed in areas of decidua infiltrated by 
polymorphonuclear leucocytes as it has been reported that endometrial 
granulocytes tend to be absent where there is infiltration by these cells 
(Dallenbach-Hellweg 1981), an observation supported by this study.
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The sections were examined without knowledge of the group from which 
they came, and the case number from each section was attributed to either 
the recurrent abortion or control group after completion of the study. If 
there were more than one section for a case then cell counts were carried 
out on each section and-'the numbers averaged. Two observations became 
apparent during the identification and subsequent enumeration of the 
endometrial granulocytes, and these were checked after the counts were 
tabulated. The first revealed in the recurrent abortion group, a consistent 
disruption of the cytoplasm of what were assumed to be endometrial 
granulocytes. There were red staining granules in the vicinity of many of 
these cells, but not in direct apposition to their nuclei (Figures 27, 28 
and 29). Secondly, there appeared to be fewer granules in many of the 
cells in sections from recurrent aborters compared with those of the 
control group.
The results are illustrated graphically in Figure 24. They have been 
re-arranged in each group to run from the lowest cell count to the highest 
(see Tables 5 and 6). The Mann-Vhitney U-test calculated from these 
figures (the highest from each group was omitted) indicates that the 
results are statistically significant (p<0.006). The statistical 
calculations can be found in the appendix at the end of this chapter.
A cell marker for non-granulated endometrial granulocytes was not 
identified using the panel of lectins available. The results recorded in 
Table 7 and Figures 30 to 35, are disappointing in this respect, in that 
they do not support the findings of Lee and Damjanov 1984, who used lectins 
derived from the same source but visualised with a fluorescein dye rather 
than horseradish peroxidase.
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Table ..5.
Details of the recurrent abortion -.series,
19 cases (1-19) were assessed involving cell counts of 29 sections, 
reasons given in the discussion, case number 19 was not included when 
calculating the statistical significance of the results.
For
85
NUMBER CASE NUMBER AGE(PATIENT) NUMBER OF GESTATIONAL AGE NUMBER OF CELLS
PREGNANCIES (WEEKS) (lOxHPF)
1 1567-8/82 28 3 14 0
2 10665/80 36 3 10 0
3 20-21/79 25 4 11 0
4 627/78 24 3 13 0
5 2637/75 21 5 9 0
e 10912/79 42 5 8 0
7 85/2915 39 6 12 0
8 5436-9/79 25 5 14 0
9 10853-4/80 39 7 10 3
10 1804/80 39 6 11 3
11 8878/78 26 3 12 3
12 84/9367 23 3 15 4
13 13314/81 21 3 10 6
14 9629/74 18 3 11 7
15 8708/32/79 22 4 7 11
16 7939-40/76 32 4 9 15
17 6607-8/82 26 7 11 18
18 2418-9/75 28 3 14 25
19 13855/82 24 3 11 42
TOTAL NUMBER OF CELLS COUNTED 95 
MEAN CELL NUMBER 5,3
STANDARD DEVIATION 7.17
Table 6
Details of the control ■.series
19 cases (20-38) were assessed involving cell counts of 37 sections. 
For reasons given in tbe discussion, case number 38 was not included when 
calculating tbe statistical significance of tbe results.
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NUMBER CASE NUMBER AGE(PATIENT) NUMBER OF GESTATIONAL AGE NUMBER OF CELLS
PREGNANCIES (WEEKS) (lOxHPF)
20 6520-1/82 31 1 10 0
21 9731-4/82 23 1 14 0
22 11866-8/82 27 2 8 0
23 10508-9/82 27 5 11 0
24 - 11247-50/82 33 2 8 1
25 9611-2/82 24 2 9 10
25 10905/82 20 2 8 12
27 12339-40/82 20 1 10 16
28 6307/82 19 1 10 26
29 10848-9/82 20 1 8 26
30 7161/82 23 2 8 30
31 2888/86 24 1 9 35
32 1757/85 28 1 8 41
33 7718-9/82 27 2 9 43
34 2009/85 32 4 6 50
35 6498-9/81 24 3 12 62
35 '9438-41/82 26 3 14 78
37 1753/85 21 1 7 78
38 1755/85 16 1 9 188
TOTAL NUMBER OF CELLS COUNTED 508 
NEAN CELL NUMBER 28,2
STANDARD DEVIATION 25,48
Figure 24
Endpinetr.i&i...graPtilqoyjbfi.-ge.ll.-gQvintg..iII.«g.trated--gcapMcalIy.
Graph showing the number of granulated endometrial granulocytes in 
recurrent aborters and matched controls. The highest figure from each 
group was deleted (see discussion). .
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Table 7
Lectin...staining.
Fone of the lectins used, stained endometrial granulocytes or their 
granules. Other cell entities were positive however, and these are recorded 
as +. ¥here staining was weak this has been denoted +/-, and negative 
results are -. Fo significance has been attributed to this staining, but 
the results are generally in accordance with other workers (see text).
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Concanavalin A Vhsat g e m  . 
agglutinin
Peanut
agglutinin
Dolichos
biflorus
Uiex europaeus • 
agglutinin
PRE-DECIDVAL CELLS ' 
(secretory endometrium)
4 - - 4 -
ENDOMETRIAL GLAND EPITHELIUM 
(secretory phase)
+(A) - +/- + +(A)
DECIDUAL CELLS OF PREGNANCY 4 - - V -
DECIDUAL GLANDS 4 +/- 4 4 -
ENDOTHELIUM OF BLOOD VESSELS 4 +/- - - 4
CHORIONIC VILLI 4 4
I) cytotrophoblast - - - - -
II) syncytiotrophoblast 4 4
' ' '
ENDOVASCULAR CYTOTROPHOBLAST - - -• - -
INTERSTITIAL CYTOTROPHOBLAST - - - - “
ENDOMETRIAL GRANULOCYTES “ - - - *>
PLACENTAL BED GIANT CELLS V V - - -
ARIAS-STELLA GLANDS 4 4 4 4 4
ENDOGENOUS PEROXIDASE 
(eg red blood cells)
4 4 4 4 4
(A); positive with apical staining (staining is restricted to the luainal area of the cytoplasm) 
(V); variable staining (positivity is inconsistent. Some cells have stained in one area of the 
section but are negative in other areas),
Figure 25<a)
Haematoxylin and eosin stained section of endometrial granulocytes In 
decidua,
A haematoxylin and eosin stained section of decidua (D) with large 
numbers of endometrial granulocytes in the vicinity of a blood vessel (V). 
The cells can be recognised by their dark staining oval, or slightly 
indented nuclei, and pink cytoplasm. Microscope magnification x250.
Figure 25 <b)
Haematoxylin and eosin stained section, illustrating endometrial granulocyte. 
granule ...staining:
A high power view of the field in Figure 25 <a) above, shows clearly the 
eosinophilic granule staining associated with endometrial granulocytes. 
Microscope magnification x400
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Fig.ur.e_26.
Endometrial granulocytes stained by Phloxine-tartrazine
An example of a phloxine-tartrazine stained section in which there are 
only 1-2 cells in a high power field <a positive cell is arrowed). Case 
number 9629/74 (recurrent abortion group). Microscope magnification x400
F-ig]jr.g-2Z
Endometrial-.granu.lqg.yt.e.g-Stained ,.by -Ehl.Qx.inert.ar.trazine.
An example of a phloxine-tartrazine stained section in which there are a 
moderate number of positive staining cells (5-8) in a high power field.
This section also shows positive staining granules in the vicinity of 
probable endometrial granulocytes, although the granules appear to have 
been liberated from the cell (arrowed). Further evidence of this can be 
seen in Figures 28 and 29. Case number 2418/82 (recurrent abortion group). 
Microscope magnification x400
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An example of a phloxine-tartrazine stained section in which there are 
large numbers of positive staining cells (10-15) in a high power field. 
Case number 12339/82 (control group). Microscope magnification x400
Figure -29.
Endometrial granulocytes stained by phloxine-tartrazine
An example photographed from the control series (case number 1756/85) 
in which there were large numbers of granulated endometrial granulocytes 
(in excess of 15 in a single high power field). This case was 
unrepresentative of sections examined in both groups in respect of the 
number of positive staining cells, Microscope magnification x400
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Figur.e..3-Q
Imrounoperoxidase staining using. the..lectinJ¥hea_t_ Gem-Agglutlnin _(¥GA)_
¥ith the exception of trophoblast staining (shown here), ¥GA only 
stained the apical portions of endometrial glands, and this was not a 
consistent finding. Case number 4619/85. Microscope magnification x400
Figure 31
Immunoperoxidase staining using the lectin. Concanavalin A
The staining of trophoblast is much stronger than that illustrated 
above. Vhilst impressive, Concanavalin A staining is too widespread to be 
of any value as a marker for the endometrial granulocyte. Case number 
4619/85. Microscope magnification xlOO
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Figure 32
Iffiffiu.aQ.p.erQKi<iase...gl;ain.ing-using, ■tiie- legiip.-£Qn.Q,a.naY.ali.n.-A
Concanavalin A stains the cytoplasm of endometrial gland cells strongly. 
Both stromal cell cytoplasm and pre-decidual cells in late secretory phase 
endometrium also stain well. In this Figure, involuting decidual cells (DC) 
are staining positively with this lectin, as is the endothelium of the blood 
vessels (E), Case number 8831/82. Microscope magnification x250
Figure..33.
Immunoperoxidase staining using the lectln-Peanut.Agglutinin.
Endometrial glands stain positively with this lectin, although the 
stroma, stromal cells and pre-decidual cells are negative, as are 
endometrial granulocytes. As shown here, decidual glands stain strongly. 
Vessel endothelium and syncytial staining is negative. Case number 
8831/82. Microscope magnification xlOO
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E i g M E f i L - S A .
ImmnDQfiecQKidase-Staliilng using the lectin Peanut Agglutinin (PM)
The positive staining of endometrial glands extends to the staining of 
the cytoplasm of Arias-Stella affected cells, as shown here. Case number 
0046/86, Microscope magnification xlOO
Figure 35
Immunoperoxidase staining for endometrial granulocytes using Peanut 
agglutinin (PNA)
The cells arrowed are probably endometrial granulocytes, Cells that 
morphologically fulfilled the criteria of granulocytes did not react 
immunocytochemically with any of the panel of lectins available.
Case number 8831/82. Microscope magnification x250
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Cell counts were undertaken on 19 cases from each group (recurrent 
abortion and control). Due to a very high figure recorded in the control 
group (case number 38) an alternative case was considered. The next 
suitable specimen that was received in the department, i.e. one that 
fulfilled the criteria presented in the materials and methods section, was 
cut and stained with phloxine-tartrazine. Unfortunately the subsequent cell 
counts made, yielded results virtually identical to those already tabulated. 
It was decided on the grounds of statistical accuracy, to draw conclusions 
after deletion of this case and the case with the highest cell count in the 
recurrent abortion group (case number 19), The statistics calculated before 
and after these deletions, are available in the appendix section, and the 
aberrant figures are included in the results section and graph for 
completion.
Endometrial granulocytes in recurrent abortion
Of the 18 cases in which cell counts were performed, 44% of these had 
decidua which appeared entirely free of granulated endometrial granulocytes 
(cell counts in 10 high power fields totalling 0). Vhilst this contributed 
substantially to the low mean cell number for this group (5.3), it is 
equally apparent that compared to the controls, the majority of cases in 
this group yielded low cell counts. The enumeration of granulocytes also 
revealed in this group, that many of the cells were not counted possibly 
because the cell granules were not in direct' apposition to the nucleus of 
the cell, but liberated and some distance from it. In addition it was noted 
that there tended to be, quantitatively, less granules in many of the cells
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counted. These two observations were made prior to the knowledge of the 
group to which the tissue section belonged.
Endometrial granulocytes in first .trimester pregnancy (control group).
In contrast to the recurrent abortion series, 22%, (or half the number of 
cases in the recurrent abortion series), of the cases examined in this 
group contained decidua which appeared free of endometrial granulocytes.
The mean cell number is some 5-6 times higher (28.2) than the recurrent 
abortion group, however, and the remaining cases returned counts, 56% of 
which were higher than the highest recorded for the recurrent abortion 
series.
Lectins as cell markers.
Lectins are proteins found primarily in plant tissues. They bind 
covalently to specific carbohydrates that occur predominantly on the 
surface of cells. Labelled to fluorescein dyes or enzymes like horseradish 
peroxidase, lectins have provided a way of selectively identifying 
particular populations of cells. Their value in distinguishing normal cells 
from abnormal cells has led to a more comprehensive understanding of 
tumour pathology of the breast for example (Walker 1984), and in the 
classification of lymphoid tissue (Strauchen 1984). Their highly selective 
recognition of oligosaccharides that constitute part of the outer cell 
membrane, is in many ways, analogous to that of antibody recognising 
epitopes of antigens complementary to its binding sites.
The use of lectins in this chapter was at the outset, unjustified. 
Evidence for their potential value as cell markers was subsequently sought 
however, and positive staining of granulocytes in human pregnancy by 15 
different fluorescein conjugated lectins has been reported (Lee and Damjanov 
1984, 1985).
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As stated in the previous section, none of the 5 lectins used in this 
study detected any cells morphologically resembling endometrial 
granulocytes. Figures 27 to 31 illustrate the distribution of staining for 
each of the lectins. The discrepancies that exist between the staining 
reported by Lee and Damjanov (1984) and that reported in this chapter, can 
most likely be explained by their use of a fluorescein conjugated dye. 
Fluorescence microscopy has the advantage of amplifying positive staining 
compared with conventional staining techniques, by providing the maximum 
contrast between positive entities and their background. The morphological 
characteristics of individual cells not organised as tissues is however 
largely lost, and it is this criterion which is crucial to the aims of this 
chapter. For this reason positive cells were visualised using 3,3'- 
diaminobenzidine tetrahydrochloride (DAB) in preference to a fluorescein 
dye, which allows the use of conventional light microscopy. The lectins 
(concanavalin A, wheat germ agglutinin, peanut agglutinin, dolichos biflorus 
(DBA), and Ulex europaeus) and their appropriate anti-lectins were obtained 
from a highly reputable source and their efficacy was not in question.
From the results obtained in this chapter there was no evidence to suggest 
any false negative staining of endometrial granulocytes. The granulocyte 
staining reported by Lee and Damjanov (1984) was reported as an 
observation, and did not constitute the main thrust of their article. This, 
and the knowledge that fluorescence microscopy was used as a means of 
determining the positive staining of discrete cells (endometrial 
granulocytes) as well as less transient populations of cells and organised 
tissues (Hofbauer cells, trophoblast), suggests to the reader that the cells 
identified as endometrial granulocytes were not subjected to critical 
evaluation.
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Whilst the results of lectin staining used in this chapter (Table 7) are 
in accordance with other workers (Johnson and Faulk 1976, Lee and Damjanov 
1984,1985) they are of no value in the identification of endometrtial 
granulocytes in this study.
The endometrial granulocyte in the synthesis of relaxin
It has not been possible to determine whether there is a reduction in 
the total number of endometrial granulocytes in the maternal decidua of 
recurrent aborters compared to that of a control population. However this 
study does suggest that the number of granulated endometrial granulocytes 
is reduced in recurrent aborters. In view of the incidental finding of 
phloxine staining granules scattered in the vicinity of cells resembling 
granulocytes, and an observation that there are fewer granules in many of 
these cells, it is tempting to speculate that the total cell population of 
the endometrial granulocyte in both groups is similar. In which case, the 
endometrial granulocytes in the recurrent abortion group are de-stabilised 
cells that have liberated their granules in an untimely fashion.
If it is believed that endometrial granulocytes synthesise the 
polypeptide hormone relaxin, then an uncontrolled, overt release of this 
hormone could result in dissociation of the placenta from its maternal 
interface. One of the effects of relaxin is to bring about localised 
dissociation of connective tissue (reticulin and collagen fibres) (Schwabe, 
Steinetz et al, 1978, Dallenbach-Hellweg 1981). Relaxin secretion is likely 
to be controlled by steroids (Hisaw and Hisaw, 1964, Cardell, Hisaw et al, 
1969, Schwabe, Steinetz et al, 1978, and Stewart, Stabenfeldt et al, 1982) 
and it has been shown that the greatest concentration of circulating 
relaxin occurs under physiological conditions regulated by progesterone 
(Zarrow 1961). Low or falling concentrations of progesterone, or perhaps a
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change in the ratio of oestrogen to progesterone (effectively a 'dilution' 
effect on progesterone) has the effect of altering the permeability of the 
endometrial granulocyte cell membrane, inducing de-granulation (Bitensky 
and Cohen 1965, Dallenbach-Hellweg 1981). If low levels of progesterone 
can induce de-granulation then an explanation for the numerical reduction 
of these cells in recurrent aborters has been found, as many of these 
patients experience low levels of serum progesterone.
The endometrial granulocyte as an immune cell
Regardless of the function of the endometrial granulocyte within the 
broadest concept of the immune system, its numerical reduction in recurrent 
aborters means it is less able to perform a particular function. In 
contrast, if there is no numerical reduction, but de-granulation is occuring 
(which could be misinterpreted as a numerical reduction of cells since de­
granulated cells would not be counted), then the granulocyte may be 
performing its role only too well. The significance of these facts is 
dependent upon the role attributed to this cell. This is exploited in a 
later chapter (Chapter 5) in relation to the immunology of pregnancy. As 
outlined earlier in this chapter, there is strong evidence in support of an 
immunological role for the endometrial granulocyte. Morphologically it 
fulfills the descriptions given for a class of lymphocytes known as 'third 
population' or 'null' cells (Roitt, Brostoff et al, 1985).
This chapter has reinforced the need to determine the functional 
characteristics of the endometrial granulocyte. Their numbers may be 
significantly reduced in recurrent aborters. Alternatively, these cells may 
under defined physiological conditions not manifest normally in pregnancy, 
release their cytoplasmic granules prematurely or untimely.
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CHAEEEELS.
APPETOIX
HAEMATOXYLII AffD EQSIH
METHOD.
1 Dewax paraffin sections in xylene, 2 mins.
2 Hydrate sections through alcohol to distilled water.
3 Stain in alum haematoxylin (approximately 2 mins)
4 Vash ('blue') sections in running tap water, 5 mins.
5 Differentiate in 2% acid alcohol..
6 Vash ('blue') sections in running tap water, 5 mins.
7 Stain in 2% eosin, approximately 5 mins.
8 Vash off stain in running tap water, dehydrate through alcohol,
clear section in xylene, and mount in a resinous medium.
RESULTS:
nuclei, calcium and some mucins: blue
cytoplasm and other cell entities: shades of pinh/red
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LEI*DRUH' S PHLOX I IE-TARTRAZIIB
METHOD.
1 Dewax paraffin sections in xylene, 2 mins.
2 Hydrate sections through alcohol to distilled water.
3 Stain in Mayer's haematoxylin, 3-5 mins.
4 Vash ('blue’) sections in running tap water, 5 mins.
5 . Stain sections in a coplin jar of 0.5% phloxine in 0.5% aqueous
calcium chloride, 30 mins.
6 Rinse section in water, drain, and place into a coplin jar 
containing a
saturated solution of tartrazine in 2-ethoxyethanol (cellosolve). 
Differentiation is controlled microscopically, until the 
phloxinophilic granules contrast well against a yellow, tartrazine 
background. This can take between 30 mins and overnight.
7 Rinse sections well in alcohol, clear in xylene and mount in a 
resinous medium.
RESULTS?, 
nuclei: blue
cytoplasmic granules of endometrial granulocytes: red
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EAPAKI.CQLAQff. ..TECHfflQUE
IEXHQD.
1 Dewax paraffin sections in xylene, 2 mins.
2 Hydrate sections through alcohol to distilled water.
3 Stain in alum haematoxylin (Harris', 2 min).
4 Vash ('blue') sections in running tap water, 5 mins.
5 Differentiate in 27* acid alcohol.
6 Vash ('blue') in running tap water, 5 mins.
7 Rinse sections in alcohol and stain in 0G6 for 2 mins.
8 Rinse sections in alcohol and stain in EA 50 for 2 mins.
9 Rinse sections in alcohol, dehydrate, clear in xylene and mount in
a resinous medium.
RESULTS;
nuclei; blue
Differential staining of: Toxoplasma pseudocysts <orange/brown), 
inclusion bodies when present, in cytomegalovirus, infarcts, atherosis 
of decidual basal vessels, vascular lesions of fetal chorionic villi.
The above, lists a few examples of the range of entities that was 
reported by Difruscio and Desa (1977) to stain, using the method of 
Papanicolaou.
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IKKUNQPERQXIDASE METHOD FOR LBCTIFS
METHOD.
1 Dewax paraffin sections in xylene, 2 mins.
2 Hydrate sections through alcohol to distilled water.
3 Rinse sections well in TRIS buffer (pH 7.6), and
4 Incubate sections in a wet chamber for 1 hour with the appropriate
diluted (lOpg/ml) lectin:
i) Concanavalin A (lmg/ml), diluted 1 in 100 in TRIS buffer 
(pH 7.6)
ii) Vheat germ agglutinin (VGA) (lOOpg/ml), diluted 1 in 10 
iii) Peanut agglutinin (PHA) (lOOpg/ml), diluted 1 in 10
iv) Dolichos biflorus (DBA) (lmg/ml), diluted 1 in 100
v) Ulex europaeus agglutinin (UEA) (lmg/ml), diluted 1 in 100
5 Vash sections in TRIS buffer, 3x2 mins.
6 Incubate sections with the appropriate rabbit anti-lectin 
diluted 1 in 200 in TRIS buffer, for 30 mins.
7 Vash sections in TRIS buffer, 3x2 mins.
8 Incubate sections in swine anti-rabbit immunoglobulin serum 
diluted 1 in 100 in TRIS buffer, 30 mins.
9 Vash sections in TRIS buffer, 3x2 mins.
10 Incubate sections in rabbit PAP (peroxidase/anti-peroxidase 
complex) diluted 1 in 200 in TRIS buffer, 30 mins.
11 Vash sections in TRIS buffer, 3x2 mins.
12 Treat sections in 3,3'-Diaminobenzidine tetrahydrochloride (DAB) 
solution, 10 mins
13 Vash sections in running tap water, stain nuclei lightly using 
Mayer’s haematoxylin, 1 min.
14 'Blue' sections in running tap water. Dehydrate in alcohol, clear
in xylene, and mount sections in a resinous medium
RESULTS:
nuclei: blue
sites of positivity: brown
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METHOD FOR LECTIffS (CONTINUED),
SOLUTIONS:
0.05M TRIS/HC1 buffer pH 7,6
TRIS 18.3 gram (BDH Product number 27119)
distilled water, approximately 2.5 litre
Dissolve the TRIS in the distilled water, with stirring.
Add molar hydrochloric acid (86 ml concentrated HCl/litre) and pH 
to 7.6
Make up buffer to 3 litre with distilled water.
3,3'-Diaminobenzidine tetrahydrochloride (DAB).
200 mg 3,3'-Diaminobenzidine tetrahydrochloride (Sigma Catalogue 
number D-5637))-kept frozen in aliquots.
Dissolve one aliquot in 400 ml of TRIS buffer (pH 7.6)
Add 400 pi of stock 30% (100 volume) hydrogen peroxide immediately 
before use.
Source of lectins and anti-lectins 
• Concanavalin A/"anti-concanavalin A *
Vheatgerm agglutinin/anti-wheatgerm agglutinin *
Peanut agglutinin/anti-peanut agglutinin *
Dolichos biflorus/anti-dolichos biflorus **
Ulex europaeus agglutinin/anti-Ulex europaeus agglutinin **
* Gift from: Dr A Leathern,
The Bland Sutton Institute of Pathology 
The Middlesex Hospital Medical School,
London VIM 8AA
** Purchased from: Joint Laboratories Products Co-ordinator
of the above address
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CHAPTER 3 
STATISTICS
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Descrip tive Statistics
Column i Total freq = 19
Min: 0.000 Max: 42.000 Range: 42.000 
Sum: 137.00 Sum of squares: 3191.0
M e a n : . 7.2105 Variance: 115.96
s.e. mean: 2.5381 Std. dev: 10.768
Median: 3.0000 Mean deviation: 7.9723
Unbiased est o-f variance: 122.40 
and the std dev: 11.063 
Coefficient o-f variation: 1.493
3rd moment about mean: 2434.33 
4th moment about mean: 84480.7 
Skewness: 1.950 Kurtosis: 6.283 
Unbiased est o-f 3rd moment: 2871.88 
Pearsons 2nd coe-f-f of skewness: 1.1730
Des criptive Statistics
Column 2 Total freq = 19
Min: 0.00 Max: 188.00 Range: 188.00 
Sum: 696.00 Sum of squares: 6.14E4
Mean: 36.632 Variance: 1887.8
s.e. mean: 10.241 Std. dev: 43.449
Median: 26.000 Mean deviation: 29.850
Unbiased est of variance: 1992.7 
and the std dev: 44.640 
Coefficient of variation: 1.186
3rd moment about mean: 1.759E5 
4th moment about mean: 2.848E7 
Skewness: 2.144 Kurtosis: 7.992
Unbiased est of 3rd moment: 2.075E5 
Pea rsons 2nd coeff D f  skewness: 0.7341
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Columns 1 and 2
Mann-Wh itney U-test 
First preceding, U = 273 
Second preceding, U = 88
Standardised Normal = 0.886 
Tail probability = 0.1877
r- .
iUeAZ. ^ ckjM-CG- "cs- < VgQ
t-test hypothesis 3 tested 
C olumns 1 and 2
t-value = -2.789 
Degrees o-f -freedom = 21 
Tail probability = 0.0053
> Da t a  Display (19 rows x 2 cols)
>
>Row col 1 col 2
>1 0.0000 0.000
2 0.0000 0.000
3 0.0000 0.000
4 0.0000 0.000
5 0.0000 1.000
6 0.0000 10.000
7 0.0000 12.000
8 0.0000 16.000
9 3.0000 26.000
10 3.0000 26.000
11 3.0000 30.000
12 4.0000 35.000
13 5.0000 41.000
14 8.0000 43.000
15 11.0000 50.000
16 15.0000 62.000
17 18.0000 78.000
18 25.0000 78.000
19 42.0000 188.000
Date. Display (18 rows x 2 cols)
Row col 1 col 2
1 0.0000 0.0000
Oi. 0.0000 0.0000
q 0.0000 0.0000
4 0.0000 0.0000
0.0000 1.0000
6 0.0000 10.0000
7 0.0000 12.0000
0 0.0000 16.0000
9 3. 0 000 26.0000
10 3 r 0000 26.0000
11 3.0000 30.0000
12 4.0000 35.00CC
13 5.0000 41.0000
.14 8.-C000 43.0000
15 11.0000 50.0000
16 15.0000 62.0000
17 13.0000 73.0000
13 25.0000 78.0000
Co 1 uivrvs 1 and 2
Mor n-Wh i t ney 'J- test 
First preceding, U - 249 
Second preceding, U « 75
Stendandised Normal = 0.929
Tail pro bability = 0.1765
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CHAPTER 4,
STUDIES OH RELAXIN
IHTKQDUCTIOH
Relaxin was first alluded to in the first chapter of this thesis, where 
the evidence for its synthesis in the endometrial granulocyte in human 
pregnancy was evaluated. This perhaps became a more interesting concept 
when it was demonstrated in Chapter 3 that there was a reduction in the 
number of endometrial granulocytes in recurrent aborters. The work 
undertaken in this chapter is then, in part, an extension of this theme in 
that an attempt was made to demonstrate relaxin activity in the endometrial 
granulocyte. As will be illustrated, there is evidence to suggest that 
relaxin has an important role in human pregnancy. Its characterisation in 
terms of which tissues are responsible for its synthesis and which have 
appropriate receptor sites (ie, are target tissues) has become an issue of 
considerable interest in recent years. This chapter attempts also then to 
review the role of relaxin in human pregnancy addressing in particular, 
problems encountered in its isolation, purification and subsequent use as a 
diagnostic tool. On the basis of this review, an attempt will be made to 
purify human relaxin, and from this prepare an anti-relaxin antibody. The 
distribution of relaxin might then be determined in reproductive tissues in 
normal pregnancy, and a comparison made with tissues from recurrent 
aborters.
The structure of relaxin
The structure of relaxin has been determined in several species and now 
in man. In all cases it has been identified as a polypeptide with a 
molecular weight of approximately 6,000 Daltons (KacLennan 1983, Weiss
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1984). In both the pig and the rat, relaxin derived from the corpus luteum 
is first synthesised as a prohormone of molecular weight 20,000 (Kwok et al 
1978, Hudson et al 1981, and Haley et al 1982) and then converted to 
relaxin. Conformationally the relaxins that have been examined are alike, 
and indeed they also share a similar tertiary structure to insulin 
(Bedarkar et al 1977). Both relaxin and insulin are made up of A and B 
chains connected by cross-linking disulphide bonds in similar positions 
(KacLennan 1983). The two chains of relaxin are connected also by a C 
peptide, the size of which varies depending on the species under 
consideration. In rat relaxin for instance, the C peptide is twice the size 
of the native molecule (Niall et al 1982). The human C peptide is similar 
in length to that identified in both the pig and rat.
Where is relaxin found?
Relaxin has been detected in the plasma and tissues of several species 
including man. The forerunner of more recent studies was undertaken by 
Dallenbach-Hellweg et al, 1965, who sought to identify the distribution of 
relaxin in the placenta, uterus and ovaries of rats using a fluorescein 
labelled anti-relaxin antiserum. The relaxin used to prepare the antiserum 
was crude by current techniques, but there was specific labelling of the 
granular cells of the metrial gland and mesometrial decidua. The human 
counterparts of these tissues correspond functionally, in the case of the 
metrial gland cells to basal trophoblast, and in the case of the 
mesometrial decidua, to cells analogous to the endometrial granulocytes 
found at implantation sites in human pregnancy. This work was 
supplemented by a comprehensive range of histochemical techniques designed 
to characterise the cells and tissues implicated, further. There was no 
fluorescent staining of the ovaries.
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Ten years later a further attempt was made at localising relaxin in the 
rat (Anderson et al 1975). On this occasion, there was specific 
immunofluorescent staining of the luteal cells of the ovary. The granular 
cells of the rat metrial gland did not give consistent results however and 
the role of these cells could not be clarified further.
Whilst support for an ovarian source of relaxin was gaining momentum 
(Larkin et al 1977 demonstrated relaxin in the granulosa lutein cells of 
porcine ovary), there was a need to utilise the improved highly purified 
forms of relaxin that were available (Sherwood and 0 'Byrne 1974), if 
consistent results were to be achieved in these studies. Later studies did 
..address this problem and relaxin extracts purified using the basic 
methodology of Sherwood (Sherwood and O ’Byrne 1974, Sherwood 1979) began 
to appear in the literature. Support for an ovarian source of relaxin was 
firmly established in the 1980's as workers like Fields (1984) for example, 
identified the intracellular localisation of this hormone in membrane-bound 
granules in pregnant rat luteal cells. A similar localisation was 
described in pregnant mouse luteal cells, using an anti-rat relaxin 
antibody. The changing pattern of relaxin staining observed in this study, 
that is the numerical distribution of granules in the luteal cells of the 
ovary, was interestingly, reflecting the serum levels of immunoreactive 
relaxin (O’Byrne and Steinetz 1976). This implies that the luteal cells of 
the mouse ovary contain granules that synthesise relaxin. The number of 
granules within the luteal cells changes during gestation and these 
numerical changes are reflected in serum levels of relaxin.
Relaxin synthesis is not confined to the ovaries in all species however. 
In the pregnant mare for example, the corpus luteum involutes during 
gestation and the placenta becomes main source of relaxin activity (Stewart
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et al 1982(a)). There appears to be little contribution by the mare ovary, 
and removal or shedding of the placenta results in a decline of relaxin 
levels (Stewart et al 1982(b)). The placenta is also the main source of 
relaxin in the hamster (Renegar et al 1987), and is the first report of 
relaxin in haemochoreal placentation in a rodent (as reported earlier the 
ovary is the main source of relaxin synthesis in rats and mice). Whilst in 
the mare there was no attempt to identify the cell types associated with 
relaxin synthesis, in both the hamster and rabbit (a further example of 
placental relaxin activity (Eldridge and Fields 1985)) cell types were 
identified. Relaxin in the hamster was localised in trophoblast cells 
adjacent to uterine decidua, and endometrial granulocytes in the walls of 
ensheathed arteries (Renegar et al 1987), and in the rabbit, in the 
syncytiotrophoblast of the placental labyrinth (Eldridge and Fields 
1985,1986).
The guinea-pig identifies yet another probable source of relaxin. Anti- 
porcine relaxin was localised in supranuclear granules luminally distributed 
in endometrial gland cells. This study utilised a very sensitive 
immunocytochemical procedure, applied to tissue sections and examined at an 
ultrastructural level. It appears conclusive that relaxin is synthesised 
and stored in the endometrium in the guinea-pig (Pardo et al 1980).
Virtually all studies on relaxin utilise either porcine or rat relaxin. 
The combination of poor structural homology between relaxins and the 
diversity of sites in which it is synthesised in different animals make the 
extrapolation of data between species, and more importantly between animals 
and man, potentially erroneous. This is well illustrated in the development 
of a homologous radioimmunoassay for rat relaxin described by Sherwood and 
Crnekovic in 1979. The slope of the dose/response curve for rat relaxin in
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a homologous radioimmunoassay for porcine relaxin was not parallel with the 
slope obtained for porcine serum in this radioimmunoassay. In their 
homologous radioimmunoassay for rat relaxin, rat serum produced a 
dose/response slope virtually identical to that of porcine serum in the 
homologous porcine relaxin radioimmunoassay. It is frustrating therefore 
to witness a porcine relaxin radioimmunoassay, used in 1977 to measure 
human serum levels of relaxin (Weiss et al 1977), still in use, in principle 
unchanged, in an immunocytochemical procedure in 1987 (Bryant-Greenwood et 
al 1987). The studies of relaxin on human serum and tissues must then be 
evaluated with some caution.
There have been numerous studies on the synthesis of relaxin in the 
human. From the studies undertaken on animals it is perhaps not surprising 
that the corpus luteum of human pregnancy would be a likely contender for 
its synthesis. Animal studies have also shown that other reproductive 
tissues may manufacture this hormone and therefore tissues other than the 
ovary have warranted and received investigation. Early studies of the 
‘renewed interest' era (Weiss 1977, 1978) certainly implied that the corpus 
luteum of pregnancy was likely to be the sole' source of this hormone, at 
least in the immediate post partum period. Its synthesis throughout mid­
term to term correlated well with progesterone synthesis by the ovary and 
was continuous throughout the puerperium. Although relaxin was not 
detected in the non-pregnant corpus luteum (O'Byrne et al 1978), it was 
believed to be present in amounts below the sensitivity of the assay. This 
observation was retracted the same year however, and predominantly the 
same group of workers (Weiss et al 1978) concluded that the corpus luteum 
was the only source of relaxin. On the assumption that serum levels are a 
reflection of ovarian relaxin activity, Quagliarello et al (1979) supported
110
and extended these contentions. They demonstrated relaxin by the time of 
the first missed period in pregnant patients, but failed to detect serum 
relaxin in non-pregnant, cycling WGmen. More recent evidence initially 
confused the issue further. Using a porcine antiserum derived from the 
same source as that used by Weiss et al (1978), O'Byrne et al (1978) and 
Quagliarello et al (1979) in an assay of comparable sensitivity, Loumaye et 
al in 1984 reported on the levels of relaxin in peritoneal fluid throughout 
normal menstrual cycles in women. Peritoneal fluid is predominantly an 
exudate of a functioning ovary, its volume rising and falling throughout 
each cycle. Whilst the follicular phase of the menstrual cycle did not 
produce measurable amounts of relaxin, in common with the first days after 
ovulation, from about day 20 of the menstrual cycle there was an abrupt 
change and for approximately 2 days (day 22) high levels of relaxin could 
be detected. Thereafter, the peritoneal concentrations of relaxin declined 
until below the levels of detection again by day 2. These observations 
suggest by their pattern of secretion that the corpus luteum was the source 
of relaxin secretion; its appearance coincides well with nidation. It would 
be tentative tD suggest that relaxin detected in peritoneal fluid is subject 
to delay, its appearance representing a physiological event occuring some 
time earlier. Since the post-ovulatory rise in plasma progesterone 
correlated well with peritoneal levels of progesterone, this is unlikely.
The observations are then, not in agreement with those described earlier 
for the pig (Matsumoto and Chamley 1980), in which relaxin was detected in 
the follicular fluid of developing follicles and encompassing thecal cells, 
the probable site of synthesis (Evans et al 1983). Hor are they in 
agreement with the results published recently by Wathes et al 1986 who 
described relaxin in the follicular fluid of pre-ovulatory, artificially
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stimulated follicles. The earlier conclusions of O ’Byrne et al (1978) and 
others now appear unlikely, and there is little doubt that the ovary 
secretes relaxin during the normal menstrual cycle. Whether this begins 
after the formation of the corpus luteum or whether relaxin is secreted by 
thecal cells surrounding a maturing follicle, ie during the follicular phase 
of the menstrual cycle before ovulation, is inconclusive. Current reports 
favour the latter.
With respect to the probability of relaxin synthesis in sites in the 
human other than the ovary, the story has been just as unclear. Weiss et 
al (1978) as stated, regarded the corpus luteum as the sole source of 
relaxin. These workers excluded activity in a range of both fetal and 
maternal tissues (fat, myometrium, skin and placenta) and maternal and cord 
blood, and concluded reasonably, that relaxin does not reach the fetal 
circulation, is not manufactured by fetal tissues, and is not found in 
amniotic fluid.
The first paper to provide evidence of an extra-luteal source of relaxin 
was published in 1980 (Bigazzi et al 1980), although immunoactivity in 
normal human placenta and decidua was reported much earlier (Dallenbach- 
Hellweg 1964). Relaxin was extracted and purified from term decidua and 
identified also in the incubation media of cultured human decidua. Whilst 
it was acknowledged that the relaxin may be derived from the ovary and 
adsorbed onto the surface of decidual cells and subsequently extracted, the 
evidence suggested that the decidual cells might also be secreting relaxin. 
Dual synthesis of hormones is not unusual, and this finding correlates well 
with progesterone synthesis for example.
Bigazzi et al (1980) provided the impetus for other workers in the field 
when they tentatively suggested a role for relaxin in satisfying local
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tissue needs during gestation. This logically resulted in a 'seek and 
identify' approach to relaxin in all tissues associated with human 
pregnancy. Fields and Larkin <1981) purified a biologically active relaxin 
fraction from human term placenta but used an antiserum raised to porcine 
relaxin to identify the cells of the placental basal plate and septae, where 
this hormone may be synthesised or stored. A later communication in which 
Larkin was involved (Koay et al 1985) modified the above observations 
(Fields and Larkin 1981) and on the basis of results common to four 
different antisera to porcine relaxin, identified in addition to staining of 
the placental basal plate, staining of parietal decidua in contact with the 
fetal membranes and cells of the chorionic cytotrophoblast. The staining 
of the chorionic cytotrophoblast is interesting. Bryant-Greenwood et al 
(1987) found this to be distributed in a rather discontinuous fashion. One 
might be tempted to discount the legitimacy of this result but for the fact 
that Sakbun et al 1987 discovered and partially characterised a c-connect- 
ing peptide belonging to human relaxin, in these cells.
Meanwhile, the earlier work undertaken by Dallenbach and Dallenbach- 
Hellweg (1964) was being substantiated: Yki-Jarvinen et al (1983) confirmed 
the existence of human relaxin in normal secretary endometrium aswell as in 
syncytiotrophoblast cells and the corpus luteum. The paper was reporting 
principally though on the demonstration of relaxin in gynaecological 
tumours - hydatidiform moles and choriocarcinomas. Yki-Jarvinen and 
Vahlstrom were fortunate a year later (Yki-Jarvinen and Vahlstrom 1984) in 
being able to study relaxin in the placenta of a woman who had had a 
normal pregnancy despite removal of the corpus luteum at the beginning of 
the second trimester. They again demonstrated specific staining for
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relaxin in placental syncytiotrophoblast, and substantiated that the corpus 
luteum was not the only tissue synthesising relaxin during pregnancy.
The diversity of relaxin staining in tissues other than the ovary is 
intriguing. In addition to the cells implicated above, relaxin has been 
found in the cervix, myometrium, connective tissue of the breast, and the 
prostate (MacLennan 1983). In oestrogen primed mice, mammary gland duct 
growth was induced by human tissue extracts of relaxin (Bani and Bigazzi
1984), and it seems conceivable there are similar target tissues for relaxin 
in the human. Vhat is of concern, is whether these results are the 
consequence of using an heterologous relaxin preparation? It is possible 
now that this important question can, at last be answered. A synthetic 
analogue of human relaxin is now in use (Eddie et al 1986) and it remains 
for much of the work undertaken to date, to be repeated when this becomes 
more widely available, as only then can extrapolated data be evaluated 
accurately. A relevant example of this is seen in the homologous 
radioimmunoassay of relaxin in sera from non-pregnant (Eddie et al 1986) 
and pregnant patients (Bell et al, 1987). The assay did not detect relaxin 
in the sera from non-pregnant patients although the sensitivity was above 
the detection limit used in previous assays utilising porcine relaxin. This 
must put into doubt the specificity of heterologous assays in current use.
Eunc.t icms .-Qf relaxin
There are now several well defined physiological characteristics 
attributed to relaxin. These have been determined over a number of years 
from studies performed on animals mostly, as identifying the sites of 
synthesis has proved less difficult than in humans. As mentioned earlier, 
the non-availability of human relaxin has meant that studies in man have
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been dependent on the extrapolation of data from animals, or the use of 
inappropriate relaxin antiserum. Consequently, there are some well defined, 
but speculative functions for relaxin too.
One of the most widely reported actions of relaxin is utilised in 
isolation and purification studies to determine biological activity of crude 
extracts. Still in current use, in the absence of anything more precise, is 
the guinea pig pubic symphysis palpation technique CSteinetz et al 1969). 
This is dependent upon an increase in the flexibility of the pelvic girdle. 
The other commonly used measure of relaxin biological activity is the mouse 
interpubic ligament technique, where the distance between the pubes is 
measured before and after the administration of relaxin (Larkin 1974).
Both methods rely on the 'relaxing' or softening effects of relaxin on the 
connective tissue ligaments of oestrogen-primed animals. This response is 
accordingly less obvious in man, although in a clinical trial of pregnant 
patients near term, the vaginal application of porcine relaxin did produce 
cervical ripening in most of the patients treated (MacLennan et al 1980). 
The effects of relaxin on collagen synthesis is one of the main functions . 
attributed to this hormone then, and pregnancy is accommodated by the 
constant re-modelling of connective tissue under control by this and other 
hormones, working in concert.
The effects of relaxin on collagen synthesis at a cellular level has been 
determined predominantly from animal studies. It appears that collagen 
synthesis is greater than collagen degradation in early pregnancy where 
there is a rapid growth of fetal tissue requiring accommodation (MacLennan 
1983). The overall effect however is one of collagen loss because of the 
change in viscosity of the ground substance, brought about by an increase
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in water and glycosaminoglycan content '(Zarrow et al 1956). In 
physiological terms, newly formed collagen in a ground substance that 
allows mobility provides for the re-modelling that is constantly occuring 
in early pregnancy. The action of relaxin on the ligaments of guinea pigs 
and mice discussed above however, is more likely due to relaxin's ability to 
activate the collagenolytic enzymes, collagenase and collagen peptidase. In 
studies of amnio/chorionic membrane, (Koay et al 1985) it was found that 
both relaxin and prolactin increased the release of plasminogen activator, 
another enzyme associated with collagen breakdown. In concert with human 
chorionic gonadotrophin, relaxin was found to stimulate collagenase 
activity. The action of relaxin at this site is likely to be important at 
parturition. Relaxin is able therefore to maintain a collagen framework in 
a state of flux. It can stimulate collagen synthesis via fibroblasts in 
target tissues. It can change the viscosity of the medium in which it lies 
thus allowing for increased distensibility. In complete contrast, it can 
activate enzymes that can break down collagen, perhaps of particular 
importance at parturition.
A further method of determining the biological activity of relaxin, 
involves suspending segments of rat uterus in solution, attaching a heart 
lever to one end and recording the uterine contractions (described by 
Steinetz et al 1969). The introduction of relaxin into the system even as 
a crude extract, inhibits these contractions. Although not specific (Weiss
1985), this represents another function of relaxin that has been used to 
evaluate purification studies. As discussed, there is good evidence now to 
suggest that the corpus luteum of pregnancy is not the sole source of 
relaxin, and the decidua may assume some or all of this responsibility. It 
synthesises prolactin for its local needs (Riddick et al 1978, Golander et
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al 1979) as dt~does prostaglandin PGF2a (Koay et al 1985), and it is 
conceivable therefore in the light of recent evidence, that it might also 
synthesise relaxin for its local needs. As the decidua lies in close 
proximity to the myometrium, decidual synthesis of this hormone is in a 
prime position to exert its effects on the inner, circular myometrial muscle 
as suggested by Liggins (1985). In vitro studies in the rat have shown an 
increase in cyclic AMP in such target tissues following the administration 
of relaxin, providing support for this hypothesis since it is acknowledged 
that cAMP inhibits smooth muscle contractions by inactivating the enzymes 
responsible for their contraction (Cheah and Sherwood 1980). The effects 
of relaxin activity throughout pregnancy are however, as in vitro 
experiments show, very dependent upon the concentrations of steroids. In 
common with other functions of relaxin, uterine quiescence is likely to be 
controlled indirectly by the constantly changing ratios of oestrogens with 
progesterone.
Relaxin may also have a role at parturition. Koay et al 1985, have 
identified receptor sites for relaxin in cells associated with the chorio- 
amniotic membrane, and it is believed that relaxin could be instrumental in 
bringing about the rupture of these membranes when the right hormonal 
conditions prevail. Membrane rupture would probably still be dependent on 
the activation of collagenolytic enzymes.
More recent experiments have shown in vitro, that porcine relaxin can 
inhibit the release of rat neuropeptides, oxytocin and vasopressin, by the 
neurohypophysis (Dayanithi et al 1987). The significance of this is 
obscure. Oxytocin controls milk ejection from lactating breast and may 
have a role in the initiation of labour, but this will proceed in its 
absence (Zilva and Pannall 1979). Porcine relaxin in combination with
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oestrogen has been shown-to^have a synergistic effect on promoting the 
growth of mammary gland ducts in mice (Bani and Bigazzi 1984) and perhaps 
the association is with the breast rather than the effects of oxytocin at 
parturition. Until there is human relaxin easily available, alleviating some 
of the problems introduced by the use of animal data, it would be 
inappropriate to speculate further.
Relaxin may have one other important function pertinent to human 
pregnancy. In 1986, Vasilenko et al demonstrated the growth-promoting 
effects of relaxin following its administration to mature and immature 
oestrogen-primed and ovariectomised rats. This resulted in a gross 
increase in uterine weight which was significant in both groups but more 
dramatic in the immature group of rats. Histologically, the collagen 
associated with the myometrium had lost its highly organised appearance 
and was loosely arranged and widely separated - features described earlier. 
In addition to these features however, it was observed that relaxin was 
also able to affect the uterine vasculature by increasing the size of the 
blood vessels that lie between the muscle layers, and consequently 
increasing the blood flow through the uterus. Endothelial hyperplasia and 
dilatation of maternal endometrial blood vessels is a feature of early 
pregnancy in monkeys too (Dallenbach-Hellweg et al 1966), and it has been 
shown in the non-pregnant monkey to be largely due to the administration 
of relaxin (Hisaw et al 1967). For the full changes to occur, both 
oestrogen and progesterone are required. Relaxin in humans may, as in 
animals, be instrumental in altering the uterine vasculature during 
pregnancy. This would undoubtably be of importance in the first trimester 
when the placental bed is formed and the entire vasculature is established.
118
It is also of interest to note that relaxin concentrations are at their 
highest during the first trimester in human pregnancy (Eddie et al 1986). 
How is relaxin controlled?
The mechanisms controlling relaxin are poorly defined, but there are 
several observations of interest which will need pulling together when more 
is known about the functions and sites of synthesis of this hormone. The 
previous section has emphasised on more than one occasion the need for 
'appropriate' hormonal conditions for relaxin to be effective. As 
illustrated by Hisaw in 1926 (MacLennan 1983), relaxin induced relaxation 
of the pelvic ligaments in guinea-pigs is dependent either upon the animal 
being in oestrus, or being artificially primed with oestrogens. Relaxin 
control of collagen synthesis, one of its most important functions, relies 
on a combination of oestrogen, progesterone and relaxin acting together to 
produce an increase in uterine connective tissue (Cullen and Harkness 1964). 
The control of relaxin therefore, appears partly to be the province of the 
steroids. Hisaw et al in 1967 demonstrated that the entire histological 
pattern of changes of the endometrium in early pregnancy in the monkey 
depended on oestrogen, progesterone and relaxin. Relaxin appeared 
responsible for inducing the progestational changes seen, but in turn was 
controlled by large doses of oestrogen which inhibited its activity. In 
rats, relaxin may be stimulated by either testosterone, oestradiol or 
progesterone, as all three attenuated the decline of relaxin following 
hysterectomy (Goldsmith et al 1982). It was thought that testosterone 
might be an active component only after its aromatisation to oestradiol, 
although either hormone seems to have the potential to regulate relaxin. 
There was evidence too that the controlling mechanisms for relaxin and 
progesterone were similar. Perhaps, as suggested above, relaxin activity
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under oestrogen control, diberates progesterone only when the oestrogens 
fall below a critical level.
This relationship between relaxin and progesterone should not be over 
simplified however. Priming rat uterus in vitro with progesterone for 
instance reduces the amount of relaxin required to inhibit electrically 
stimulated myometrial contractions (Sarosi et al 1983). Progesterone has, 
in essence, increased the potency of relaxin by increasing the sensitivity 
of target tissues towards it. In a study by Thomas et al (1980) in which 
the corpus luteum was sustained with human chorionic gonadotrophin, a rise 
was evident in plasma levels of both relaxin and progesterone. Relaxin 
levels subsequently fell, but not before progesterone had fallen. A similar 
observation was reported by other workers during the same year 
(Quagliarello et al 1980). In this case, human chorionic gonadotrophin 
administered in the luteal phase of the menstrual cycle induced relaxin 
secretion. It also induced a rapid response from progesterone, so much so, 
that progesterone levels were on their way down whilst relaxin levels were 
still rising. The stimulus was the same for these two hormones but their 
response suggests different mechanisms of control. Mathieu too reported on 
the induction of relaxin by human chorionic gonadotrophin (Mathieu et al 
1981), and more recently it has become evident from in vitro fertilisation 
programme studies that it is not only the number of corpora lutea that 
determine relaxin out-put but another factor, associated with pregnancy 
(Bell 1987). As low levels of relaxin (seen in their patients that aborted) 
correlated well with low levels of human chorionic gonadotrophin but not 
normal levels, it was suggested the 'other factor' was human chorionic 
gonadotrophin.
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Relaxin synthesis has also been stimulated by other-hormones. Human 
menopausal gonadotrophin used to mature ovarian follicles, increases relaxin 
synthesis, as does luteinising hormone-releasing hormone (Thomas et al 
1980). This increase in relaxin production to detectable levels in plasma, 
may of course only indirectly be due to the hormones incriminated, as it 
has now been shown that the cells around a developing follicle synthesise 
relaxin which they export into the follicular fluid (Evans et al 1983, 
Loumaye et al 1984, Wathes et al 1986). The hormones in question are 
artificially encouraging follicular growth and presumably other 
physiological activities associated with this development, including the 
synthesis of relaxin by follicular cells.
Relaxin is controlled then partly by the steroids oestrogen and 
progesterone and partly by human chorionic gonadotrophin. The arrangement 
with steroids, especially progesterone, may be reciprocal in that relaxin 
may exert some effect over progesterone. In practice this probably means 
that they work in harmony. They may be induced by the same means but may 
or may not, be controlled by the same mechanism.
Purifying human relaxin
To date, most studies involving relaxin characterisation of some sort, 
have utilised relaxin derived from the corpora lutea of pigs. Pregnant and 
non-pregnant ovaries are suitable for use providing there is a corpus 
luteum, and pregnant pig ovaries are the richest source currently available. 
This, coupled with the fact that they are relatively easy to obtain, 
explains why pig ovaries are used. For obvious reasons human corpora lutea 
can only be obtained opportunistically. As it happens, which is fortuitous 
for the women concerned, it seems likely that the human corpus luteum of 
pregnancy synthesises considerably less relaxin than the pig anyway!
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The need to obtain an extract of human relaxin has been explained: There is 
poor homology with regard to amino acid sequences between relaxins of all 
species studied. This means that extrapolated data could be misinterpreted. 
As many studies rely on the use of immunoreactive relaxin, that is to say 
antibodies are raised against a biologically active, purified extract of 
porcine relaxin, there is a concomitant risk of recognition of the wrong 
epitopes, or there may be poor avidity between the antigen and antibody.
In fact these might be the very reasons why relaxin levels in the human are 
low compared to other species. As reported earlier, Sherwood and Crnekovic 
(1979) illustrated clearly the dangers of using heterologous radio immuno­
assays. Poor sensitivity and specificity of porcine relaxin antiserum for 
human relaxin binding sites may give an artificially low impression of the 
amount of immunoreactive relaxin present in the system under study.
Numerous studies have investigated the possibility of another, extra- 
luteal source of relaxin synthesis. Whilst it is now agreed by most 
workers that human decidua is that source, the amounts secreted even at its 
peak during the first trimester, of pregnancy, are still very low. There are 
obviously problems then, in obtaining sufficient amounts of decidua from 
which a crude extract can be obtained. Until 1974, the quality of purified 
relaxin was very low. The introduction of extraction and purification 
techniques based on those of Sherwood and 0 ‘Byrne 1974 revived an interest 
in this hormone. Further improvements identified the multiple relaxin 
forms characteristic of isolation methods, as being due to proteolysis of a 
single major stored form of relaxin (Walsh and Niall 1980). The other 
obvious corollary of only being able to extract and purify small amounts of 
human relaxin concerns the preparation of an anti-relaxin antiserum.
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Firstly, the purified extract (antigen) has to be shown to be biologically 
active. The biological assays are relatively heavy on 'reagent'. Secondly, 
conventional methods of antibody production utilise quantities of antigen in 
excess of those achieved for human relaxin. Thirdly, determining 
immunoreactive relaxin in tissues or serum should include a control system 
whereby the anti-relaxin antiserum is shown to be absorbed by relaxin 
(purified extract), thus confirming the specificity of the antibody for the 
the antigen. All of these procedures create a demand for human relaxin, 
that is greater than the yield. The first of these problems has 
traditionally been addresed by performing biological assays with crude 
extract, as this is usually available in relatively large quantities. This 
does not consider the possibility of losing the active fraction at a later 
stage though. Vaitukaitis et al 1971, have helped to satisfy the 
shortcomings of the second drain on resources by developing a technique of 
immunising rabbits when only very small amounts of antigen are available. 
The third demand on the purified relaxin is also the smallest, but cannot 
be circumvented, only left out.
Some of the problems that can be anticipated in the preparation of an 
extract of human relaxin have been considered. With the advent of a 
synthetic analogue of human relaxin (Eddie et al 1986), it is likely that 
isolation procedures, which produce such poor yields of this hormone, will 
soon become redundant. However, the following work is an attempt within 
the resources available, to purify relaxin from human tissue. The intention 
was to address as many of the problems as possible and then prepare a 
purified extract sufficient for the demands of a conventional protocol. If 
this procedure was successful, then antibodies to this purified extract 
would be raised in the sera of rabbits. The resultant 'anti-relaxin'
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antiserum would then be used immunocytochemically to determine the •- 
distribution of the hormone in a range of reproductive tissues, and in 
particular the endometrial granulocyte. Depending on these results the work 
would be extended to tissues from recurrent aborters, and the same criteria 
evaluated.
KATERIALS AID METHODS
1. Preparation of crude extract
Tissue for this study was obtained from two sources. The first was 
from first trimester products of conception following elective, suction 
termination of pregnancy. This largely defied dissection and therefore no 
attempt was made to select decidua from any of the tissue collected from 
this source. The second source was obtained from term placentae after 
elective caesarean section. This was dissected and the decidua scraped 
from the maternal surface of the placenta. The primary aim of collecting 
material from either source was to minimise the time lapse between removal 
of tissue' from the patient and its processing, thus reducing the effects of 
tissue degradation. In practise it was found that this could be readily 
achieved with suction termination material, as the patients were booked for 
theatre sessions. Consequently, the maximum time delay was 20 minutes.
This was theoretically true for the other source of material, but for a 
variety of reasons was less practical, and delays it was felt important to 
avoid, were occuring. For this reason only 6 placentae were collected. For 
the remainder of the study crude extract was prepared from first trimester 
material.
The preparation of the crude extract broadly followed the method of 
Griss et al 1967, and Fields and Larkin, 1981 and is as follows:
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Weighed tissue was^homogenised with 5 volumes of chilled extraction 
medium (acetone 5 volumes, water 2.83 volumes, and concentrated 
hydrochloric acid 0.17 volumes) in a Waring blender. The extraction medium 
was transferred to specimen bottles and mixed by gentle rotation overnight 
at 4*C. The following morning, the samples were centrifuged (2000 
revs/minute) and the supernatent tipped over into fresh containers. Five 
volumes of acetone were added to this supernatent and the resultant 
precipitate centrifuged. The acetone was decanted off and the pellet 
resuspended in fresh acetone. This procedure was repeated several times. 
The end stage involved decanting the acetone and drying the pellet by 
allowing the residual acetone to evaporate off. The resulting dry, white 
powder was stored in a glass container at -20*C.
A crude extract was also prepared using the method adopted by Sherwood 
1979 and Bigazzi et al 1980. Tissue was homogenised in a Waring blender 
with 10 times the volume of the following chilled solvent: 0.14M sodium 
" chloride and 0.01M disodium hydrogen phosphate (pH 7.0). The homogenate 
was mixed by gentle rotation overnight at 4*C, and then centrifuged at 
150,000 g. for 2 hours.
£»rificdtipn..by .HP.LC.
The above supernatent was dialysed and, together with aqueous dilutions 
(between 1% and 10%) of the powdered extract, a sample of each was 
ultrafiltered and subjected to high pressure liquid chromatography, using an 
LKB Blue Column for protein separation and a Pye Unicam HPLC with LC3 UV 
detector.
As an additional method of isolating human relaxin from the tissue 
extracts, an attempt was made to raise an antiserum to porcine relaxin in 
rabbits. If this was succesful, then the antiserum would be used in
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affinity column chromatography. The human relaxin, bound to the antiserum 
on the column, could subsequently be eluted, recovered and freeze-dried. 
Preparation of porcine relaxin antiserum
One milligram of highly purified porcine relaxin was obtained from the 
National Institute of Arthritis, Metabolism and Digestive diseases, 
University of Maryland School of Medicine, Maryland, United States of 
America, as a gift. The antiserum was prepared for inoculation using the 
method of Morris (personal communication) as follows:
1 400pg of porcine relaxin in 1ml of sterile water.
800/jtg of egg albumen in 1ml of sterile water.
Each of 2 New Zealand white rabbits received the following prepared
innoculum:
2 0.5 ml of egg albumen (carrier protein)
0.5 ml porcine relaxin
0.1 ml reconstituted BCG
0.2 ml of 0.25% glutaraldehyde (conjugation medium)
3 An emulsion was prepared by syringe-exchange of the above solution 
with 2.5 ml of Freund's oily adjuvant. This was tested at intervals 
until a single drop put onto the surface of water remained as a round, 
intact and discrete white blob that did not dissipate on standing.
4 Immediately prior to inoculation the rabbits were bled from the ear.
The serum recovered was placed into 10 ml glass tubes and preserved by
adding 0.1 ml of 10% sodium azide/10 ml of serum. This serum 
represented the pre-inoculation sample and would be used as a negative 
control.
5 Each rabbit was sheared over its back and 0.05ml inoculated 
intradermally in approximately 70 sites, running as an inverted 'V'
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down the back from the neck.
6 After 30 weeks, the rabbits were boosted as follows:
7 150/ig of porcine relaxin in 1ml of sterile water 
300/ig of egg albumen in 1ml of sterile water.
8 Prepare 2 emulsions for the booster innoculum:
0.5ml of egg albumen
0.5ml of porcine relaxin
0.2ml of 0.25% glutaraldehyde
Prepare an emulsion as before by syringe exchanging this solution with 
2.5ml of Freund's oily adjuvant.
9 Each rabbit was inoculated intramuscularly after a further pre­
inoculation bleed, with 0.5ml injections: two in each rear leg and one
in each front leg.
10 The rabbits were bled 8 days later.
Standardisation of immunocytochemistry and testing of antisera for 
immunoreactivity
Pig ovaries were obtained from the slaughter-house and dissected from 
the extraneous tissue. Each ovary was bisected and examined for corpora 
lutea, and then fixed in 10% buffered formalin. Ovaries were also kindly 
supplied by University of Bristol (see acknowledgements). The tissues were 
processed routinely and embedded in paraffin wax. Tissue sections were cut 
at 4pm, mounted onto poly-L-lysine coated microscope slides and dried at 
37 *C.
Using the peroxidase anti-peroxidase method, a range of dilutions of the 
porcine relaxin antisera was prepared from each rabbit sample: neat, 1/10,
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1/50, 1/150, 1/1000, 1/2000. The ^ control, pre-inoculation serum was treated 
in an identical manner, and replaced the primary relaxin antiserum 
appropriately. Immunoreactivity was determined using an adaptation of the 
peroxidase anti-peroxidase technique of Sternberger et al 1970. Prior to 
its use for the demonstration of relaxin activity in pig ovary, the method 
was standardised and appropriate dilutions for both the second layer 
antibody (swine anti-rabbit immunoglobulins) and the rabbit peroxidase 
anti-peroxidase complex were determined. The definitive method is as 
follows:
1. Paraffin sections are taken to alcohol, via xylene.
2. The endogenous peroxidase is blocked using 1% hydrogen peroxide in 
methanol, 20-30 mins.
3. Wash off in tap water,
4. Rinse sections in 0.2M TRIS buffer (pH 7.6). The following steps 
are performed in a moisture chamber (*):
5. Incubate sections in 3% bovine serum albumen in TRIS buffer, 20 
mins.
6. Tip off above solution and replace with diluted relaxin antiserum in 
3% bovine serum albumen or control serum, and incubate for
1 hour,(*)
7. Rinse sections individually with TRIS buffer and then wash with 
gentle stirring, in fresh buffer for 30 mins.
8. Incubate in second layer antibody, swine anti-rabbit immunoglobulin 
diluted 1 in 100 (in TRIS buffer), for 30 mins. (*)
9. Wash sections with gentle stirring, for 30 mins in TRIS buffer.
10. Incubate sections in 1 in 200 (in TRIS buffer) rabbit peroxidase 
anti-peroxidase complex, for 30 mins. (*)
11. Vash sections in stirred TRIS buffer for 30 mins.
12. Visualise the sites of activity with 0.05% 3,3'-diami nobenzidine 
tetrahydrochloride (DAB), for approximately 10 mins.
13. Vash all sections in water and counterstain the nuclei lightly with 
haematoxylin. Vash sections in running tap water, differentiating 
in 1% acid alcohol if necessary.
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14. Dehydrate sections in alcohol, clear in xylene and mount • -
permanently.
Steps 8 and 10 required standardisation and were titrated against each 
other to achieve optimal visual staining prior to the evaluation of the 
relaxin antiserum.
Purification of relaxin antiserum
An attempt was made to absorb out non-specific, non-immune reactivity 
of the sera with the tissue under study. The relaxin antiserum was applied 
to a selection of tissue sections regarded to be free of relaxin, and 
incubated overnight at 4'C. Each section had previously been taken through 
the steps of the above method up to the stage in which the relaxin 
antiserum is applied. The following morning the serum was pipetted off the 
tissue sections, dispensed into labelled tubes and kept at 4*C. To test the 
effect of this procedure, the tissue sections were taken through the 
remaining steps and visualised as above, using DAB. This purification 
procedure was repeated twice more on sections cut from the same blocks.
BBSHLXS.
Purification by HPLC After lengthy standardisation, two HPLC 'blue' protein 
columns (on loan from LKB) were run with samples of the 2 crude extracts. 
The results of these runs confirmed that the columns were functioning 
poorly. Both columns subjected to both samples at several dilutions, failed 
to detect any proteins of low molecular weight. Although standardising the 
columns was a problem, these results were nevertheless regarded as 
legitimate. Initially there were alternative, means thought to be at my 
disposal for the purification of the crude extract, but these proved 
subsequently to be non-available.
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... The preparation of a relaxin antiserum was undertaken as this was 
considered a very selective means, if there was sufficient cross-reactivity, 
of extracting relaxin from the crude samples by affinity column 
chromatography.
Evaluation of relaxin antiserum
Five months after immunisation, blood was drawn from the two rabbits 
and evaluated prior to the administration of a booster innoculum. Both 
neat sera and dilutions of 1 in 50 and 1 in 100 used in the peroxidase 
anti-peroxidase technique, were negative in sections of human corpus luteum 
and thecal cells (follicular) of porcine ovary.
Blood was drawn 8 days after the booster innoculum and the sera re­
tested neat, 1 in 50 and 1 in 100. On this occasion, there was heavy, 
indiscriminate immunocytochemical staining of the sections of pig ovaries. 
This could be diluted out at dilutions greater than 1 in 160, but was 
associated with an acccompanying loss of positive staining. Repeat runs 
only served to confirm the erratic staining observed: the same serum 
samples used under the same defined conditions on sections from the same 
blocks of tissue, produced positive staining in totally different areas of 
the sections. Several attempts were made to identify the cause of this 
indiscriminate staining (see Table 8). Seven groups of unstained tissue 
sections were dewaxed and rehydrated. In addition to porcine ovary, each 
group ("slide number") contained sections of human corpus luteum. Slides 
numbered 1 and 7 were immunocytochemically negative with the exception of 
the detection of endogenous peroxidase staining in slides numbered 7. This 
staining was blocked in slides 1-6, by methanolic hydrogen peroxide. The 
slides in group 5, subjected to trypsinisation (which is used to unmask 
epitopes otherwise hidden from the antibody in use) reacted similarly to
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those not subjected to trypsin (group 2), staining strongly and 
indiscriminately. Substituting rabbit PA? with rabbit anti-mouse 
(peroxidase conjugated) and rabbit anti-sheep (peroxidase conjugated) 
antisera, had no effect on reducing the overt, patchy, dark brown staining 
seen throughout this exercise (groups 3 and 4). Sections from group 6, 
which were subjected to bovine serum albumen instead of normal swine serum 
did little to confer protection immunocytochemically as these sections too, 
stained poorly. Substitution of the primary porcine relaxin antiserum with 
non-immune rabbit serum (see Table 8 for details) again had no effect on 
the net staining result.
Purification of relaxin antiserum The non-specific reactivity of the 
antiserum was not absorbed by incubating with tissue sections regarded to 
be free of relaxin. The second incubation did show a marked reduction in 
the intensity of staining, which prompted the third overnight incubation. 
This however was similar in staining to the second set of sections and it 
was concluded that any further absorption of non-specific immunoreactivity 
was unlikely. The staining throughout remained heavy and totally 
unselective.
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Table 8
Imn.unQsyiQQhemical staining. for relaxin
This table breaks down the peroxidase anti-peroxidase method into its 
component steps (running down the page). Each of these were checked to 
see what effect, if any, they had on the staining (slides 1-7). In addition 
where these were available, sera raised against other species were 
substituted (eg. peroxidase conjugated rabbit anti-mouse).
SLIDE NUMBER
METHOD 1 2 3 . 4 . 5 .  6 7
U  HYDROGEN 
PEROXIDE IN 
METHANOL / s / y y y
TRYPSIN • V
NORMAL SWINE 
SERUM y y
BOVINE
SERUM
•ALBUMEN
i
PRIMARY SERUM NORMAL 
RABBIT 
SERUM * V- V-
NORMAL 
RABBIT 
SERUM *
NORMAL 
RABBIT 
SERUM *
SWINE ANTI 
RABBIT y y y
RABBIT PAP y
PEROXIDASE 
CONJUGATED 
RABBIT ANTI­
MOUSE
PEROXIDASE 
CONJUBATED 
RABBIT ANTI­
SHEEP
y y
DA 3/
HAEMATQXYLIN / y y y y y
Results:.
Slide 1 was negative except for nuclear staining
Slide 7 was negative except for endogenous peroxidase staining
Slides 2, 3, 4, 5 and 6 were strongly positive, ,Non~selective and overt, brown background 
staining was evident in all these slides regardless of the serum used,
NotesL
i) I; normal rabbit serum was diluted 1/20 with TRIS buffer
ii) “primary antiserum" was either relaxin antiserum or pre-inoculation serum (all sera were 
evaluated), unless otherwise stated,
This study has failed to isolate human relaxin from extracts prepared 
from first trimester products of conception and term placentae. The 
collection of this material was straightforward especially with respect to 
tissue obtained by suction termination. With few exceptions, tissue was 
removed from the patient, weighed and plunged directly into the chilled 
extraction medium. Vhilst term placentae were originally thought to be 
another viable source of material, the patients were not 'on site' and 
delays quickly became inevitable. In addition some preparative work was 
required which introduced an unacceptable level of delay between collecting 
the placentae and instigating its preparation as a crude extract. In the 
knowledge that the first trimester represented a period in which relaxin 
concentrations reached a peak in human pregnancy, and in considering the 
ease with which this material could be obtained - primary objectives of 
this study - the collection of term placentae became unecessary and was 
therefore stopped.
The first serious problem presented with the separation of the extracts 
by high pressure liquid chromatography (HPLC). The length of time and 
difficulty in standardising the two columns on loan ought to have been an 
indication that the columns were not performing well. In fact both columns 
subsequently proved to be beyond their useful life and needed re-packing. 
The equipment and instruments needed for an alternative means of 
purification were not available during the period in which experimentation 
could be performed, and for this reason no further purification was 
undertaken.
Vhilst the use of porcine relaxin and porcine relaxin antiserum cannot 
be advocated for human studies for the reasons previously described,
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evidence of its cross-reactivity, with human relaxin prompted its use as a 
tool for selectively removing human relaxin from samples of crude extract.
It was for this reason that a source of porcine relaxin was sought. As 
synthetic human relaxin had recently become available for research 
purposes, attempts were made in the first instance to secure a sample from 
the research groups involved (Australia and America). Their kind refusal 
provided the impetus to contact other workers interested in relaxin with a 
view to obtaining porcine relaxin. This was eventually obtained as a gift 
from the National Pituitary Agency (see acknowledgements), but in an amount 
generally regarded as insufficient for an immunisation programme and 
evaluation. As this appeared to be the only source available, a restricted 
protocol was prepared. Because of animal licensing restrictions, the 
inoculation and subsequent boosting of the rabbits with antigen (highly 
purified porcine relaxin) was not performed by myself. The incubation 
period between immunisation and boosting was unavoidably protracted, and 
this delay was further complicated when one rabbit died a few weeks after 
the second, booster injection of antigen.
Evaluating the antisera From each rabbit, there were four bleeds:
1) pre-immunisation bleed, 2) post immunisation, post incubation bleed 
3) pre-booster bleed and 4) post booster, post incubation bleed, and for 
one rabbit, a terminal bleed. All sera were tested in dilution using the 
peroxidase anti-peroxidase method for polyclonal antisera, on tissue 
sections of porcine ovary and human corpus luteum. The staining, as the 
results illustrated, was totally unselective, inconsistent in that areas of 
positivity would vary in subsequent runs/ and would not withstand dilution 
(to remove non-specific binding). Efforts to identify the source of binding 
using a small range of rabbit antisera raised against other animal species,
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were ineffective. By a process of elimination it was concluded that-the 
problem lay principally with the use of rabbit serum in the method, as even 
non-immune rabbit serum produced heavy staining of the tissues under 
investigation. This is not a common finding. It suggests that there is an 
endogenous substance in the tissues under investigation, perhaps high 
levels of steroids, that is cross-reacting with rabbit serum. An 
alternative option would be to raise relaxin antibodies in another species, 
perhaps sheep or goat. This fails to acknowledge the success of other 
workers in this field however, who have obviously made use of rabbits to 
raise antibodies and then subsequently used these antibodies to detect 
relaxin activity in reproductive tissues.
The lack of antigen obviated any attempt at affinity purifying the 
antiserum, but as a last resort an attempt was made to 'clean up' the 
antiserum, in the hope of demonstrating some degree of specificity. This 
involved incubating relaxin antiserum with sections of tissues thought to 
be entirely free of relaxin activity. The effects of this procedure were 
monitored after each incubation by completing the peroxidase anti­
peroxidase method on the sections, and looking for evidence of staining.
As the results show, there was no apparent improvement after three 
overnight incubations. For completion, the sera were run on the porcine 
ovary and human corpus luteum sections, but perhaps as predicted, there was 
no improvement in the distribution of staining.
This has been a disappointing chapter in that none of the problems 
reported by other workers on the purification of human relaxin have even 
been confronted. This was largely due to the non-availability of the right 
equipment at an appropriate time, and the failure of both HPLC columns. 
There is reasonably, little doubt that problems of purification would have
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been encountered. However, it would:;:have been more challenging if this had 
occurred later rather than sooner during its preparation. The availability 
of fresh tissue was excellent, as was the initial response time to its 
preparation. In hindsight, more thought should have been given to the 
water soluble properties of relaxin and alternative means of reducing the 
number of contaminating proteins in the tissue extracts, addressing also 
the problems of proteolytic activity. There would still have been the 
problem of establishing a biological assay, which is regarded as subjective 
and, even in experienced hands is a selective, rather than specific means of 
determining relaxin biological activity. On the plus side, if a rapid 
screening process could have been adapted for the initial purification of 
human tissue samples, it is conceivable that human relaxin could be 
obtained in quantities sufficient for both biological and immunological 
evaluation.
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CHAPTER_5 
IMMUMQLQGY OF PREGffAMCY
IUTPODUCTIOfl
Most reviews and research papers concerning this area of research begin 
by identifying a phenomenon that still defies total explanation. Under 
normal circumstances, a pregnancy remains intact and a fetus remains 
protected from the immune system of its host. This holds true even though 
the paternal component is immunologically foreign. A breakdown of this 
protection conferred upon the fetus is thought to be a cause of spontaneous 
abortion, and in particular, recurrent spontaneous abortion. This chapter 
seeks initially to identify the protective measures involved in maintaining 
pregnancy. Secondly, it will look at what happens in recurrent abortion 
when there may be a breach of the barriers that maintain the integrity of 
the fetus. Finally, there is a practical section which selectively examines 
the cell types present in recurrent abortion and control tissues of 
decidualised endometrium and placenta. Particular emphasis is placed on 
characterising further the role of the endometrial granulocyte, as it is 
thought this cell may have an important immunological role in pregnancy 
(see Chapter 1 - Introduction).
The way in which a foreign substance is presented to the immune system 
dictates significantly the speed and type of immunological response. For 
instance, there is rapid immunological rejection where there is graft tissue 
to host tissue contact with associated lymphatic drainage. The vascular 
system is, by contrast, an inefficient route of antigen transfer, although 
rejection is not dependent upon either vascuiarisation or access to
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lymphatics. On the basis of this fundamental evidence, several workers 
have attempted to identify a physical barrier that effectively prevents 
histocompatibility antigens expressed by the fetus being recognised by the 
mother.
A Physical Barrier
In 1964, Kirby et al described such a barrier in'the mouse placenta. 
Using electron microscopy they identified an electron dense, amorphous 
layer surrounding the trophoblast of the placenta. The layer, 0.1-0.2pm in 
thickness, was particularly obvious around trophoblast giant cells in 
contact with the decidua, and thin and ill-defined around lacunae. 
Histochemically, the material was identified as a weakly sulphated 
mucopolysaccharide, rich in hyaluronic and sialic acids. These reactions 
conform to what Pearse (1960) describes as fibrinoid. Support for 
fibrinoid as a physical barrier can be found in the work undertaken by 
Billingham and Silvers in 1964, who were investigating the hamster cheek 
pouch as an 'immunologically privileged' site. Tissue grafted onto the 
hamster cheek mucosa is accepted by the host for extended periods of time 
before ultimately undergoing rejection. This tolerance to grafted, foreign 
tissue is due in part to the connective tissue matrix lining the hamster 
cheek. It is this surface that Kirby et al (1964) examined and 
subsequently reported as structurally and histochemically similar to the 
fibrinoid layer of the placenta described above. A further and interesting 
observation made by Kirby et al 1964 illustrated the variation of fibrinoid 
deposition that exists between genetically different species. It seems 
that the greater the genetic disparity, the greater the deposition of 
fibrinoid material separating the incompatible components.
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Evidence of a physical barrier^ .has also been sought in less obvious 
areas of contact between maternal tissues and the fetus. In mice, in 
common with other species including humans, as pregnancy advances the yolk 
sac or chorio-allantoic membrane makes intimate contact with the maternal 
uterine surface. Avery and Hunt in 1967 investigated fetal membranes for 
antigenicity by grafting them onto skin. In pre-sensitised mice, that is 
mice that had been previously challenged with the antigen, rapid rejection 
of the grafted membranes occurred regardless of the orientation of the 
membrane surface. In mice previously unexposed to the antigen however, the 
response was dependent upon the side of the membrane in contact with the 
skin surface. When the fetal side of the membrane was in contact with the 
skin surface, there was good survival and vascularisation of the graft. 
Placing the opposing membrane (i.e. that normally in contact in situ with 
maternal tissue) down onto the graft resulted in poor survival times as 
well as a failure to vascularise. More important was the elaboration of an 
amorphous material between the membranes and the graft bed. This material 
had properties similar to those of fibrinoid and physically contributed to 
the isolation and prevention of antigen exchange across the two tissues.
It seems then, that fetal membranes also produce a physical barrier 
amorphous in nature, and morphologically and chemically similar to the 
fibrinoid described by Kirby et al in 1964. Antigen exchange was further 
impeded by the inherent inability of the maternal vessels to vascularise 
fetal tissue.
However, it is perhaps not surprising that a physical barrier of the 
sort described by Kirby et al (1964) has not been universally accepted. 
Simmons et al (1967) found no evidence of an electron dense, fibrinoid 
layer separating fetal and maternal tissue. Additionally, they pointed out
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that whilst the hamster cheek pouch was receptive to tissue grafts., .in 
effect a privileged site, second set grafts were quickly rejected. This is 
obviously not true in pregnancy, as second, third or multiple pregnancies 
are not, as a matter of course, rejected.
Antigen presentation
The view of Simmons et al (1967) holds that the integrity of the fetus 
is dependent upon an intrinsic deficiency of the fetal trophoblast to 
express surface histocompatibility antigens. Immunologically this 
interpretation should not be contested: more recent studies have shown that 
whilst cells within the chorionic villi express HLA positivity, trophoblast 
around these villi are negative (Bulmer and Johnson 1985). HLA A,B and C 
Class I antigens are itherefore isolated from recognition by maternal 
cytotoxic T lymphocytes. This observation would also seem to support 
histological findings, as the trophoblast appears to intervene freely 
between fetal and maternal circulations. Trophoblast giant cells are 
commonly reported to invade deeply into the myometrium of the pregnant 
uterus, and remain there, unchallenged after delivery of the placenta. 
Neither is there an adverse immunological response to ectopic trophoblast 
emboli, found quite commonly in maternal lungs and peritoneum in late 
pregnancy. Finally, it is worth mentioning that tumours of fetal origin, 
benign trophoblastic syncytiomas and choriocarcinomas also do not appear 
to be challenged by the maternal immune system.
Almost in direct defiance of these observations, it is equally well 
established that transplantation antigens are expressed in early embryonic 
life in chickens (as early as 4 days post conception) and mice (see 
Simmons and Russell, 1967). In man, the histocompatibility antigens 
expressed on blastocyst stage embryos prior to trophoblast differentiation
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are likely to be protected from jfche^maternal immune system by tbe zona 
pellucida. This membrane is impermeable to most proteins and all cells.
As a barrier, the zona pellucida is effective where there is ectopic 
implantation, all the time it persists intact in the immune host. In 
delayed intrauterine implantation, the zona pellucida may be lost 
prematurely, and under these circumstances there is no further trophoblast 
development, and the ovum is lost.
It is apparent that the maternal response to the fetus is complex. The 
fetus after all, manifests both inherited paternal major histocompatibility 
complex (MHC) and non-MHC antigens. The major histocompatibility complex 
in humans is represented by a region on chromosome 6 that is made up of a
t
series of genes coding for the cellular expression of transplantation ■ 
antigens. The series, known collectively as HLA (human leucocyte antigens) 
is composed of two types of transplantation antigens, Class I and Class II. 
Class I gene products whilst associated with for example, the destruction 
of virally infected cells, are also targets in graft rejection processes. 
Class II gene products, whilst similar in that there is an association with 
graft rejection and possibly graft versus host disease, are more dependent 
upon cell to cell contact and close alliance with other immune cells. In 
addition to MHC and non-MHC antigens there are oncofetal (embryonic) and 
organ-specific antigens, which the mother's immune system must be prepared 
to challenge.
The mother was once thought to be immunocompromised during pregnancy, 
thus providing an explanation as to why the fetus was accommodated 
throughout pregnancy. The philosophy is reasonable as both maternal 
antibody and red blood cells appear quite able to cross the trophoblast 
barrier and do mix freely with fetal cells (Hunziker et al 1984). Maternal
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.antibody directed against paternal MHC antigens, does not appear to damage 
the fetus in any observable way (see Clark, 1985).
However, there is little doubt that both humoral and cell-mediated 
immunity can develop as a consequence of immunological recognition of fetal 
antigens, and this has been seen both in vivo and in vitro (see Billington 
and Bell, 1983) where fetal cells are lysed by maternal effector 
lymphocytes.
Blocking , antikQdy.
Serum obtained from patients in pregnancy has been shown to inhibit 
maternal T lymphocyte function. This has been illustrated in vitro by 
several, well defined measures of lymphocyte activity. For instance, in the 
mixed lymphocyte reaction, pregnancy.: serum suppresses lymphocyte activity 
(Kasakura 1971). Cell proliferation induced by phytohaemoglutinins is 
suppressed (Petrucco et al 1976), and cytotoxic cell activity has likewise 
been shown to be inhibited (Fizet et al 1983). In addition to a non­
specific serum factor capable of blocking maternal lymphocyte activity, 
several other blocking factors or antibodies with well defined specificities 
have been described.
In 1975, Pence et al demonstrated an IgG class of antibody present in 
maternal serum, which blocked maternal immunoreactivity to paternal 
antigens. It became apparent, from evidence attained by in vitro 
techniques, that this response was specific. Lymphocytes from both 
partners incubated with serum unrelated to either party resulted in the 
elaboration of a factor known as-migration inhibitory factor (MIF). It is
generally acknowledged that this factor is a product of sensitised 
lymphocytes in culture. Replacement of the incubating serum with 
autologous serum (ie. serum from the mother) had the effect of blocking the
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production of migration inhibitory factor, interpreted as conferring 
protection specifically in respect of the paternal antigens.
This particular blocking antibody does not often develop before the 
third pregnancy and is therefore characteristically an antibody associated 
with multiparous women. Interestingly, it has been shown to be absent in 
the sera of some recurrent aborters and there is evidence to suggest that 
this might be a consequence of the sharing of HLA antigens betwen partners 
(Rocklin et al 1976). Subsequent studies (Albrechtsen et al 1977 [see 
Lancet, November 19831) indicate that the antibody is specifically directed 
towards HLA-DR antigen, and consequently the inhibition seen in, for 
example, the mixed lymphocyte reaction,.is probably due to the masking of 
the HLA-DR antigen on the maternal T lymphocytes (stimulator cells) by the 
serum antibody.
Other blocking antibodies which appear to have an affinity far specific 
paternal antigens have also been described (Lancet, November 1983). Anti- 
idiotypic antibodies directed against maternal T cell receptors that 
recognise other paternal HLA-type antigens have been identified in 
pregnancy sera. It is known that similar antibodies are stimulated after 
blood transfusions and these antibodies are not therefore unique to 
pregnancy.
A further antibody that appears to be HLA linked was described in 1983 
by Power et al. The antibody has been described as non-cytotoxic, and 
binds in vitro to paternal B lymphocytes and inhibits Fc receptor binding. 
Vhilst the inducing antigen is HLA linked the locus has not been identified, 
and studies so far have not been able to assign the antibody to a single 
set of antigens. Interestingly, these Fc receptor-blocking antibodies are 
another example of antibodies that are present in most first trimester
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sera, but .absent in almost all sera (90%) obtained from patients 
experiencing first trimester abortion (Power et al 1983).
Perhaps the final blocking antibody that warrants description, is one 
that is induced, or stimulated by the so-called TLX antigens (trophoblast- 
lymphocyte cross-reactive antigens). Trophoblast cells and maternal 
lymphocytes have membrane antigens that are common to both cell types.
The evidence points towards most trophoblast cell populations bearing these 
antigens which are, or appear to be, MHC (major histocompatibility 
complex)-linked (Johnson 1983). McConnachie and McIntyre (1984) provided 
evidence that pregnant women do produce antibodies to TLX antigens, and 
this would imply that trophoblast cells are potentially vulnerable to 
immunological attack. Antibodies to TLX antigens raised under laboratory 
conditions inhibit the mixed lymphocyte reaction though (Beer et al 1972), 
and in vivo it is likely that the titre of maternal antibody to TLX 
antigens is raised upon exposure to trophoblast (McIntyre and Faulk 1979), 
whereupon presumably the antibody blocks and consequently protects the 
trophoblast determinants.
The cells involved
Both the mouse and human have evolved a similar, haemochoreal type of 
placentation. This makes the mouse placenta a credible model for man and 
consequently there has been considerable extrapolation of data from this 
species. In both species, successful pregnancy induces a suppressor T cell 
response specific for both major histocompatibility complex (MHC) and non- 
MHC paternal antigens. Whether these cells are of major importance in the 
maintenance of pregnancy is debatable. Vhilst they may be detected after a 
single pregnancy, their potency has been shown to be insufficient in 
preventing the rejection of either sub-cutaneous or intrauterine MHC-
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incompatible paternal allografts (Nagarkatti and .Clark 1983). The cells are 
slow to appear in pregnancy which does not favour their importance either, 
as one would expect a rapid response if suppressor T cells were responsible 
for suppressing - the maternal immune system to an allograft. Maternal 
immunocorapetence is in fact, generally well maintained throughout pregnancy 
(Sunderland et al 1981). The same statement holds true with regard to the 
humoral antibodies discussed above. Whilst competent to specifically block 
maternal T lymphocytes, recognising paternal antigens, it is unlikely that 
these antibodies protect the integrity of the fetus in this way. An 
observation which supports this, is the ability of patients with hypo- or 
a-gammaglobulinaemia to carry a pregnancy to term.
Successful allopregnancy in mice also induces a suppressor cell 
response, initially at sites of implantation. These cells are small 
lymphocytes that lack T cell markers, but possess Fc receptors for IgG. 
Maternal immunological suppression is associated with an increase in these 
small, granulated lymphocytes which appear to block the generation of anti- 
paternal cytotoxic lymphocytes and therefore cytotoxic lymphocyte activity.
The suppression which is not MHC specific, is mediated by a factor 
which prevents T lymphocytes from responding to T cell growth factor 
(interleukin 2). This blocking of cytotoxic lymphocyte cell activity 
demonstrable in vitro, may in vivo, prevent the growth of a large 
population of graft-destroying, cytotoxic, effector lymphocytes (Asher et al 
1983). There is certainly experimental evidence supporting a correlation 
between the absence of granulated lymphocytes of the type described and 
pregnancy failure. Xenopregnancy (where the paternal complement is 
entirely foreign to the host - eg sheep/goat), unlike allopregnancy does not 
stimulate suppressor cell activity at implantation sites, and the fetuses
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are resorbed. Histologically, it can be seen that maternal lymphoid 
(effector) cells infiltrate the fetus, breaching the trophoblast as if this 
physical barrier did not exist (Clark et al 1984).. It is tempting to 
speculate further, as a population of cytotoxic lymphocytes with 
similarities to interleukin 2-activated killer T cells has been identified 
in dying xenoembryos (see Clark 1985).
With regard to human pregnancy, several attempts have been made to 
identify and characterise the cell populations seen in decidua of early 
pregnancy. Important advances have been made following the advent of 
immunocytochemistry, and interpretation of the significance of some of 
these cell populations is currently limited by a combination of technical 
limitations, imposed by the nature of the tissue,, and the availability of 
appropriate monoclonal antisera.
The study by Bulmer and Sunderland (1984) on the distribution of 
leucocytes in first trimester placental bed, shows that many of these cells 
are derived from bone marrow, a proportion of which are immunochemically 
HLA-DR positive. A larger proportion of these cells, by their distribution 
and morphology, are thought to be endometrial granulocytes. These cells 
are identified from other cell populations by their negative staining-for 
HLA-DR and peripheral pan-T cell antigens, and positive staining for E- 
rosette receptors. E-rosette staining implies that such cells in vitro, are 
capable of binding erythrocytes from animal species (eg sheep, ox). It is 
traditionally a feature of T lymphocytes, and in fact this characteristic is 
used in vitro to separate mixed populations *of T and B lymphocytes (Roitt 
et al 1985). Some of these T cells have receptors for the Fc portion of 
IgG.
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The other large population of cells described, expressed a marker 
synonymous with either immature or activated T cells. The existence of a 
large population of these cells in normal first trimester placental bed 
tissue would imply the interleukin-2 blocking factor referred to by Asher 
et al in 1983, may not in fact be a feature of human pregnancy.
The role of fetal trophoblast
In more recent years, the fetal trophoblast has been a focus of
t
attention. Its significance immunologically revolves around its intimate 
relationship with cells of maternal origin. Although at an interface with 
maternal tissue, trophoblast cells are, never the less, normally resistant 
to cell lysis by anti-paternal effector lymphocytes of maternal origin 
(Billington and Bell, 1983). .
In the mouse this may be because the trophoblast cell layer of the 
placenta loses surface histo-compatibility antigens at the time of 
implantation. There is some re-expression of both MHC and non-MHC H 
antigens later in pregnancy around day 5, in populations of trophoblast 
that are in direct contact with decidua. There is a similar lack of 
expression of paternal MHC antigens on human trophoblast, although 
expression of Class I paternal MHC-like surface antigens has been reported 
for one cytotrophoblast cell population in contact with decidua (Clark 
1985).
It is conceivable that the trophoblast is instrumental in recruiting the 
two types of suppressor lymphocytes seen at implantation sites. The first 
can be generated experimentally by priming the uterine endometrium with 
hormones or other exogenous inducers of decidualization. This results in 
the appearance of cells that inhibit cytotoxic lymphocyte activity. These 
conditions are not conducive to the generation of the second population of
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suppressor cells, however, as these cells remain numerically low and may 
even be absent. Of the two suppressor-type cells associated with decidua, 
one inhibits the detrimental effects of maternal immunity, but not its 
expression, whilst the other, a small granulated lymphocyte, inhibits both 
the generation and expression of immunity associated with transplantation 
antigens.
Regulation of immune response in pregnancy appears to occur 
predominantly within the local confines of the uterus, Skin grafts that are 
tolerated for long periods of time on decidua during pregnancy are promptly 
rejected if placed elsewhere (Beer and Billingham, 1974). Likewise, paternal 
intrauterine skin grafts implanted in pregnancy in immunised hosts are 
rejected although the fetus, also a paternal allograft, develops unchallenged 
(Sio et al 1983). There is an important distinction that must be made 
however between these allografts. Skin expresses MHC Class II paternal 
antigens, skin specific antigens and in particular, highly antigenic 
dendritic cells, all of which contrast with the immune status of the fetus. 
It would be reasonable to assume also, that an antibody response to the 
skin antigens described would be more likely to be of an antibody-dependent 
neutrophil challenge rather than a T cell induced graft rejection more 
characteristic of fetal incompatibility (as seen experimentally).
Previous allogeneic pregnancy in mice (as distinct from immunised 
pregnancy described above) has no effect on uterine skin grafts despite the 
possible presence of suppressor T cells from a previous pregnancy. However 
grafts are rejected in the uterine horn that does not have a fetus (Clark 
1985), providing further evidence of the protection conferred upon the fetus 
by factors discussed in this introduction.
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Immunological concepts In practice ..
At the beginning of the 1980's, several groups of workers were involved 
in putting into practice the immunological concepts believed to be behind 
successful allograft pregnancy. The work of Taylor and Faulk <1981),
Taylor et al 1985 and Denegri et al 1986 is representative of these aims. 
Although the evidence is conflicting, there are several studies which 
support the concept that recurrent aborters share HLA (transplantation) 
antigens with their partners (Komlos et al 1977, Gerencer et al 1979), a 
phenomenon that does not appear to exist in the population as a whole. It 
has also been established that many recurrent aborters lack the blocking 
antibodies previously described, which are associated with maintaining 
pregnancy (Eocklin et al 1976). In addition there are TLX antigens which 
are linked into the major histocompatibility complex (MHC). If the mother 
does produce antibodies to TLX antigens as suggested by McConnachie and 
McIntyre (1984), then HLA sharing between parents could nullify any 
stimulation generated between trophoblast TLX antigens and maternal 
antibody produced in response to these antigens. A poor antibody 
protecting response would confer little protection upon the fetal 
trophoblast and consequently provide the conditions for maternal reactivity 
against fetal tissue.
The studies cited above profess to stimulate in recurrent aborters, the 
protective antibodies demonstrable in normal pregnancy. This is achieved 
by immunising the mother t with allogeneic leucocytes, a principle that has 
been refined somewhat since its inception (Denegri et al 1986). A potential 
problem arises when one considers that immunity could conceivably be 
directed against non-MHC antigens of the fetus and trophoblast, rather than 
against such sub-populations as MHC Class I antigen-bearing trophoblast.
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Under these circumstances, abortion could occur for the reasons previously 
described, i.e because blocking antibodies are absent or present in 
ineffectual amounts. Alternatively, if local intrauterine suppressor 
mechanisms are effective, then inappropriate immunisation would again do 
little to prevent pregnancy loss, as the immunity and inevitable risk to 
the fetus is directed against non-MHC antigens.
There are other possible risks attached to immunising mothers of couples 
sharing HLA antigens. Firstly, by virtue of their antigen sharing there is 
a pre-disposition for creating lethal gene combinations incompatible with 
early embryogenesis. Secondly, shared histocompatibility may favour graft 
versus host disease which could be particularly distressing, as this 
condition may only be evident after a successful pregnancy.
Maternal immunity then, directed against paternal-MHC antigens results 
in the production of antibodies that are effective in preventing spontaneous 
abortion. The vaccination of aborting mothers with her partners treated 
leucocytes has been a successful means of artificially stimulating these 
antibodies. Vhilst in humans the cellular mechanisms involved are not 
known, analogous immunisation procedures in mice have demonstrated an 
increase in non-T suppressor cell activity in decidua (Clark et al 1984), 
and an increase in the ability of placental digests to inhibit the lytic 
activity of UK (natural killer) cells (see Clark 1985). Anti-paternal MHC 
antibody may possibly activate non-T suppressor cells through their Fc 
receptors (Clark et al 1984) and, as discussed, trophoblast is blacked by 
antibody thus preventing its recognition by maternal lymphocytes.
The preceding, somewhat selective, review of immunological concepts of 
pregnancy, identifies several antibodies and cell types that undoubtably, 
collectively contribute to successful human pregnancy. The practical
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section of this chapter is aimed at addressing and clarifying some of the 
anomalies currently in print and presented also in this thesis. The main 
attempt has been to characterise further the role of the endometrial 
granulocyte, but in doing this the distribution of other cells has also been 
noted.
The first section of the practical work is devoted to establishing the 
histochemical nature of the endometrial granulocyte, as the previous chapter 
failed either to exclude or incriminate this cell with the synthesis of 
relaxin. There are available several indicators, some tinctorial, some 
histochemical, that have been useful in characterising cells of this type 
(Dallenbach-Hellweg and Nette 1964, Dallenbach-Hellweg et al 1965, and 
Dallenbach-Hellweg cet al 1966), and some of these have been exploited here.
The remaining section addresses two related problems experienced by 
experts of reproduction immunology. The first concerns the limited use of 
monoclonal antibodies on formalin-fixed, paraffin wax-processed material.
The second considers the problem identified by Bulmer initially in 1985 and 
reported subsequently (Bulmer et al 1987), concerning the disruption of 
endometrial granulocyte cell granules in cryostat (frozen) sections. The 
need to use frozen sections for some monoclonal antibody markers has 
prevented conclusive study of the endometrial granulocyte. Interpretation 
has by necessity, been made on the nuclear morphology and distribution of 
these cells. Attempts to double-stain sections with phloxine-tartrazine 
have failed because the immunoreactivity is obscurred. Attempts to 
correlate staining using serial sections, whilst providing encouraging 
results, remain subjective.
The first problem was tackled by avoiding the use of both frozen 
sections (because of the disruption of endometrial granulocyte cell
152
granules), and paraffin wax-processed sections (because of the limited 
number of antibodies that can be usefully applied). Instead, imprint smears 
of endometrium from unfixed, opened uteri were prepared and subsequently 
evaluated. The second problem was overcome by modifying the methodology, 
which subsequently allowed both tinctorial and immunostaining of the same 
cell.
MATERIALS AMD METHODS
Histochemical characterisation of the endometrial granulocyte
All of the staining methods used in this section were performed on 
tissue sections from tissues fixed in 10% buffered formol saline, routinely 
processed and paraffin wax embedded. The tissue sections, cut at 4 pm, 
were of late secretory phase endometrium or products of conception removed 
by suction termination during the first trimester. Prior to performing any 
special staining techniques, representative sections were stained with 
haematoxylin and eosin and by the Phloxine-tartrazine method of Lendrum 
(see Chapter 3). The first stained section was examined to exclude any 
histological anomalies, and the phloxine-tartrazine stained section to 
establish the presence of granulated endometrial granulocytes in suitable 
numbers. The following staining techniques, for which methods are given in 
the appendix of this chapter, were then performed:
1. Chloroacetate esterase. A histochemical method for staining all cells 
of the myeloid cell series. Sections known to contain either mast cells or 
neutrophils are suitable controls.
2. a-Uaphthyl acetate esterase. A histochemical method, traditionally for 
use on blood films but adapted for use here because of its ability to stain
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its ability to stain T helper lymphocytes. All other lymphoid cells are 
negative by this method.
3. Fast blue-esterase double staining (Pearse 1985). A combination method 
utilising fast blue to stain cells of the myeloid cell series and esterase 
for cells of the leucocyte monocytoid cell series.
4. Performic acid-alcian blue (PFA-AB) (Bancroft and Stevens 1977). A 
histochemical method for detecting disulphide bonds. One feature of the 
polypeptide hormone relaxin, is the number of disulphide bonds within its 
structure. Positive endometrial granulocyte staining would therefore favour 
the existence of relaxin in these cells.
5. DMAB (p-dimethylaminobenzaldehyde)-nitrite (Bancroft and Stevens 1977). 
One of the few reliable methods for amino acids, DMAB-nitrite is a 
histochemical method for tryptophan. This method is included because 
tryptophan is a demonstrable constituent of relaxin. Once again, a 
positive result would support the presence of relaxin in endometrial 
granulocytes.
6. Haematoxylin and Van Gieson (Culling 1963). Several methods were 
chosen in an attempt to obtain some differential staining of endometrial 
granulocyte granules. Collectively, the results might characterise the cell 
further. This method is an old method and was used for this purpose.
7. Chromotrope 2R (Bancroft and Cook 1984), An empirical but selective 
stain for eosinophils. The method is included as eosinophils are sometimes 
mistaken for endometrial granulocytes and vice versa. Also, cell types that 
stain positively with phloxine-tartrazine may also stain with this method 
(eg, paneth cell granules). The method is included therefore to exclude any 
possible confusion about the identity and distribution of the endometrial 
granulocytes under investigation.
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8. Peris' stain (Culling 1963). A histochemical method used here to 
exclude the presence of ferric iron within granulocyte granules.
9. Giemsa (Bancroft and Stevens 1977). A classical stain used 
traditionally on blood films for the differential staining of leucocytes.
Its use here was in determining granule staining in relation to other 
granulocytic leucocytes.
10. Azure A (Bancroft and Stevens 1977). One of several techniques for 
demonstrating mucins. Azure A stains mast cells well, as will other cells 
secreting acid mucins.
11. Alcian'blue (Bancroft and Cook 1984). Another example of a method used 
for demonstrating acid mucins in cells. Alcian blue is the histochemical 
method of choice for this purpose because of its specificity. The type of 
acid mucin stained can be altered, by changing the pH of the alcian blue 
staining solution.
12. Periodic acid Schiff's (PAS) reaction (Pearse 1968). A commonly used 
method for demonstrating glycogen, neutral and some acid mucins. Used in 
combination with alcian blue, the methods will produce differential staining 
of both acid and neutral mucins.
13. Grimelius (Bancroft and Stevens 1977). A metallic silver impregnation 
method used to characterise cells of endocrine origin. Many of the cells 
showing argyrophilia contain secretory vesicles and show high esterase 
activity, cholinesterase and a glycerophosphate dehydrogenase activity. The 
list includes pituitary basophil cells that secrete ACTH, pancreatic islet 
cells, thyroid C cells and adrenal chromaffin cells. These cells and 
several others were known collectively as cells of the APUD cell series 
(amine precursor uptake and decarboxylation). The name remains although 
now considered to be inappropriate.
;'The following 5 methods are immunocytochemical methods (see Polak and 
Van Noorden 1983). The methodology is fundamentally the same for each of 
these, but see appendix for details.
14. Cytokeratin (CAM 5.2). A marker for all cells of epithelial origin, 
from simple glandular tissue to stratified squamous epithelium. The 
specificity is dependent upon the presence of filamentous keratins within 
the cell.
15. S100. A selective rather than specific marker, S100 is traditionally 
used for tumours of the central and peripheral nervous system, and 
melanocytic lesions of the skin and metastases. It is a marker for cells 
of some salivary gland tumours. Its reaction with interdigitating cells (an 
antigen presenting cell), prompted its use here.
16. EMA (epithelial membrane antigen). A marker of both normal and 
neoplastic epithelium, EMA is particularly useful in distinguishing between 
carcinoma and lymphoma.
17. AFP (a-feto protein). AFP is a major serum glycoprotein synthesised by 
the fetus during pregnancy, it is one of several substances described 
collectively as oncofetal antigens. Its importance in adult life results 
from its reappearance and association with several tumours, in particular 
hepatocellular carcinoma and yolksac tumours of the testis and ovary.
18. Prolactin. This marker was included because of the association thought 
to exist between decidual cells, stromal cells and their subsequent 
differentiation into endometrial granulocytes, as previously reported 
(Dallenbach-Hellweg 1981). Decidua is a source of prolactin and it was 
therefore considered prudent to exclude the endometrial granulocyte as a 
source of this hormone.
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19. Toluidine blue.' This method was included as it is commonly used for 
sections processed and embedded in plastic rather than paraffin wax.
Tissues embedded in plastic are not subjected to the reagents and 
temperature extremes that paraffin wax processed tissues are, and 
consequently the cytological appearance of the cells is improved. The 
harder embedding medium also allows thinner sections to be cut which also 
contributes to the quality of the section. Toluidine blue stains some 
granular cells (eg, mast cells) metachromatically and this embedding 
technique and staining method was used for this purpose.
Preparation and staining of endometrial imprints.
Preparatory screening of material Imprints were made from uteri 
received by the department if they satisfied the following criteria:
1. the age of the patient fell within a child-bearing range.
2. the patient was in a late secretory phase of her menstrual cycle at the 
time of operation.
3. the reason for a hysterectomy did not obviously preclude its 
use in this study.
4. they were received fresh and unfixed.
Imprints were stained if the examination of routinely processed blocks 
of the endometrium confirmed the presence of endometrial granulocytes in 
reasonable numbers. If the normal architecture was disrupted and/or 
endometrial granulocytes were not present or only in small numbers, then 
the imprints were discarded.
Preparation of imprints The uteri were bisected and opened along the 
endometrial canal. Cleaned microscope slides were then carefully and 
lightly touched onto the raw, exposed endometrial surface. Nine slides were
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••-'•prepared from each case, and for this study, 4 cases, proved suitable for"" '• 
further investigation. The slides were air dried for at least one hour, 
fixed in acetone for 10 minutes and dried once again. Each slide was then 
carefully double sealed in aluminium foil and stored at -20 CC until required 
for staining. Prior to staining the slides were removed from the deep­
freeze and allowed to reach room temperature before being unwrapped. This 
was to prevent any damage to the cells by condensate during temperature 
equilibration.
Staining of imprints The imprints were stained immunocytochemically 
using an indirect immunoperoxidase technique (see appendix), with the 
following monoclonal antisera:
1. LCA (leucocyte common antigen). A marker for all cells derived from 
leucocytes. Polymorphonuclear leucocytes and lymphocytes are suitable 
control cells.
2. EBM-11 (macrophage marker). The macrophage markers identify 
mononuclear cells of phagocytic origin. They have been especially useful in 
clearly determining the number of cells of macrophage origin, infiltrating a 
tumour. Macrophages are antigen presenting cells, •
3. Pan B. A marker for all lymphocytes of B cell origin
4. Pan T. A marker for all lymphocytes of T cell origin
5. T-helper (Ta ). This cell marker and the one below both recognised sub-
populations of T lymphocytes, specifically as their name suggests.
6. T-suppressor (T&)
7. HLA-DR. This antiserum reacts with MHC complex, HLA classll antigens. 
Before the advent of precise B cell markers, lymphocytes reacting 
positively with HLA-DR and negatively with T cell markers, were considered 
to be of B cell origin.
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Double-staining of paraffin wax---sections for endometrial granulocytes,
The tissue sections used here were cut from blocks used previously in 
this chapter (see the first section). The fallowing monoclonal antibodies 
were used in an indirect immunoperoxidase technique (see appendix):
1. LCA. See above
2. MB-1. Although a marker for B cells (plasma cells are not reactive), it 
is acknowledged that mature T cells will stain with this antibody.
3. MB-2. MB-2 stains B cells and a range of normal tissues, and some T 
cell lymphomas will react. The staining is cytoplasmic and usually strong, 
unlike MB-1 which is a cell membrane reactive antiserum.
4. MT-1. MT-1 is a cell membrane marker for T cells and granulocytes. 
There is cross-reactivity with some B cell lymphomas
5. UCHL-1. Another cell membrane marker for T cells. The marker does 
though, react with a variety of tissue and cell types including granulocytes 
and histiocytes.
6. Mac 400. A macrophage marker recognising the same cells as EBM-11, 
above.
The following polyclonal antibodies were used in a peroxidase anti- 
peroxidase technique (see appendix):
1. Lysozyme. A marker for the enzyme of the same name. Its distribution 
in epithelial cells, myeloid cells and histiocytes (in particular histiocytic 
lymphoma). Meutrophils stain with this antibody and it is used in 
differentiating between myeloid and monocytic leukaemia.
2. IgG. This antibody was included as it has been reported that 
endometrial granulocytes react positively with antiserum to IgG.
Evidence of endometrial granulocyte cell staining was sought for each of 
these cell markers. Any positive staining even remotely fulfilling the
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morphological criteria or cellular distribution of endometrial granulocytes 
was subjected to the following additional staining: Sections were
counterstained after immunostaining with haematoxylin in the usual fashion. 
The phloxine-tartrazine method of Lendrum was then performed. Tartrazine 
is used to differentiate or remove non-specific phloxine from tissue 
entities weakly binding this stain. Its only other use is in providing an 
aesthetically pleasing background to the section, improving contrast. It is 
this staining that has been reported to obscure the immunoperoxidase 
reaction, an observation apparent also in this study. The sections were 
therefore, washed in water for 2-3 minutes to remove the tartrazine 
staining, prior to dehydrating in alcohol, clearing in xylene and mounting.
RESULTS
The results are given in the form of tables (Tables 9, 10 and 11) and a 
series of figures (Figures 36-58) which are photographs representative of 
the results obtained. The staining methods and dilutions for the 
immunocytochemical markers have been collated and are presented as an 
appendix at the end of the chapter.
DISCUSSIOW
A role in relaxin secretion
The histochemical characterisation of the endometrial granulocyte can 
best be described as a 'last ditch' attempt to incriminate this cell with 
the synthesis of relaxin. For this to be in any way credible, the 
performic acid/alcian blue (PFA/AB) and p-dimethylaminobenzaldehyde-nitrite 
(DMAB-nitrite) methods should have stained endometrial cell granules 
positively, which they did not. The controls used, confirmed that the
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Table 9 Histochemical characterisation of the endometrial granulocyte
The staining reactions for cells and their products are given, 
of these are illustrated in the Figures that follow. lone of the 
methods here have stained, reacted histochemically or immunocyto- 
chemically with endometrial granulocytes.
Some
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S I M i l i i i J E I i M
C h l o r o a c e t a t e  esterase cells of the myel o i d  series; red cytoplasm
«-naphthyl acetate 
esterase
monoc y t o i d  cells; b r o w n / r e d  cytoplasm 
bright red spot in c y t o p l a s m  of 
some T-helper cells
Fast b l u e / e s t e r a s e cells of the m y e l o i d  series; red cytop l a s m  
mo n ocytoid cells; b r o w n / r e d  cytoplasm
Per formic acid/ 
Alcian blue
amino acids c o ntaining d i s u l p h i d e  groups
p-dimethylami no 
b e n z a l d e h y d e - n i t r i t e  (DMAB)
amino acids conta i n i n g  tryptophan
Ha e m a t o x y l i n  & Van Gieson C o l l a g e n  inclusions; red 
(eg involuting decidual cells)
C h r omotrope 2R eosinophil granules; pink
Peris' ferric iron; blue
Giemsa differential s t a i n i n g  of leucocyte 
granules; pink to purple
Azure A acid mucins; purple to red
Alcian blue acid mucins; blue
PAS/di a s t a s e  PAS acid/n e u t r a l  mucins 
g l ycogen (diastase labile)
Grimelius cells of n e u r o e n d o c r i n e  origin: 
brown/black gran u l e s  in cytop l a s m
C y t okeratin (CAM 5,2) :fdark brown stai n i n g  of posi t i v e  cells
3100 Idark brown stai n i n g  of p o s i t i v e  cells
Epithelial m embrane antigen *dark brown s taining of p o s i t i v e  cells
#-f e t o p r o t e i n  (AFP) :fdark brown stai n i n g  of p o s i t i v e  cells
Prolactin 4'dark brown s taining of p o s i t i v e  cells
■ Toluidine blue metach r o m a t i c  pur p l e  s t a i n i n g
% Each marker must be used in c o n j u n c t i o n  with 
a known positive control tissue s e c t i o n
laM e .JL.fi Staining of imprints with monoclonal antibodies
A total of 7 monoclonal antibodies were used in an attempt to 
positively identify or clarify some immunocytochemical characteristics 
of the endometrial granulocyte. Previous attempts have been limited by 
the problems encountered in freezing tissues for sectioning. The 
subsequent granule disruption of the granulocyte made the interpretation 
of results by necessity, comparative. The use of imprint smears of 
endometrium has not resolved this problem. Endometrial granulocytes 
appear to be poorly represented in these imprints, and phloxine- 
tartrazine staining in most cases is negative. Either the method has 
not worked, or there aren't any granulocytes in the imprints to stain. 
Appropriate control material which might have resolved the issue, could 
not be obtained.
162
PRIMARY MONOCLONAL..ANTIBODY. O l U i l l M COWTROLJLISSUE.
Le ucocyte common antigen 
(LCA)
E M B - 1 1 (macrophage marker) 
Pan B 
Pan T
7-helper cells c t 4 > 
T-suppressor cells <T8> 
HLA-DR (most lymphocytes)
in 40
in 200 
in 80 
in 80 
in 20 
in 20 
in 40
Tonsil
Tonsil
Tonsil
Tonsil
Tonsil
Tonsil
Tonsil
Control tissue sections were cut from frozen, unfixed blacks of tonsil 
The sections were rapidly air dried and subsequently fixed in acetone 
for 10 minutes.
Dilutions were made in 10% bovine serum albumen in 0.2M TRIS buffer 
(pH 7.6).
Double staining of paraffin wax sections for endometrial granulocytes
The results of this section are more encouraging. There is positive 
staining of granulocytes with several markers, although double staining 
complicates the interpretation of this staining, since there is a 
mixture of both reactive and non-reactive cells immunocytochemically and 
with phloxine.
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PRIMARY MONOCLONAL ANTIBODY Q.ILUIIQM CONTROL TISSUE
Leucocyte common a ntigen 1 in 50
(LCA)
MB-1 1 in 10
MB-2 1 in 5
MT-1 1 in 5
IJCHL-1 1 in 250
Mac 400 *1 in 5000
C y t o k e r a t i n  (CAM 5.2) *1 in 20
E pithelial m embrane antigen *1 in 400
Tonsil
Tonsil
Tonsil
Tonsil
Tonsil
Tonsil
K i d n e y
K i d n e y
Dilutions were made in 3% bovine serum albumen in 0.2M THIS buffer 
(pH 7.6).
* Sections required trypsinisation (see Appendix for details)
IaM.e-J.2L
Retails.,...of.J he_fiQX5K l.onal-.antihodjl^s-jigaLJLnJb.he . i.deiLt,lltcatlm..Qf...lha. 
endometrial granulocyte
This Table illustrates the dilutions used for each of the polyclonal 
antibody primary markers, and appropriate control tissues. Each marker 
required trypsinisation of the sections prior to their application. The 
sections were then stained using the peroxidase anti-peroxidase (PAP) 
method.
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PRIMARY POLYCLONAL ANTIBODY DILUTION CQNT.RQL ...TISSUE.
L ysozyme
IgG
SlOO
P r olactin
a-f e t o p r o t e i n  (AFP)
$1 in 500 
*1 in 2000 
*1 in 1000 
SKIT
SI in 100
T o n s i 1 / l y m p h  node 
Tonsil 
Nerve 
P i t u i t a r y  
Yolk sac tumour
Dilutions were made in 3% bovine serum albumen in 0.211 TEIS buffer 
(pH 7.6).
* Sections required trypsinisation (see Appendix for details)
Figure 36 Chloroacetate esterase (control)
Polymorphonuclear leucocytes in the lumen of an appendix staining. 
Cells of the myeloid cell series stain red with this method. 
Endometrial granulocytes did not stain positively with this method. 
Objective magnification x25, eye-piece magnification xlO
Figure 37 Chromotrope 2R (control)
An empirical, selective stain for eosinophils, seen here in a section 
of nasal polyp. Some phioxine-tartrazine positive cells are stained by 
this method (eg Paneth cells of the ileum stain rusty brown). However, 
endometrial granulocyte granules only stain weakly.
Objective magnification x25, eye-piece magnification xlO
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Figure 3d (a) Perform!c acid-alcian blue
Pig ovary is a rich source of relaxin. Relaxin is a rich source of 
disulphide groups. This control section illustrating the granulosa cell 
layer of porcine corpus luteum (GCL) is weakly positive. However, areas 
luminal to this cell layer are positive (arrowed).
Objective magnification xlO, eye-piece magnification xlO
Figure 38(b) Performic acid-alcian .blue
Decidual cells in a 'sea' of positive disulphide-rich stroma. It is 
not possible to determine whether endometrial granulocytes are 
positively stained, although other areas of the section would suggest 
they are negative by this method.
Objective magnification x25, eye-piece magnification xlO
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Figure 39 Giemsa 65/0463 <SJH)
Secretory phase endometrium stained with Giemsa. Endometrial 
granulocyte granules are not stained by this method (arrowed), 
Endometrial gland secretion has stained differentially and can be seen 
to the right of the photograph.
Objective magnification x25, eye-piece magnification xlO
Figure 40 DMAB (p-dimethylaminobenzaldehyde-nitrite) 85/0463 (SJH)
A histochemical method for the amino acid tryptophan. The only 
positive staining is attributed to red blood cells, seen here in vessels 
as homogeneous blue staining. A single eosinophil has stained (E); 
endometrial granulocytes are not stained.
Objective magnification x25; eye-piece magnification xlO
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Figure 41 Fast blue/esterase
Decidua infiltrated by a large number of fast blue staining 
leucocytes. The intensity of staining and number of polymorphonuclear 
leucocytes precludes the identification of endometrial granulocytes. In 
other sections, endometrial granulocytes identified by the size and 
shape of their nuclei, appeared to be negative for both myeloid (blue) 
and monocytoid (brown/red) cells,
Objective magnification xlO, eye-piece magnification xlO
Figure 42 Cytokeratin (CAM 5.2)
Positive immunoperoxidase staining is restricted to cells lining 
decidual glands. Remainder of decidua, blood vessels (endothelium) and 
endometrial granulocytes, are negative. Note cluster of probable 
endometrial granulocytes amongst decidual cells, in the centre of the 
photograph. Objective magnification x25, eye-piece magnification xlO
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Figure 43 Mac 400 (macrophage)
Immunocytochemical marker for macrophages. Seen here as dark brown 
staining cells in close apposition to 2 decidual blood vessels. The 
scattered, dark staining nuclei of cells reminiscent in their 
distribution, of endometrial granulocytes, are negative for this cell 
marker. Objective magnification x25, eye-piece magnification xlO
Efguxg.-_l-4 S1Q.Q.
Decidual glands in this section stained by imraunoperoxidase are 
weakly stained. The positive, dark brown staining cells morphologically 
fulfill the criteria of endometrial granulocytes. The nuclei tend to be 
oval or slightly indented and densely stained with haematoxylin,
However, other cells fulfilling this description, are negative 
(arrowed). Objective magnification x25, eye-piece magnification xlO
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Figure 45(a) and Figure 45 <b) AFP (« fetoprotein)
Immunoperoxidase staining is not always precise and easy to 
interpret, This photograph and the one below illustrates a fetoprotein 
staining in the same section. A transition in staining of the same cell 
types is evident. This observation was reproducible and evident in 
unrelated tissue sections, Objective magnification xlO, eye-piece 
magnification xlO
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Figure 46 H&E (2pm section, glvcol methacrylate)
Vhilst the cellular and general morphological criteria are better 
preserved in plastic (glycol methacrylate) sections, the range of 
specialised techniques, especially immunocytochemical, are limited 
because of the nature of the plastic. There may be several endometrial 
granulocytes in this section of secretory phase endometrium, but 
cytoplasmic granule staining is not evident (arrowed). Some acellular 
granules are identified (AG).
Objective magnification x25, eye-piece magnification xlO
Figure 47 Toluidine blue (2pm section, glycol methacrylate)
The superior cytology associated with glycol methacrylate embedded 
tissue is illustrated in this section of endometrium stained with 
toluidine blue. A mast cell has stained metachromatically, and is 
clearly seen QIC). Endometrial granulocytes, assuming they remain 
intact, do not stain similarly.
Objective magnification x25, eye-piece xlO
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An imprint smear of endometrium stained by an indirect 
immunoperoxidase method and using the monoclonal antibody HLA-DR as the 
cell marker. The staining which looks convincing, is likely to be 
artefactual. However, it is difficult to decide on the criteria for 
controlling this modified technique. EC: endometrial cells, DEC: 
discrete endometrial cells.
Objective magnification x40, eye-piece magnification xlO
Figure 49 Pan B/Phloxlne-tartrazine_Cimprint)._
Acetone fixed imprint of endometrium stained by indirect 
immunoperoxidase and counterstained with a modified phloxine-tartrazine 
method in which the tartrazine is removed, A weakly stained B 
lymphocyte (B) is identified, as is a possible endometrial granulocyte. 
The identification of endometrial granulocytes remains speculative, as 
phloxine granules could not be stained in any of the imprints.
Objective magnification x40, eye-piece magnification xlO
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Figure 5Q Pan T/Phloxine-tartrazine (imprint)
A T lymphocyte stained with peroxidase <T> together with phloxine 
positive cells which may be endometrial granulocytes (arrowed). 
Objective magnification x40, eye-piece magnification xlO
Figure 51 LCA/Phloxine-tartrazine (imprint)
Imprint smear stained immunocytochemically for leucocyte common 
antigen and counterstained with phloxine-tartrazine. LCA staining is 
intense and it is not possible to confirm the presence of LCA positive 
/phloxine-tartrazine positive cells.
Objective magnification x25, eye-piece magnification xlO
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Figure 52(a) and Figure 52<b) LCA/Phloxine-tartrazine
Paraffin wax section of decidua stained immunocytochemically to 
demonstrate leucocyte common antigen. The sections are counterstained 
with phloxine-tartrazine, and cells which are LCA/P-T positive , are 
arrowed. This staining reaction suggsts that these cells, which 
morphologically and tinctorially fulfill the criteria of endometrial 
granulocytes are, by their LCA staining, leucocytes of bone marrow 
origin. Objective magnification x40, eye-piece magnification xlO
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Figure 53 LCA/Phloxine-tartrazine
Section stained with immunoperoxidase for LCA, and counterstained 
with phloxine-tartrazine. This photograph conflicts with the 
conclusions reached in the previous 2 figures, An endometrial 
granulocyte is seen which is LCA negative/P-T positive (arrowed), and in 
the same field there is evidence of LCA positive/P-T negative cells.
This is difficult to interpret but the reverse staining patterns would 
suggest the methodology is sound. Objective magnification x40, eye­
piece magnification xlO
Figure 54 UCHL-1/Phloxine-tartrazine
Decidua stained immunocytochemically for UCHL-1, a marker of T 
lymphocytes (cell membrane staining), granulocytes and some histiocytes. 
A variety of cells exhibit cytoplasmic staining, but membrane or rim 
staining is significant in the identification of T cells. Cytoplasmic 
staining of cells morphologically resembling endometrial granulocytes is 
seen in the centre of the photograph. However, these cells have not 
stained convincingly with phloxine.
Objective magnification x40, eye-piece magnification xlO
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Figure 55 UCHL-l/Phloxine-tartrazine
The reverse of the previous figure is illustrated in this section, 
Phloxine-tartrazine positive cells are seen which are negative for 
UCHL-1, although UCHL-1 positive cells can be identified (arrowed) 
Objective magnification x25, eye-piece magnification xlO
Figure 56 UCHL-l/Phloxine-tartrazine
Uhilst most endometrial granulocytes appear to be negative for 
UCHL-1, a few cells did show weak cytoplasmic membrane staining in 
conjunction with phloxine staining which may be genuine (UCHL-1 
positive) - arrowed, However, this observation has not photographed 
well. Objective magnification x40, eye-piece magnification xlO
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Figure 57 IgG/Phloxine-tartrazine
Decidua stained immunocytochemically for IgG and counterstained with 
phloxine-tartrazine. Numerous phloxine positive endometrial 
granulocytes can be seen, which have not stained for IgG, although IgG 
staining is clearly evident in other areas of the tissue.
Objective magnification x25, eye-piece magnification xlO
Figure 58 MT-l/Phloxine-tartrazine (s/9732.82)
HT-1, like UCHL-1 is a marker of T cells (membrane staining), and 
granulocytes. Whilst there is strong staining of decidual cells in 
various stages of involution, phloxine-tartrazine positive endometrial 
granulocytes can be identified, which do not appear to be positive 
immunocytochemically. Objective magnification x25, eye-piece xlO
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methods were working, although it is acknowledged that the distribution of 
PFA/AB staining in the pig ovary was not as expected. Unlike Dallenbach- 
Hellweg and co-workers in - their series of papers, the staining reactions do 
not in this chapter, support the evidence for the synthesis of relaxin in 
endometrial granulocytes in man.
Characterisation of the endometrial granulocyte
The remaining aims of this section of the chapter, were devoted to 
establishing, confirming or excluding existing notions with regard to the 
role of the endometrial granulocyte and other cells intimately associated 
with it. The granulocyte granules do not synthesise and secrete any of the 
commonly found neutral or acidic mucins for instance (PAS, PAS diastase, 
alcian blue, azure A). Neither does the cell appear to be connected with a 
group of cells of neuroendocrine origin, namely the APUD cells (Grimelius). 
Several miscellaneous characteristics have also been discounted. The cells 
do not contain ferric iron (Peris'), and unlike the cells from which it was 
thought they were derived, endometrial granulocytes do not express 
receptors for prolactin. They do not stain metachromatically with stains 
like toluidine blue and do not therefore share the heparin and histamine 
content associated with the mast cell. Endometrial granulocytes are not of 
epithelial origin as indicated by their negative staining for the epithelial 
cell markers CAM 5.2 and EMA.
The a-fetoprotein (AFP) marker was included because of its ability to 
recognise fetal glycoprotein. Evidence of expression of this antigen at the 
fetal/maternal junction could for example,-be interpreted as making an 
environment more receptive to an allograft fetus. This predisposes that
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AFP represents a primitive protein that is re-expressed during pregnancy.
However, the reaction was negative!
»
The remaining staining methods were chosen to exclude any connection 
between endometrial granulocytes and cells of the myeloid cell series. 
Several cells in this series are granulated and being of leucocyte origin 
react with leucocyte common antigen (LCA), a feature also attributed to the 
endometrial granulocyte (Bulmer et al 1987).
The endometrial granulocyte - a lymphocyte?
Hone of the results so far detract from the possibility that the 
endometrial granulocyte could be a granulated lymphocyte, as recently 
suggested by Bulmer et al (1987). The second section of this chapter uses 
imprints prepared from fresh, bisected uteri. It was felt that fresh, late 
secretory phase endometrium (curettage) or preferably first trimester 
suction termination tissue would have been a more appropriate source of 
endometrial granulocytes, and it was unfortunate that this material was not 
available at the time. However, it was considered worthwhile to prepare 
and stain the imprints with the limited panel of monoclonal antisera 
acauired. As alluded to previously, imprints were used as a substitute for 
cryostat (frozen) sections, and cryostat sections were avoided because they 
disrupt endometrial cell granules, making certain identification impossible. 
Surprisingly, the intrinsic lack of architecture associated with imprints 
does not hinder microscopical examination.
Generally, it seems probable that imprints have only served to introduce 
different problems. Whilst accepting that the number of endometrial 
granulocytes in the imprints would be low, it was anticipated that there 
would be some phloxine-tartrazine staining cells. Indeed there was (Figure 
50), but the inconsistent appearance and disappearance of these cells from
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imprint to imprint made any evaluation very difficult. The smears prepared 
from decidual cell suspensions as entertained by Bulmer et al (1987), would 
appear to be a more fruitful option.
The HLA-DR staining looked impressive and may indeed have been genuine. 
There was however an unacceptable degree of background staining in most of 
the imprints examined, and this precluded any definitive opinion. Of the 
other markers, leucocyte common antigen staining was consistently heavy and 
peroxidase staining invariably stained the entire cell, as seen in Figure 
51. Pan B and T lymphocyte markers although more interesting, were again 
inconclusive in that peroxidase staining and phloxine-tartrazine staining 
was evident in cells of the same imprint but not in the same cell. In some 
imprints it was thought likely that the phloxine staining was due to under 
differentiation, as some phloxine staining of cell cytoplasm was evident in 
cells that were quite obviously not endometrial granulocytes. The remaining 
immunostained imprints were negative and could not therefore be evaluated. 
Double labelling - conclusive evidence?
The final section considers the prospects of double labelling. It is 
apparent by now that the endometrial granulocyte can be unequivocably 
recognised in a phloxine-tartrazine stained section. The nucleus stains 
densely, is oval and often slightly indented. The cytoplasm encompasses a 
varying number of phloxinophilic granules and the cell stands out well 
against a yellow background. An intact cell varies little from this 
description, but never the less is much more difficult to identify if there 
is no granule staining. It is precisely this problem that has prevented 
the certain identification and subsequent characterisation of this cell.
The comprehensive studies by Clark and co-workers on mice (Slapsys and 
Clark 1982, Clark et al 1983, Clark et al 1985, Krcek and Clark 1985) and
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of Bulmer and co-workers on human tissues (Bulmer and Sunderland 1984, 
Bulmer and Johnson 1985 and Bulmer et al 1987) have probably contributed 
the bulk of what is currently realised about the function of the endometrial 
granulocyte. In fact the most recent paper by Bulmer and cited here 
(Bulmer et al 1987), uses in principle the same approach that this section 
of the chapter advocates.
Figures 52 (a) and 52 (b) illustrate clearly cells that morphologically 
fulfill the criteria of endometrial granulocytes. In addition they contain 
phloxinophilic granules, and in addition to that, the cells have reacted 
with LCA (leucocyte common antigen). Bulmer made a similar observation 
using eosin rather than phloxine (Bulmer et al 1987). There are numerous 
examples of these cells'of which Figure 52 is representative. The problem 
arises in that there are quite clear examples too of endometrial 
granulocytes that are negative for LCA. Figure 53 is a good example of 
this since LCA positive cells can be seen in the same field as endometrial 
granulocytes, which would imply that the methodology is sound. Vhy aren't 
all granulated endometrial granulocytes positive for LCA then? It is easier 
to explain the reverse because this can be attributed to poor staining.
Over differentiation of phloxine would weaken phloxine staining and may 
even not stain in some areas of the section. Alternatively, we don't know 
whether the cell degranulates, perhaps it does. For a converse explanation 
we can almost certainly disregard patchy staining, since the observation is 
reproducible. Instead, on the assumption that granulocytes are derived from 
bone marrow precursor cells, and a population of these cells suggest that 
is the case, one has to look at the availability of appropriate receptors on 
the cell surface and/or a period of governed maturation in situ.
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In view of their* appearance during the menstrual cycle, and their 
distribution and appearance in pregnancy, particularly during the 
implantation stage and ensuing trimester in human pregnancy (see Pijnenborg 
et al 1980, Dallenbach-Hellweg 1981, Robertson [personal communication]), a 
'governed maturation' could realistically be attributed to progesterone. A 
separate issue perhaps, but progesterone insufficiency in early pregnancy 
such as that described in Chapter 1, could contribute to any impairment of 
this maturation process. Bulmer and Sunderland (1984) suggest that 
endometrial granulocytes arise from bone marrow, but unlike other T cells, 
are not processed through the thymus. Instead they 'mature' and 
differentiate in the decidua in response to fetal thymic hormones. If this 
is true, then secretory endometrium is a poor source of endometrial 
granulocytes for immunological characterisation. This could conceivably 
explain the poor results obtained with immunomarkers on imprints, although 
in reality the problems can equally be attributed to the preparation and 
choice of material.
UCHL-1/P-T produced a trend of staining similar to that of LCA/P-T, 
although less convincing (Figures 54, 55 and 56). • This is perhaps 
reasonable as it is cell membrane staining that is pertinent rather than 
the cytoplasmic staining frequently apparent with LCA. In this respect, 
Figure 52 is unrepresentative of LCA/P-T staining. As explained previously, 
UCHL-1 whilst staining cell membranes of T cells, also stains the cytoplasm 
of many other cell types.
KT-1 is the only other marker worthy of comment. As Figure 58 
illustrates, there is extensive cross-reactivity with involuting decidual 
cells. However, endometrial granulocyte staining appears to be negative.
The extent of cross-reactivity suggests perhaps a technical fault in the
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dilution of antisera, or possibly the age-of the antiserum. The MT and MB 
antibodies are not the most reliable of lymphocyte markers either. It is 
possible that there are positively stained cells, but these are not obvious.
An IgG marker was included because Bulmer and Peel in 1977 identified a 
population of granulated metrial gland cells in pregnant rat uterus, that 
exhibited IgG fluorescence. Later in 1984, Bulmer and Sunderland identified 
a population of cells, probably endometrial granulocytes, that stained 
positively for E-rosette receptors - a feature of T cells, some of which 
have receptors for the Fc portion of IgG. Clark (1985) also described in 
mice, small lymphocytes that lack T cell markers but possess Fc receptors 
for IgG. It is disappointing then, to find no evidence of IgG staining of 
endometrial granulocytes in the sections stained in this chapter.
The characterisation of the endometrial granulocyte is now largely 
complete. With a good source of material, technical expertise in 
immunocytochemistry and appropriate, controlled antibody markers, the cell 
can now be fully evaluated. The phloxine-tartrazine 'counterstain' is, in 
the right hands, a practical means of double-labelling immuno-reacted 
sections. It is superior to eosin because it is far more selective in its 
staining, and the staining is also much stronger. These features together 
provide the balance needed to complement peroxidase staining. The role of 
the endometrial granulocyte in the immunology of pregnancy is considered in 
context in the concluding chapter, which follows.
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GHAPJER-.5.
AEP^TOIX
The staining techniques used in this chapter are referenced to 
standard texts. The following methods are modifications of these 
techniques, as it is normal laboratory practise to make adjustments to 
staining times and reagent concentrations to best suit individual 
laboratories . The sources of reagents and stains used, is given at the 
end of this section.
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CHLQRQACETATE ESTERASE
ZEIHDH
1 Add 10 drops of pararosanilin hydrochloride (solution A) to 10 
drops of 4% sodium nitrite (solution B) in a 100ml beaker. Leave 
for at least 2 mins at 4°C.
2 Using a small acetone resistant test-tube, add a 'knife-point1 
(lOmg) of naphthol ASD-chloroacetate to approximately 0.5ml of 
acetone.
3 Add 50ml of 1% aqueous TRIS to the beaker used in step 1, and pH to
6.3 using molar HC1.
4 Bring paraffin sections to distilled water.
5 Add the napthol ASD-chloroacetate/acetone mixture to the beaker,
mix and filter the pink, floculent solution directly onto the
sections. Leave for 20-30 mins.
6 Rinse sections in tap water and counterstain lightly with Mayer's
haematoxylin.
7 Wash ('blue') in running tap water, dehydrate, clear and mount.
RESULTS,
Cells of the myeloid cell series: bright red cytoplasm
Nuclei: blue
Red blood cells: pale pink
Background: clear
SOLUTIONS
Solution A: pararosanilin hydrochloride
basic fuchsin 0,5g 
distilled water 10ml 
concentrated HC1 2.5ml
Solution B: 4% sodium nitrite
NOTES
Naphthol ASD-chloroacetate powder must be kept at -20°C.
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g-NAPHTHYL ACETATE ESTERASE
E s m m .
1. Paraffin sections are brought to water.
2. Prepare g-naphthyl acetate esterase solution:
Solution 1
buffer solution A 7.7ml 
buffer solution B 2.3ml
hexazotised pararosanilin solution 0.05ml 
Adjust pH to 6.3
Solution 2
methoxyethanol 0.5ml 
g-Haphthyl acetate 10mg 
Hix together and then add to solution 1, above.
The resultant pink, turbid staining solution is filtered directly onto 
the sections. Sections are incubated for approximately 45 mins.
3. Wash sections well in water.
4. Counterstain with haematoxylin.
5. Wash in water, dehydrate, clear and mount.
RESULTS
All nuclei, blue
Honocytoid cells: brown/red deposit in cytoplasm
Lymphoid cells: some lymphocytes will have a single red spot in the 
cytoplasm. These are T-helper lymphocytes. The remaining lymphocytes 
are unreactive.
SOLUTION
Buffer A: 0.91g sodium dihydrogen phosphate to 100ml distilled water.
Buffer B: 0.95g disodium hydrogen phosphate to 100ml distilled water.
Pararosanilin base: 0.5g pararosanilin
10.0ml distilled water 
2.5ml concentrated HC1 
Warm gently to dissolve. Filter.
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FAST BLUE/ESTERASE
1. Bring paraffin sections to water.
2. Prepare:
Solution 1
buffer solution A 7.7ml 
buffer solution B 2.3ml 
hexazotised pararosanilin solution 0.05ml 
Adjust to pH 6.3
Solution 2
methoxyethanol 0.5ml 
naphthol butyrate 0. 01ml
Mix together and then add to solution 1, above.
The resultant pink, turbid staining solution is filtered directly onto 
the sections. Sections are incubated at room temperature for 45 mins.
3. Prepare the following solution during the last 10 mins of the above 
incubation:
buffer solution A 1.9ml
buffer solution B 8.1ml
Fast blue BB 5mg ('knife-point')
naphthol AS-D chloroacetate solution 0.5ml
The resultant solution will appear blue and granular. At the end of the 
above incubation (step 2), rinse sections well in distilled water, and 
then filter the solution just prepared, onto the sections. Leave for 15 
mins.
4. Counterstain sections in haematoxylin
5. Wash ('blue') sections in water, differentiating haematoxylin if 
required. Dehydrate in alcohol, clear in xylene and mount.
•RESULTS
All nuclei: blue
Myeloid cells: blue, granular deposit in cytoplasm 
Lymphoid cells: no reaction
Monocytoid cells: brown/red deposit in cytoplasm 
SOLUTIONS
Buffer A: 0.91g sodium dihydrogen phosphate in 100ml distilled water
Buffer B: 0.95g disodium hydrogen phosphate in 100ml distilled water
Naphthol AS-D chloroacetate solution: see Chloroacetate esterase method
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PEF.FQRKIC-.ACID/ALCIAH’ BLUE (PFA/AB)
KEIHQH
1. Cut paraffin sections and mount onto poly-l-lysine coated microscope 
slides. When dried, take sections through xylene and alcohol to 
water.
2. Stand sections in a coplin jar of prepared performic acid solution,
5 mins (see 'Solutions' below).
3. Wash thoroughly but carefully in tap water, 10 mins.
4. Dry section in a 60 °C oven.
5. Rinse section in water, and stain in prepared alcian blue solution
(see'Solutions' below) for 1 hour at room temperature.
6. Wash in running tap water
7. Counterstain nuclei in 1% neutral red
8. Wash sections in tap water, differentiate neutral red staining and 
dehydrate in alcohol, clear in xylene and mount.
RESULTS
Disulphide groups: blue 
Nuclei: red
The intensity of blue staining is dependent upon the amount of 
disulphide groups present.
SOLUTIONS
1. Performic acid solution: 98% formic acid 40ml
100 vol hydrogen peroxide 4ml 
concentrated sulphuric acid 0.5ml
This solution should be freshly prepared, and then left to stand for 1 
hour before use.
2. Alcian blue solution: Alcian blue lg
98% sulphuric acid 2.7ml 
distilled water 47.2ml
NOTES.
Keratin contains abundant disulphide-containing amino acids, therefore 
hair-bearing skin is a suitable control. Pituitary is also suitable.
Because of the nature of the reagents, there is a tendency to lose 
sections. It is advisable to take several sections through the method.
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DKAB-NITRITE METHOD FOR TRYPTOPHAN 
HBIHQD
1. Take sections that have been mounted an poly-l-lysine coated slides 
and well dried, to alcohol.
2. Place in prepared DMAB solution for 1 hour (see 'solutions' below).
3. Transfer sections to nitrite solution (see 'solutions' below).
4. Wash sections gently in tap water for 30 secs.
5. Rinse sections in 1% acid alcohol, 15 seconds.
6. Dehydrate through alcohol, clear in xylene and mount sections. 
RESULTS
Sites of tryptophan containing amino acids.* dark blue 
SOLUTIONS
1. DKAB solution: 5g p-dimethylaminobenzaldehyde.
Dissolve in 100ml of concentrated hydrochloric acid
2. Nitrite solution: lg sodium nitrite dissolved in 100ml of
concentrated hydrochloric acid
NOTES
Pancreas is a suitable control tissue
As with the PFA/AB method, the strong acids used in the method tend to 
lift sections from the slides, and it is recommended to put more than 
one section through the method.
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CHPQMQTRQPE 2P FOP EOSINOPHILS
METHOD
1. Sections are taken to water.
2. Nuclei are stained lightly with alum haematoxylin, washed in running 
tap water.
3. Stain with carbol chromotrope for 30 mins.
RESULTS
Nuclei: blue
Eosinophil granules: red 
Paneth cell granules: rust-red
SOLUTIONS:
Place Igram of phenol in a conical flask and melt by running hot water 
over the outside of the flask. Add 0.5g of chromotrope 2R, and mix with 
the phenol. Dissolve the resultant sludge in 100ml distilled water.
This solution should keep well
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AZURE A METACHROMATIC TECHNIQUE FOR ACID MUCINS.
METHOD
1. Sections are taken to distilled water.
2. Treat sections with 1% aqueous potassium permanganate for 5 mins.
3.. Rinse briefly in water.
4. Bleach permanganate staining with 1% oxalic acid, approx. 1 min.
5. Wash well in running tap water.
6. Stain in 0.2% aqueous Azure A, 5 mins.
7. Wash sections in distilled water and then differentiate with 0.2% 
aqueous uranyl nitrate (10-30 secs)
8. Wash section in water and blot dry.
9. Rinse in alcohol, clear in xylene and mount.
RESULTS
Acid mucins: purple/red metachromasia 
Background: blue
TOTES
Metachromasia is enhanced if the sections are blotted before dehydration 
in alcohol (step 8).
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GIEMSA
1 I M
1. Bring tissue sections to distilled water.
2. Stain in a coplin jar of diluted Giemsa stain, overnight at room
temperature:
standard (proprietary) Giemsa stain 2ml 
buffered distilled water (pH 6.8) 48ml
3. Rinse section in distilled water.
4. Wash in 0.5% acetic acid until the section looks pink
macroscopically, approx 2 mins.
5. Vash off in tap water.
6. Blot section, dehydrate rapidly in alcohol, clear in xylene and
mount.
Differential staining of myeloid cells
eosinophil granules: red 
basophil granules: dark blue 
neutrophil granules: purple 
red blood cells: yellow/pink 
background: pale blue 
nuclei: dark blue to violet
IQJES-
The method is a modification of that used for the differential staining
of myeloid cells in blood films.
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•HAEMATOXYLIIf AND VAff GIESON
METHOD
1 Bring sections to water
2 Filter celestin blue solution onto section, 5 mins.
3 Rinse sections in water, and stain nuclei with Mayer's haematoxylin,
5 mi ns.
4 Wash in running tap water for 5 mins.
5 Blot sections lightly and counterstain with Van Gieson, 3 mins.
6 Blot off stain, rinse sections in alcohol, clear in xylene and mount. 
RESULTS.
Huclei: blue/black
Collagen (and collagen inclusions): red 
Muscle: Yellow
NOTES
A The use of haematoxylin alone is inadequate. The subsequent use of 
Van Gieson, an acid dye, tends to decolourise the nuclei.
B Van Gieson is removed from the section by prolonged washing in water, 
and also in alcohol.
C The age of collagen deposition may affect staining.
SOLUTIONS
Celestin blue.
Celestin blue B 2.5 g
Ferric ammonium sulphate 25 g
Glycerin 70 ml
Distilled water 500 ml
The ferric ammonium sulphate is dissolved in the water. Celestin blue
is added to this, and the mixture boiled for 5 minutes. After cooling,
the stain is filtered and the glycerin added.
Van Gieson
Saturated aqueous picric acid 50 ml 
1% aqueous acid fuchsin • 9 ml
Distilled water 50 ml
ORIMBLIVS
1 Prepare the following silver bath:
acetate buffer (pH 5,6) 10ml 
distilled water 87ml
YU silver nitrate (fresh) 3ml
2 Place 50ml of the above, prepared solution into a coplin jar and
warm to 60 °C in a water bath.
3 Bring sections to distilled water and transfer to the above warmed
silver solution for 3 hours at 60’C.
4 During this incubation, prepare the fallowing reducer:
hydroquinone Ig
sodium sulphite (crystals) 5g 
distilled water 100ml
5 Place 50ml of the reducer into a coplin jar and warm to 45°C in a
water bath.
6 Drain silver solution from sections and place in fresh reducer at
45*C for 1 min.
7 Rinse sections in distilled water, dehydrate, clear and mount.
8 To intensify the impregnation, after rinsing the slides in
distilled water at step 7, return slides to fresh silver solution 
(ie the remaining 50ml) at room temperature for a further 10 mins, 
and repeat the reduction using the remaining reducer.
RESULTS
Carcinoid tumours, argyrophil cells, a cells of the pancreatic islets:
brown/black granules
background:light brown
IQTES
Both silver solution and reducer should be freshly prepared.
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PAS/DIASTASE PAS
1 Take 2 test and 2 control sections to distilled water.
2 Treat one test and one control section with a freshly prepared 
solution of commercial diastase for 30 mins at room temperature. 
This involves shaking a little of the diastase powder into a small 
tube and adding 10ml distilled water. Shake well to dissolve.
3 Wash off the diastase with distilled water.
4 Treat all 4 sections with 1% periodic acid for 5 mins.
5 Wash off in tap water and then rinse sections well in distilled
water.
6 Treat sections with Schiff's reagent, 10 mins,
7 Wash sections well in distilled water, and then in running tap 
water for 10 mins (prolonged washing brings up background 
staining).
8 Stain nuclei lightly with Mayer's haematoxylin.
9 Wash ('blue') sections in running tap water.
10 Dehydrate, clear and mount.
RESffLTS
Glycogen: magenta staining in undigested sections that is absent in 
diastase digested sections
luclei: blue
MOTES
Commercial diastase is kept as a dry powder and freshly prepared before
use.
Schiff's reagent is kept at room temperature and discarded after a
maximum of 2 weeks.
1% periodic acid is freshly prepared each week.
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EERLS.1
KEIHQH
1 Using a small measuring cylinder, mix together equal parts of:
2% potassium ferrocyanide 
2% hydrochloric acid
2 Bring paraffin sections to distilled water
3 Blot sections lightly to remove excess distilled water, place on a
staining rack, and flood with the above freshly prepared solution. 
Leave for 10-30 mins.
4 Vash in tap water
5 Counterstain lightly with neutral red
6 Vash sections in water, dehydrate and control nuclear staining in
alcohol, clear in xylene, and mount.
RESULTS.
Sites of ferric iron deposition :blue 
luclei: red
SPIES
The length of time required in the solution prepared in step 1, will 
vary according to the amount of iron present, and the strength of its 
bond with protein.
The method must be controlled with a section known to contain ferric 
iron.
Use reagents of pure grade (Analar).
Rationale: hydrochloric acid reacts with ferric iron that is bound to 
protein in tissue. The released ferric iron reacts with potassium 
ferrocyanide to form ferric ferrocyanide, and insoluble blue compound 
not removed by washing (so-called Prussian blue).
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INDIRECT IMMUNQPERQXIDA5E TECHNIQUE FOR IMPRINTS
METHOD.
1 Acetone fixed, air dried imprint smears were treated as folllows:
2 Each smear and appropriate control, is placed in a moisture 
chamber. The appropriate antiserum, at the appropriate dilution in 
10% bovine serum albumen in TRIS is pipetted onto the slide, and 
incubated at room temperature for 30 mins.
3 Rinse each slide"'in TRIS buffer (0,2M, pH7.6) and then together in 
fresh, stirred buffer, for 2x2 mins.
4 Apply the second layer antibody, peroxidase conjugated, rabbit 
anti-mouse diluted 1 in 50 in 10% bovine serum albumen in TRIS 
buffer, 30 mins.
5 Vash in stirred buffer, 2x10 mins
6 Visualise using DAB <240mg sodium azide/400ml TRIS added to block 
endogenous peroxidase)
7 Vash in running tap water
8 Stain nuclei lightly in Mayer's haematoxylin
9 ’Blue' in running tap water, dehydrate, clear and mount (or 
counterstain in phloxine-tartrazine).
BBSfflJS.
sites of immunoreactivity: brown
nuclei: blue
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INDIRECT IMUNQPERQXIDASE TECHNIQUE FOR PARAFFIN SECTIONS
KETHQD
1 Tissue sections are cut at 5pm and mounted onto poly-l-lysine 
coated
slides and dried overnight at 37°C
2 Sections are brought to alcohol.
3 Block endogenous peroxidase with 1% hydrogen peroxide in methanol
30 mins.
4 Rinse sections in tap water. If trypsinisation is required then 
preheat sections in warm distilled water.
5 Trypsinisation: Place 0.2g trypsin and 0.2g calcium chloride in
400ml of distilled water, pH to 7.8 with sodium hydroxide. It is 
important that the trypsin is stirred for exactly 10 mins. Place 
rack of sections into trypsin and incubate for 12 mins.
Place rack into running cold water to stop reaction.
6 Place sections into TRIS buffer, 2-5 mins.
7 Incubate sections in 3% bovine serum albumen in TRIS buffer, 20
mins
8 Incubate in primary antiserum, appropriately diluted in 1% bovine 
serum albumen in TRIS buffer, 1 hour.
9 Vash sections in TRIS buffer, 2x2 mins.
10 Incubate sections in peroxidase labelled rabbit anti-mouse diluted 
1:50 in TRIS, 30 mins.
11 Vash sections in TRIS buffer, 2x2 mins
12 Incubate sections in diaminobenzidine <DAB) solution (0.2g DAB in 
400 ml TRIS with 400/jlI of hydrogen peroxide added), for 10-15 mins.
13 Vash in tap water, counterstain lightly in haematoxylin, 'blue*
section in running water, dehydrate in alcohol, clear in xylene,
and mount.
RE-SILLI S.
Sites of immunoperoxidase reactivity: dark brown 
Nuclei: blue
SOLUTIONS
See following, ‘GENERAL NOTES'
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PEROXIDASE AFTI-PEROXIDASE (PAP) TECHNIQUE FOR PARAFFIR SECTIONS 
KETHQD.
1. Cut sections at 5pm and mount onto poly-l-lysine treated slides.
2. Dewax test and control slides and take to alcohol.
3. Block endogenous peroxidase with 1% hydrogen peroxide in methanol 
30 mins.
4. Stop' the reaction by plunging in cold water.
5. Hold slides in warm (37°C) distilled water until trypsin is 
prepared
6 . Treat sections with 0.05% trypsin in 0.05% calcium chloride,
pH 7.8 for 12 mins at 37'C if trypsinisation is required. Plunge 
* sections into cold water to stop reaction.
7. Wash sections in 0.05M TRIS buffer, pH 7.6, 5 mins.
8. Drain sections well (but do not allow them to dry), and treat with
swine serum diluted 1/10 for 20 mins.
9. Tip off excess serum, apply primary antiserum appropriately 
diluted in 1% bovine serum albumen in TRIS buffer, 1 hour.
10. Rinse sections individually and then wash for 2x15 mins in stirred 
TRIS buffer.
11. Apply second layer antibody (swine anti-rabbit, 1 in 100 in TRIS), 
30 mins.
12. Vash in TRIS buffer, 2x15 mins.
13. Apply rabbit-PAP, diluted 1 in 200 in TRIS, 30 mins.
14. Vash in TRIS buffer, 2x15 mins.
15.. Visualise in DAB substrate for approximately 10 mins.
16. Vash sections in water.
17. Stain nuclei in haematoxylin, 'blue*, dehydrate, clear and mount. 
(Rote: steps 8 to 13 are carrried out in a moisture chamber)
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GENERAL NQTES FOR USE IN IMMUNQCYTQCHEMISTRY
1 Paraffin sections are cut routinely at 5 pm and mounted on poly-1- 
lysine coated microscope slides (PLL; Sigma p-1399). The sections are 
dried overnight at 37°C. with control sections, also cut.
2 Microscope slides are treated with poly-l-lysine as this is a very 
good adhesive. The details are as follows:
PLL is prepared as a 1 mg/ml solution. It is dispensed into small 
volumes (plastic tubes) and frozen and stored at -20*C. For use, an 
aliquot is thawed and with the use of a cotton bud or wooden applicator, 
a thin layer is applied to the surface of a microscope slide. This is 
allowed to dry. The slides are then ready for use.
3. Endogenous tissue peroxidase is blocked using 1% hydrogen peroxide 
(stock 100 vol) in absolute methanol, for 30 mins at room temperature. 
This solution is stable for 3-4 hours.
4. Trypsinisation. The working solution is prepared by dissolving 
trypsin (Sigma chemicals, number t-8128) at a concentration of 0.05% in
0.05% calcium chloride. This is adjusted to ph 7.8 with dilute sodium 
hydroxide. All glassware, distilled water, tissue sections etc., must 
be equilibrated to 37°C before commencing digestion (a 'hot room' is 
ideal). Standardisation is important as trypsin has a short activity 
period. Therefore, the solution is prepared on a stirrer exactly 10 
mins before it is needed, and the sections are incubated for exactly 12 
mins. The sections are plunged into running tap water to stop the 
reaction, and then transferred to TRIS buffer.
5. TRIS buffer. The standard buffer is 0.05% TRIS/HC1, prepared by 
dissolving 18.3g TRIS (B.D.H. product no 27119) to 2400 ml distilled 
water. The pH is adjusted to pH 7.6 with molar HC1 (86 ml concentrated 
HCL/litre) and the volume made up to 3 litre. Buffer is used to wash 
sections and dilute antisera. Vhen used for diluting antisera, it is 
usual to add up to 3% bovine serum albumen. This buffer is also used to 
prepare the DAB solution.
6 . Blocking of non-specific binding sites. Non-specific binding sites 
(eg Fc receptors on collagen), may be blocked by applying serum or serum 
based products. Polyclonal antisera are usually pre-treated by applying 
a 1 in 10 dilution of serum from the host species of the second layer 
(usually 1/10 normal swine serum). Monoclonal antisera are usually 
successfully pre-treated with 3% bovine serum albumen in TRIS buffer.
7. Visualising with peroxidase. Stock 200mg aliquots of 3,3'-diamino- 
benzidine tetrahydrochloride (DAB; Sigma chemicals, number D-5637) are 
prepared in 4 ml volumes of TRIS buffer. For use, an aliquot is thawed 
and the contents made up to 400ml with TRIS buffer, providing a 0.05% 
solution of DAB in buffer. 400pl of 100 vol hydrogen peroxide is added 
immediately before use.
8 . Decontamination of DAB contaminated equipment. DAB is readily 
degraded by dilute solutions of hypochlorite. All equipment exposed to 
DAB is placed in the incubating chamber used to visualise the reaction.
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The whole is submerged in dilute (5-10%) sodium hypochlorite and left 
overnight in a fume cupboard. It is then thoroughly washed in running 
tap water. Sodium hypochlorite is corrosive and should therefore be 
handled with care. Gloves should also be worn.
9. Controls. Both positive and negative controls must be used. The 
positve control must be of a tissue acknowledged to be positve in 
respect of the antigen under investigation, and sections cut and treated 
in the same manner as the test sections (processing (if any), thickness 
of sections, drying temperatures etc). The negative control sections 
should also fulfill the above criteria. It is negative by virtue of the 
first layer antibody, which is substituted with normal diluted serum as 
used to block non-specific binding. The sections are treated in an 
identical fashion in all subsequent steps.
All the dyes and prepared stains used in the methods described above, 
were obtained from the following manufacturers:
Warwickshire
The antisera used in the immunocytochemical techniques were all obtained 
from Dakopatts Limited unless otherwise specified.
Dakopatts Limited 
22 The Arcade 
The Octagon 
High Wycombe 
Buckinghamshire
MB-1, MT-1: Cytokeratin (CAM 5.2):
Bio-nuclear Services Limited Becton Dickinson UK Limited
24 Westleigh Drive Between Towns Road
Sonning Common Cowley
Beading Oxford
Reagents other than antisera used in the immunocytochemical techniques 
were obtained from either British Drug Houses Limited, or Sigma Chemical 
Company Limited.
SOURCES ■OF REAGENTS
British Drug Houses Limited 
Fourways
Carlyon Industrial Estate 
Atherstone
Sigma Chemical Company Limited
Fancy Road 
Poole 
Dorset
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CHAPTER -0.
THE ABTIOPATHQGBNBSIS OF RECURRENT ABORTION - A DISCUSSION
The Problem
Spontaneous abortion is the commonest complication of pregnancy. Whilst 
recurrent spontaneous abortions represent only a small proportion of these 
losses, they are too often investigated as if they represented a single 
loss. The converse is also true however, and in some instances 
investigations are initiated under inappropriate guises. The first problem 
is then, one of defining recurrent abortion. The second is to acknowledge 
that some investigators potentially complicate the issue by including 
patients that do not fulfill the criteria intended by the definition. There 
is, reasonably, nothing wrong in counselling and examining patients who 
have had less than three consecutive abortions, and indeed some ‘recurrent 
aborters' have gained from such early intervention. However, the term 
'recurrent abortion' need not consider any circumstances beyond those 
envisaged and defined, to exist as a group in its own right.
The causal factors encountered in the course of investigating recurrent 
aborters raises the question of determining whether this type of abortion 
is in fact a genuine phenomenon. They are linked as a group only by their 
pregnancy history. The development in recent years of clearly defined 
causes of abortion (see Table 1(b)), largely as a consequence of more 
intense investigative procedures, has resulted in an erosion of ‘recurrent 
aborters' as a group where the aetiology of the abortion is unexplained. 
Whilst the problem of recurrent abortion is perhaps diminishing in 
numerical terms, it is increasing in propensity in that the cause is
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becoming progressively elusive. This is complicated further'by anomalies. 
For instance, whilst cervical incompetence is an acknowledged cause of 
spontaneous abortion (and recurrent abortion, if left untreated), first 
trimester losses in some of these patients remains unexplained.
Determining the aetiology of recurrent abortion is restricted to a 
certain extent by emotive issues invariably associated with pregnancy and 
the post partum period. For example, the administration of drugs during 
pregnancy is contra-indicated. However, steroids given pre-conceptionally 
and in very early pregnancy may it seems, restore the hormonal harmony 
that one sees in patients in normal pregnancy. Most studies which 
generated these observations were however largely uncontrolled and 
consequently the results lost credibility. Perhaps a situation worse than 
this can be invisaged in the current trend to immunise recurrent aborters 
with transfused leucocytes (Taylor and Faulk 1981, 1985). Although these 
patients are screened with the intention of determining the aetiology of 
their abortions, the reasoning and consequences of treating these patients 
have yet to be fully determined. Various blocking factors associated with 
the immunological mechanisms of pregnancy appear to be absent in the sera 
of recurrent aborters. If these factors are considered essential to normal 
pregnancy then a problem arises, as some have only been detected in the 
sera of normal multiparous patients.
There are then, a number of areas which need to be resolved and which 
may be necessary to our understanding of the consequences of treatment.
The role of placental bed giant cells, the true effects of smoking,, the 
relationship between steroids and polypeptide hormones like relaxin, 
represent other, diverse examples, the effects of which have yet to be 
evaluated in normal pregnancy, let alone abortion. It is evident that
several issues concerning recurrent abortion will probably remain 
contentious. Investigative procedures are expensive and time-consuming and 
currently performed in the knowledge of evidence, albeit subjective, which 
suggests that recurrent abortion may actually resolve itself if left 
untreated (Candiani and Fedele, 1987).
The Evidence
The morphological changes in recurrent abortion The value of examining 
tissue samples histologically from recurrent aborters is dependent upon 
several factors. The first and perhaps potentially the most important, is 
an accurate history of the patient. There is little point in evaluating 
histological changes, to find that there is some pre-existing pathology or 
physical anomaly - by themselves, good reasons that could account for 
maternal disability. The provision of a comprehensive patient history and 
the investigative procedures embarked on, is the responsibility of an 
enthusiastic clinician.
The second requirement relates to the quality of tissue samples sent for 
microscopical examination. Assuming that the requirements outlined for the 
first factor are fulfilled, the removal and processing of abortion tissues 
becomes an important issue, if only because one or more people have gone to 
great lengths to ensure ’quality of sample'! It is also important then, that 
collaboration in the laboratory is established prior to collection of 
samples and that pre-conceived ideas of the value of histological 
examination are ones of optimism.
Other problems still exist. Chapter 2 highlighted the need for suitable 
control tissue, as several features seen in this group, were thought not to 
reflect the processes associated with the intervention of a normal 
pregnancy. Ironically perhaps, one of the most influential factors relates
not to quality of investigation, but to' time (and. therefore money) versus 
results. It is perhaps inpractical to invest in these resources in a manner 
most likely to yield results: long-term studies with large patient inputs, 
and supported by comprehensive histological examination when previous 
morphological assessments appear to have yielded little of value.
The observations reported in Chapter 2 have been informative, but again
their value is in need of support. There is no point in acknowledging that
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some 40% of a group of recurrent aborters have blighted ova, without 
attempting to identify the cause as well as the effect.
The effects of smoking in pregnancy Xenobiotic metabolism (the 
metabolism of drugs) in the placenta, unlike the liver, is not readily 
induced. However, polycyclic aromatic hydrocarbons present in cigarette 
smoke are able to adversely affect placental steroid biosynthesis. 
Cholesterol side-chain cleavage and aromatisation are both known to be 
affected by an alteration in some way and probably by inhibition of the 
enzymes involved in steroid biosynthesis, which are themselves mediated by 
cytochrome P-450 and cytochrome P-448.
The number of alternative pathways available for the synthesis of • 
steroids is a reflection of the importance of the manufacture of steroids 
in the placental unit. Consequently, it is less likely that the induction of 
cytochromes by xenobiotics produces any profound effect upon the 
cytochrome-mediated enzymes and subsequent steroid biosynthesis. A 
prominent feature of smoking during pregnancy appears to be that the 
effects of smoking are dose related. This may explain some low birth 
weight babies associated with smoking.
Cigarette smoke contains a very high number of chemical compounds.
There is evidence that some of these compounds or their metabolites, bind
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covalently to placental D M. These adducts as they are known, are distinct 
from polycyclic aromatic hydrocarbons but share a similar correlation - 
that of smoking levels and birth weight. One adduct described by Everson 
et al 1988 appears to be especially associated with both smoking and 
caffeine consumption. Whilst the adduct is not present in non-smokers and 
is not induced by caffeine, caffeine levels in smokers does appear capable 
of adversely affecting D M  repair. Perhaps the more worrying aspect 
concerning the level of adduct, which is not evident in respect of 
polycyclic aromatic hydrocarbons, is that adduct concentrations appear to 
be unaffected by the practise of shallow inhaling or the use of low yield 
cigarettes. There is some concern also that the offspring of smoking 
mothers may be normal at birth, but more prone to cancer later in life.
An association between smoking and spontaneous abortion has not so far 
been established, and this lack of correlation extends to recurrent abortion 
also. This could be due, at least in part, to the number of variables that 
warrant consideration.
The importance of progesterone in pregnancy Progesterone is instrumental 
in establishing a secretory endometrium adequate to nourish the peri- 
implantation blastocyst. The period in which progesterone levels are 
critical is short in duration, generally days 18 to 21 of a 28 day 
menstrual cycle. There are several other well defined and established 
functions attributed to progesterone, usually in association with other 
steroid or polypeptide hormones. Progesterone contributes to breast 
development during pregnancy although it suppresses lactation by inhibiting 
the enzyme involved in lactose synthesis. Changes of a more subtle nature 
(eg. alterations in kidney water retention) illustrate the diversity of this 
hormone. Progesterone synthesis by the corpus luteum in early pregnancy is
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itself controlled by pregnancy-associated hormones. The life-span of the 
corpus luteum is extended by HCG elaborated by the implanted blastocyst. A 
little later in pregnancy, the production of oestrogens by the fetus 
inhibits HCG production, which in turn reduces the production of 
progesterone. By this time the placenta can assume the synthesis of 
physiologically huge quantities of steroids needed during pregnancy.
The pregnant mother should perhaps be consoled by the number of ways in 
which cholesterol can be generated for the biosynthesis of pregnancy 
steroids! However, under normal circumstances the predominant source of 
cholesterol is derived from low density lipoproteins, and the rate of 
progesterone synthesis is likely to be governed by the number of receptors 
for these on the trophoblast cell membrane. The diversity of resources in 
respect of progesterone synthesis may be evolutional and, may in part 
reflect the importance of sustaining levels of progesterone at critical 
times during early pregnancy. Less well documented functions of 
progesterone have been referred to in the preceding chapters. Zarrow 
(1961) for example, reported that levels of circulating relaxin were highest 
under physiological conditions regulated by progesterone. Progesterone has 
also been administered with some degree to success to a group of first 
trimester recurrent aborters. Of interest too, is the identification of a 
serum blocking factor absent in recurrent aborters prior to progesterone 
therapy, but detectable after progesterone therapy (Bousquet and Fizet 
1977). A relationship between steroids and the immunological roles 
identified in pregnancy is further endorsed following the discovery of 
steroid receptor sites on the surface of lymphocytes (see Bousquet and 
Fizet 1977). Smoking and other factors are of particular concern therfore,
■-'as they are able to alter the normal functional activities of steroids and 
their biosynthesis.
Relaxin biosynthesis There is currently a resurgence of interest in this 
pregnancy associated polypeptide hormone. It is conceivable that it has 
significant influence on the outcome of pregnancy but has not, in spite of 
this, received the wide attention given for example, to steroids or other 
peptide hormones which influence and work in concert with relaxin. There 
is some suggestion that a change in this delicate hormone balance might 
identify relaxin as having teratogenic properties. The inbalance would 
however, have to occur during organogenesis, and is most likely the 
consequence of therapeutic intervention of diabetes in pregnancy (Edwards 
and Uewell 1988).
The review of relaxin synthesis identifies the corpus luteum as the 
main, if not sole source of this hormone in man. The endometrial 
granulocyte was considered a strong contender for an additional ectopic 
source of relaxin, distinct from the ovary, but this possibility has 
essentially been reduced to one of convenience - It would be convenient if 
endometrial granulocytes manufactured relaxin because of their location at 
specific times in early pregnancy. 'On-site' relaxin production could 
conceivably account for re-modelling of connective tissue and other factors
aimed at accommodating a fetus during the first trimester. Vhat is _
difficult to explain however, is the diverse localisation of relaxin in 
animal species. The hamster synthesises relaxin in trophoblast and 
endometrial granulocytes in artery walls (Eldridge and Fields 1985, Renegar 
et al 1987). Endometrial glands secrete the hormone in guinea-pigs (Pardo 
et al 1980) and in the rat and mouse the source is luteal (Fields 1984). 
These results may be due partially to the heterologous structure associated
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with relaxins of different species and consequently in many studies perhaps 
the subsequent use of antisera raised against an inappropriate epitope of 
the hormone. The answers do not provide an entirely convincing argument 
and further work in this area would be justified. The diversity of roles 
entertained for relaxiif'are in conflict with most other hormones whose 
function can be extrapolated across species.
The endometrial granulocyte A large part of this thesis has' been devoted 
either directly or indirectly to clarifying particular features or 
characteristics associated with the endometrial granulocyte. At this 
juncture, observations were reported. Some of these were pursued further, 
either to resolve an issue of conflict or to contribute towards a 
hypothesis.
A primary aim was to establish the role of the endometrial granulocyte 
in the synthesis of relaxin. The evidence for this has lost credibility in 
two key areas. The first, denouncing decidua (and therefore endometrial 
granulocytes) as a source of relaxin synthesis in humans. The second, as a 
result of promising studies on the immunology of this cell. The proposal 
that the endometrial granulocyte is a contender for relaxin synthesis was 
not proven. However, extensive histochemical studies could not support this 
concept and subsequent studies placed this cell clearly amongst those 
having an immunological role. Having established an immunological bias, 
steps were taken to determine an appropriate avenue and apportion a role 
for the endometrial granulocyte in the light of existing knowledge of the 
immunological aspects of pregnancy.
The evidence favouring an immunological role for the endometrial 
granulocyte is now strong. This has been strengthened further by the 
simultaneous demonstration of leucocyte common antigen (a marker for all
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cells of' leucocytic origin) in cells containing phloxinophilic cytoplasmic 
granules. There is impetus to extend this observation, but at present, the 
technical expertise needs refining, as does the prohibitive cost of 
antisera. However this area of research is likely to yield definitive 
results in the near future.
Information on an analogous cell to the endometrial granulocyte, in mice, 
may provide insight into the role of the endometrial granulocyte in humans 
once the characteristics of this cell have been fully determined. Its 
importance in recurrent abortion can then be re-evaluated and the 
significance of their reduced numbers taken out of the realms of 
speculation.
Immunological mechanisms in pregnancy It is a well established fact that 
a fetus in normal pregnancy defies immunological rejection. Some recurrent 
abortions may be the result of a flaw in the mechanisms that maintain the 
integrity of the fetus, and consequently, in these patients abortion ensues.
It is probable that pregnancy is protected by a series of overlapping 
barriers designed to conceal immunological recognition and/or actively 
block an immunological response. Ironically, the success of the fetus is 
likely to be dependent on the maternal immune system recognising the fetus 
as foreign, and responding accordingly.
Initially, prior to implantation and trophoblast formation, protection is 
conferred by the zona pellucida. As fetal trophoblast does not express 
histocompatibility antigens (but see reference to TLX antigens), unlike the 
cells formed within the chorionic villi, post-implantation trophoblast 
development is initially protected from maternal recognition. This lack of 
identity is enhanced further by the formation of an amorphous fibrinoid 
material, representing an additional means of physically impeding antigen
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exchange. The mechanisms described, make provision for fetal integrity in 
early pregnancy. However, the recognition of HLA Class I antigens by 
maternal cytotoxic T lymphocytes is predictably, an unavoidable consequence 
of pregnancy, and there is ample evidence of maternal exposure to fetal 
'antigens’. Therefore, other barriers must come into play. The mother in 
pregnancy has to be able to avoid responding adversely to non-MHC antigens 
aswell as to paternal MHC antigens. To this end, several 'blocking 
antibodies' have been described and it is thought likely that these 
contribute significantly to successful pregnancy. Of the five blocking 
factors identified, two are reported to be largely absent in recurrent 
aborters. The first of these elicits a response directed against the 
paternal antigens specific to the partner. It cannot generally be detected 
until after several pregnancies, and even then appears to be dependent on 
HLA histo-incompatibility. The second antibody may also be HLA-linked. It 
is a non-cytotoxic antibody that in vitro, inhibits Fc-receptor binding.
This antibody can be detected in first trimester pregnancy, but tends not 
to be found in first trimester serum from aborters.
Whilst it has been shown that trophoblast cells do not express 
histocompatibility antigens, this does not totally preclude maternal 
immunological aggression towards fetally derived tissue. The 
trophoblast/lymphocyte cross-reactive antigen (TLX) common to both cell 
types, stimulates in the mother on exposure to fetal trophoblast, a blocking 
antibody that confers protection upon the trophoblast cell layer. In 
summary, there are a variety of antibodies generated by the mother in 
pregnancy, that supplement the physical barriers that collectively maintain 
the fetus even prior to implantation.
There has also been some discussion about the cells involved in the 
immunological mechanisms associated with pregnancy. Much of this work is 
now being evaluated in humans, in part, with the help of monoclonal 
antibodies. Prior research was performed largely on mice and several 
interesting features have emerged. It has been suggested that not all 
humoral antibodies (blocking antibodies) are essential to the acute survival 
of the fetus. The function of these antibodies that can only be detected 
late in pregnancy, or after several pregnancies, is not yet established. 
Pregnancy also induces suppressor T lymphocytes however, that are 
specifically directed towards MHC and non-MHC paternal antigens, and these 
too may not be essential to maintaining first trimester or indeed the first 
pregnancy. It is speculated that the same reasons as those suggested in 
respect of humoral antibody production, apply. If studies on mice can be 
extrapolated to humans, then one of the suppressor T lymphocyte cell 
populations can be assigned to the endometrial granulocyte. Small 
lymphocytes lacking T cell surface markers but possessing Fc receptors for 
IgG, block the growth of T cell growth promoter (interleukin-2), thus 
blocking the generation of anti-paternal cytotoxic lymphocytes in mice.
The human analogy too, identifies a population of granulated lymphocytes 
with T cell characteristics, but not markers. Some of these cells have 
receptors for the Fc portion of IgG, which may explain the positive IgG 
fluorescent staining of morphologically similar cells identified by Bulmer 
and Sunderland in 1977.
The Hypothesis
In Normal Pregnancy The following is a brief account of the general 
mechanisms involved in pregnancy. Much of this is predictably, well 
documented. However, there are other areas that remain open to
interpretation and others still, that are contentious. For obvious reasons 
this gives licence to hypothesise, not only in respect of recurrent abortion 
but to certain features associated with normal pregnancy too. Therefore, 
areas especially relevant to this thesis have been reviewed, where these 
may contribute to a clearer understanding of the changes evident in 
recurrent aborters.
A fertilised ovum is protected prior to implantation by the zona 
pellucida, which is impermeable to most proteins and all cells. At 
implantation the zona pellucida is superseded by trophoblast emanating from 
the periphery of the ovum. The menstrual cycle is interrupted at a point 
when the endometrium is secretory and physiologically receptive to 
implantation. These conditions are largely due to progesterone, which 
probably also controls the synthesis of relaxin, a polypeptide hormone that 
acts locally on collagen and connective tissue, at the site of implantation. 
Eelaxin reaches the endometrium via terminals of spiral arteries which 
themselves are traced back to the ovary via radial and arcuate arteries 
deep in the myometrium. It is likely that in human pregnancy at least, the 
corpus luteum of the ovary is the predominant if not sole source of 
relaxin.
Trophoblast development has long been considered a problem area 
immunologically, as it represents a defiant example of foreign tissue 
developing aggressively but harmoniously with host tissue. As reported, it 
has since been shown to be deficient in, or does not express Class I 
histocompatibility antigens (although fetal cells beneath the trophoblast 
cell layer do express such antigens). Other trophoblast antigens to which 
the maternal immune system is at liberty to respond, are protected by 
blocking antibodies such as those elaborated in response to TLX antigens
common to both trophoblast and maternal lymphocytes. Villous trophoblast 
is then allowed to grow unhindered immunologically into maternal decidua, 
However, whilst its growth is rapid it is controlled and physiologically 
impeded by areas of decidual necrosis. Only villous tips are able to 
extend deep into decidua- between these areas of necrosis. The bulk of 
trophoblast growth is restricted until inflammatory cells have alleviated 
the area of cellular debris. This is probably aided by relaxin, released 
intermittently to allow re-modelling of the connective tissue to 
accommodate the placenta.
In human pregnancy, decidual necrosis is localised, indirectly provoked 
in some way by the action of trophoblast invading the maternal blood 
supply. Cytotrophoblast, as distinct from villous trophoblast, 'colonizes' 
decidual spiral arteries. The spiral arteries are converted to large 
funnel-shaped vessels at their termini - the ends that serve intervillous 
spaces created between villous trophoblast columns. These vessel chabges 
it is thought could be mediated by steroid production by non-villous 
trophoblast that has reached myometrium (Brosens 1975). There are two 
waves of endovascular cytotrophoblast migration. The first occurs clearly 
in the first trimester and involves decidual segments of spiral arteries. 
The second waves occurs during the second trimester and affects segments 
of the same arteries deep into myometrium (Robertson et al 1984). The 
ensuing decidual necrosis is likely to be a consequence of endovascular 
cytotrophoblast 'plugging' segments of spiral arteries which in turn 
deprives areas of decidua local to this block, of a vascular supply. It is 
conceivable too, that this is enhanced by the progressive development of 
'converted' spiral arteries opening into intervillous spaces. Under these 
circumstances, decidua is likely to be served less effectively.
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Eventually there Is regression of glandular tissue and replacement by 
trophoblast invading the entire thickness of the decidua and abutting the 
myometrium, which boasts some scattered cytotrophoblast cells. It is 
probable that syncytiotrophoblast giant cells are formed at this site, by 
the coalescence of the above cytotrophoblast giant cells, as these cells 
would not easily penetrate the myometrium as 'giant' cells. The role of 
giant cells remains a mystery. They may represent a means of confusing 
the maternal immune system as each giant cell may present different 
epitopes to its cell surface as a result of random fusion of 
cytotrophoblast.
Cytotrophoblast, unlike the villous trophoblast, does itself express HLA 
Class I antigens. An explanation for maternal immunological tolerance must 
be sought from several quarters until a definitive explanation can be found. 
The first observation is that the physical location of endovascular 
cytotrophoblast does not offer the maternal immune system much of an 
opportunity to respond. Any cytotrophoblast cells that detach from the 
vessels will be carried back into the intervillous space which courses with 
maternal blood. These cells may be destroyed immunologically. Intact 
migrant cytotrophoblast may be involved in cell to cell contact with 
cytotoxic lymphocytes. The cytotrophoblast in crisis will either dissipate 
along the spiral arteries as cellular debris to be discharged into the 
intervillous space, or block the artery, introducing localised areas of 
necrosis because of poor vascular supply. The latter feature is not an 
unfamiliar finding. Alternatively, it may be the cytotrophoblast that 
induces an immune response in the mother which leads to the induction of 
blocking antibody. Endovascular cytotrophoblast will, under these 
circumstances encroach upon the vessels unchallenged, protected by blocking
antibody. Interstitial cytotrophoblast is-likely to generate blocking 
antibody either as a result of maternal recognition of TLX antigen or 
alternatively induce the non-cytotoxic, Fc receptor inhibitor antibody 
described by Power et al in 1983. Recent evidence suggests that whilst 
extravillous trophoblast is positive for MHC Class I antigens (which means 
that cytotoxic T lymphocytes will recognise these cells as foreign) they 
are, when characterised, unrelated to paternal HLA antigen. An alternative 
explanation identifies a population of MHC Class II positive-antigen 
presenting cells resident in the decidua (Sargent and Searle 1988). These 
cells which are macrophages, are in intimate contact with fetal trophoblast 
and are therefore in a prime location to act as antigen-presenting cells of 
alloantigens to unprimed T lymphocytes. The presence of antigen-presenting 
cells supports the existence of local suppressor cells creating a state of 
immune tolerance, rather than immune tolerance due to the absence of 
antigen-presenting cells. However, the role of such cells is still 
contentious. The presence of macrophages may serve to activate 
interleukin-2 in T lymphocytes, stimulating the development of a population 
of T cells from blast cells. If this is valid, then the endometrial 
granulocyte also present in decidua may be the cell responsible for 
controlling the extent of T cell transformation by blocking interleukin-2. 
This does of course in essence, make the endometrial granulocyte 'non-self', 
in that it is able to react with maternal cytotoxic lymphocytes, blocking 
or controlling their proliferation. It is believed that this may happen in 
mice. Similar cells - small lymphocytes that lack T cell markers but 
possess Fc receptors for IgG, block the generation of anti-paternal 
cytotoxic lymphocytes and therefore cytotoxic lymphocyte activity, by
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elaborating a factor that blocks interleukin-2. The suppressor lymphocytes 
do not appear to be specific for either MHC or non-MHC antigen.
Finally there exists an antibody that only becomes manifest after 
several pregnancies. This has been described by Pence et al 1975 as an IgG 
blocking antibody and is a product of sensitized lymphocytes. Its 
formation seems to be dependent upon antigenic disparity between partners, 
the antigen probably directed against HLA_DR.
In summary, the integrity of the fetus is protected by the following 
mechanisms:
1. Physical separation of the fetal and maternal vascular and lymphatic 
circulations by decidua and trophoblast.
2. MHC Class I antigens are not expressed on the trophoblast surface.
3. Suppressor lymphocyte activity (? endometrial granulocytes) in decidua 
controlling or preventing the proliferation of cytotoxic lymphocyte 
activity.
4. Blocking antibody (TLX) to prevent immunological damage to non-MHC 
trophoblast antigens.
5. IgG class of blocking antibody elaborated by sensitized lymphocytes in 
multiparous women.
In Recurrent Abortion There will always be speculation about the true 
level of clinically undetectable pregnancy loss. Very early losses are 
likely to be due to many factors including premature loss of the zona 
pellucida, inappropriately primed endometrium, chromosomally 'bad eggs', and 
others. It has been acknowledged that the cause(s) of recurrent abortion 
are diminishing (see Chapter 1) and the trend looks set to continue. This 
chapter identifies three probable causes of recurrent abortion, two of which
217
have been specifically identified"in the literature. The third has received 
less attention although its mode of action (immunological rejection) is well 
established!
In multiparous pregnancy, the successful counterpart to recurrent 
abortion, an IgG blocking antibody is elaborated by sensitised lymphocytes 
which prevents a cytotoxicity reaction between maternal sensitised 
lymphocytes and allogeneic lymphocytes. The absence of a blocking antibody 
is a feature of recurrent abortion, and is believed to be the consequence of 
a lack of antigenic disparity between partners. That is to say, the success 
of the pregnancy is dependent upon the generation of an immune reactivity. 
Some studies have been able to demonstrate sharing of HLA antigens between 
couples, in particular HLA-DR, but equally, other studies have not supported 
these findings. As reported earlier, there have been attempts to create 
maternal immunoreactivity and hence blocking antibody, by treating 
recurrent aborters with pooled lymphocytes at regular intervals. Whilst 
early indications indicate success, this procedure is not without risk. 
Perhaps the real problem however is identifying the reason why pregnancy 
in these patients was unsuccessful the first time, or indeed the second!
Progesterone insufficiency in early pregnancy has not received wide 
acclaim as a cause of recurrent abortion. It is difficult to determine the 
reason for a poor progesterone response, particularly if reference is made 
to the diverse means by which progesterone can be generated by 
biosynthesis. In pregnancy, progesterone synthesis, or lack of it, may be ' 
due to poor stimulation by human chorionic gonadotrophin. This in turn may 
be due to faulty trophoblast development around the periphery of the 
fertilised ovum. There may also be insufficient receptors for progesterone, 
on target tissues. Alternatively, it is possible that there is a poor
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progesterone response in the light of adequate levels of chorionic 
gonadotrophin. Perhaps less well documented is the observation by Bousquet 
and Fizet (1984), who illustrated that IgG blocking antibody reported above, 
absent in recurrent aborters but present in multiparous patients, could be 
restored when progesterone levels were corrected. It is believed that 
progesterone acts with steroid receptors on maternal lymphocytes, and in 
some way contributes to the inhibition of cellular cytotoxicity.
A third passible cause of recurrent abortion was identified in 
Chapter 3. If the results from this small study can be reproduced in 
larger studies, then the significance of the endometrial granulocyte is 
profound. This of course is dependent upon the role attributed to the 
endometrial granulocyte in human pregnancy. The evidence in favour of this 
cell being of leucocytic origin has been generated from several sources now 
and is supported also in this thesis (Chapter 5). Results from 
characterising this cell further, are less encouraging. However, with the 
current and prospective availability of monoclonal antibodies and 
immunocytochemical techniques, any restriction is likely to be relinquished 
in the near future.
The most likely role for the endometrial granulocyte in human pregnancy 
reflects that proposed for a cell with analogous characteristics studied in 
mice. If, as proposed in the factual/hypothetical account presented here 
for normal pregnancy, the endometrial granulocyte does control or inhibit 
interleukin-2 activity, then the suppression of cytotoxic lymphocyte 
activity is significantly dependent upon the number of effective endometrial 
granulocytes. If, as reported in Chapter 3, there are fewer endometrial 
granulocytes in the decidua of recurrent aborters, the consequences are self 
explanatory. Abortion is the result of cytotoxic lymphocyte activity
219
directed against- :fetal tissue expressing transplantation antigens, 
reminiscent of the cytotoxic lymphocyte activity with characteristics of 
interleukin-2 killer T cells seen in dying xenoerabryos (Clark 1985).
The appearance, distribution and proliferation of endometrial 
granulocytes seen in both secretory phase endometrium <ie conditions that 
pre-empt a state of pregnancy), and in early pregnancy (at implantation 
sites) support the important role postulated for this cell. The cells are 
abundant too, around decidual blood vessels - a port of entry for an immune 
response. The identification of Fc receptors for IgG on the endometrial 
granulocytes may perhaps, provide a means of stimulating cell activity, or 
of acknowledging in some way that IgG is at liberty to be selectively 
transferred across the trophoblast cell layer (there are receptors on 
villous trophoblast cells for this). Maternal IgG confers passive immunity 
at birth.
This thesis has served then to extend morphological studies on tissue 
from recurrent aborters. It has also, by various means, further 
characterised the endometrial granulocyte and in so doing, excluded some 
functions of this cell still in question. Chapter 5 has demonstrated a 
simple and effective way of confirming the cell type staining immunocyto- 
chemically in future investigations by counterstaining with phloxine- 
tartrazine. This technique allowed for the first time, definitive identity 
of the cell type under scrutiny. A way forward has been identified in 
respect of the endometrial granulocyte. With respect to relaxin, 
discounting the endometrial granulocyte as a source of relaxin synthesis, 
weakens views which suggest the decidua has more than a passive role in 
relaxin synthesis. Taking into consideration the quantitative studies on 
relaxin activity in decidua, it is likely that the corpus luteum of the
2 2 0
ovary is the sole provider of relaxin; the decidua having multiple receptors 
for this hormone, particularly evident in the first trimester.
Some of the diminishing group of 'unexplained' recurrent aborters can be 
directly attributed to the immunological deficiencies discussed above. 
Progesterone insufficiency, smoking, drinking (alcohol and caffeine) in 
excess, and anomalies like systemic lupus erythematosus, comprise the 
remainder of this group. The cause of some of the very early losses - 
manifest as blighted ova, are difficult to determine. However, together 
these factors contribute to the conclusion that the cause of recurrent 
abortion is multifactorial, and whilst clinically the condition exists , in 
reality it can legitimately be due to one of several entirely unrelated 
factors.
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